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ABSTRACT 
Oxidative damage is implicated in the pathogenesis of a number of diseases. Scientific 
research shows positive links between accumulated free radical damage and age-related 
diseases such as atherosclerosis and osteoarthritis. There is great interest in the 
possibility that the antioxidant potential of plant-derived compounds such as flavonoids 
may reduce the risk of developing these conditions. The aim of this study was to 
evaluate the antioxidant activity of selected non-food plants, traditionally used by 
herbalists in their treatment of osteoarthritis, using crude plant extracts and herbal 
tinctures, the most commonly used form of plant extract. As herbalists traditionally 
argue that herbs used in combinations or formulae will increase in efficacy when used 
together, an exploratory study was further carried out to investigate whether the 
antioxidant activity of two herbs tested in combination was greater than the sum of both 
herbs tested singly. 
Eight plants were selected for phytochemical analysis and investigation for antioxidant 
activity, based on discussions with clinic supervisors from four herbal medicine training 
clinics and a review of patient's case notes. The prescriptions from a pilot study 
investigating outcomes for the herbal treatment of osteoarthritis were used as selection 
criteria. 
Chromatographic analysis of each plant by TLC, HPLC and GCMS confirmed the 
presence of a number of flavonoids reported in the literature and of other compounds 
which were not possible to identify. Previous studies have established that certain 
flavonoids in vitro can exert pro-oxidant or antioxidant effects according to the 
concentration and presence of transition metal ions such as copper and iron. In view of 
the pro-oxidant effects observed for some extracts during biochemical analysis, metal 
analysis by ICP was carried out on the selected plant material to test for the presence of 
selected metal ions known to catalyse free radical reactions. ICP analysis showed the 
presence of most of the selected metals in all the plant samples. 
Several pathways, by which flavonoids and other plant phenolics may exert their effects 
on chemical oxidation have been identified, one of which is their free radical 
scavenging capacity to halt the propagation stage of lipid peroxidation. Since lipid 
peroxidation is implicated in the pathogenesis of osteoarthritis, assays to measure this in 
vitro were investigated and the following two assays selected: - lipid peroxide assay 
using the ferric thiocyanate method for the detection of peroxides and an assay using the 
stable free radical 1,1-diphenyl-2-picrylhydrazyl (DPPH) an established method for 
investigating the potential free radical scavenging activity of plant extracts. The lipid 
peroxide assay and method of analysis was re-evaluated and a standardised procedure 
established. 
All eight crude plant extracts showed marked antioxidant activity in both assays. 
Results for the crude plant extract in the lipid peroxide assay varied according to 
concentration, with 0.1% w/v giving the best results. The crude plant extracts in almost 
all cases seemed to be more active as antioxidants than tinctures (fluid extracts). When 
combinations of crude plant extracts were tested in pairs for antioxidant activity, results 
demonstrated synergy from five of the pairs and antagonism from three, approximately 
one third of the possible 28 two-herb combinations tested. The synergistic interactions 
observed could form the foundation for the future development of an antioxidant 
formula to offset the effects of free radical damage. 
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GENERAL INTRODUCTION 
Over the last few decades, research into the role and involvement of oxygen and 
nitrogen-generated free radicals in the pathogenesis of many of the degenerative 
diseases of ageing has advanced, with the establishment of a greater body of evidence in 
regard to the number of essential biological functions associated with these species and 
their specific contribution to disease pathology. A fine biological balance exists 
between the normal physiological formation of reactive oxygen and nitrogen species 
and their removal. An excess of oxidative stress can lead to the oxidation of lipids, 
DNA and proteins, which is associated with cell injury. Oxidation of the 
polyunsaturated fatty acids in cell membranes by reactive oxygen species can lead to a 
biologically significant process implicated in many cell and tissue abnormalities known 
as lipid peroxidation. The uncontrolled reaction of lipid peroxidation in cellular and 
sub-cellular membranes can cause or amplify pathological phenomena in degenerative 
diseases such as atherosclerosis, cataracts, cancer and osteoarthritis (Scott, 1995; Behl, 
1999). 
There is evidence that a diet high in antioxidants can favourably influence the primary 
`intrinsic' ageing process, as well as many of the secondary age-associated pathological 
processes (Aruoma, 1993). It has been suggested that a high consumption of fruits and 
vegetables is associated with a lowered risk of degenerative diseases like cancer and 
atherosclerosis and that dietary flavonoids can repair a range of oxidative radical 
damage sustained by DNA (Eastwood, 1999; Anderson et al, 2000). 
In recent years there has been an increased interest in the use of antioxidants for the 
treatment of certain conditions. Research to date has focussed mainly on diet-derived 
antioxidants like vitamins C and E and carotenes (Cao et al, 1998). Some of these 
studies suggest that combinations of synergistic antioxidants acting by complementary 
mechanisms are more effective than individual antioxidants. For example, vitamin E 
alone is relatively ineffective without ascorbic acid (Scott, 1995). Clinically, the 
current view is that single nutrient therapy is not as effective as multiple nutrient 
interventions, which are both more effective and safer (Crayhon, 2001). Since it is 
argued that medicinal herbs contain a multiplicity of chemical compounds which 
interact synergistically, it is suggested that whole plant extracts could help in alleviating 
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some of the problems associated with ageing processes which are linked to free radical 
damage. Consequently there is now a growing interest in the role of plant phenolics, 
especially flavonoids, which have demonstrated considerable antioxidant activity in 
vitro (Bohm, 1998). Although some isolated plant antioxidants can exhibit potent 
effects in vitro, it is not known whether whole herb extracts can replicate this action. 
Herbalists generally believe in plant synergy, i. e. that the active constituents are 
balanced within the plant and are made more (or less) powerful by the numerous other 
substances present. 
Herbal remedies have a long history of use in the treatment of chronic age-related 
conditions like osteoarthritis. Interestingly however, the contribution of their 
antioxidant activity to the prevention or treatment of these conditions has received little 
attention. The main body of antioxidant research has been carried out by the Food 
Industry on foods associated with dietary intake. Research into the therapeutic 
properties of medicinal plants that do not constitute a normal part of the diet, currently 
in its infancy, is desirable. 
The purpose of this thesis is to investigate a small selection of medicinal plants 
traditionally used by herbalists in their treatment of chronic degenerative disease, in 
particular osteoarthritis, with a view to identifying antioxidant activity that may be 
contributing to their efficacy. The Herbal Medicine Department of Middlesex 
University recently carried out a pilot outcome study on the treatment of osteoarthritis, 
mainly with positive results (Bell et al, unpublished work, 1999). Based on this study, 
in vitro investigations were conducted for this thesis on herbs selected from the herbal 
formulae used in this trial and from those generally used by herbalists for this condition, 
with a view to the preparation of whole plant extracts, to assess their antioxidant 
propensity and to identify any phenolic compounds within these extracts which may be 
contributing to their antioxidant effects. 
Synergy is a well known concept in phytotherapy and, although evidence is 
accumulating to show that it does occur in extracts and mixtures, there is still a paucity 
of reports in the scientific literature (Williamson, 2001). In addition to the assessment of 
single crude plant extracts for antioxidant activity, these extracts were also tested in 
pairs for any demonstrable synergistic interactions. 
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Tinctures used as herbal medicines are the most widely used pharmaceutical preparation 
form of plant origin, traditionally used by herbalists in their prescribing (Bilia, 2001). 
For this reason, as an adjunct to the assessment of the antioxidant activity of the crude 
plant extracts, a comparison of these extracts with herbal tinctures used therapeutically 
and prepared commercially by a phytopharmaceutical company was carried out, to 
assess the comparative antioxidant activity of the two types of extract. Selected 
phytochemical methods were used to identify the constituents, especially flavonoids, of 
the crude plant extracts and the tincture (fluid extracts). The resultant understanding of 
the chemistry involved may we hope lead to the development of more effective 
treatment strategies. 
Due to its biological significance in the pathogenesis of many age related diseases, 
assessment of antioxidant activity was focused on the propensity of the chosen plant 
extracts to inhibit lipid peroxidation. Athough flavonoids may exert a number of 
biological effects, their inhibitory effects on lipid peroxidation are considered to be their 
primary action (Bors, 1998). 
The ability of flavonoids to act as antioxidants or pro-oxidants in vitro is now well 
documented (Kessler et al, 2003). As pro-oxidant activity is often related to the 
presence of transition metal ions known to catalyse free radical reactions, all the 
selected plant parts were tested for the presence of metal ions. 
Following a review of the literature, the first part of this thesis concerns the selection, 
extraction and analysis of the identified plant material. The second part covers 
biochemical analysis by which the antioxidant propensity of the plant extracts were 
determined, with a view to the future development of an herbal formula based on any 
synergistic interactions observed between these extracts. 
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CHAPTER 1: FREE RADICALS, OXIDATIVE 
STRESS, AGE-RELATED DISEASES AND 
ANTIOXIDANTS 
1.1 FREE RADICALS, ENDOGENOUS DEFENCE AND 
THE ROLE OF OXIDATIVE STRESS IN HUMAN 
DISEASE 
1.1.1 Origins of the free radical theory 
Denham Harman, the pioneer of free radical research, first made the connection 
between free radical chemistry and ageing in the early 1950's. His initial life span study 
was presented as an abstract in 1956 at the American Federation of Clinical Research. 
It showed that 2-MEA (2 - mercaptoethylamine), a radiation protection compound 
synthesised by the Atomic Energy Commission, could extend life span by decreasing 
the level of free radical reactions. Little support was generated for his theories at this 
time. 
Harman proposed that a single common process, the production of free radicals, was 
responsible for ageing and death of all living things (Harman, 1956: 1992). This theory 
was based on the chemical nature of free radical reactions and their ubiquitous 
prominent presence in living systems (Harman, 1956). 
The free radical theory of ageing cites oxygen-derived free radicals as being responsible 
for age-associated impairment at cellular and tissue levels. This assumes that cellular 
ageing is associated with oxidative stress [an accumulation of pro-oxidant molecules in 
sufficient concentrations to outweigh antioxidant compounds (Sies, 1986)]. The theory, 
hitherto viewed with some degree of scepticism, gained credibility with the discovery 
by McCord and Fridovich (1969) of superoxide dismutase (SOD), a natural enzyme that 
destroys superoxide free radicals in the body. Subsequently, the free radical theory has 
inspired more research than any other concept in ageing, with evidence accumulating to 
support Harman's original conception that free radical damage is a major factor 
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contributing to the ageing process and possibly to many other age-related diseases such 
as atherosclerosis, cancer, arthritis and neurodegenerative diseases (Beckman and 
Ames, 1998; Wilcox et al 2004). 
40 years after its original conception, Beckman and Ames (1998) in a review entitled 
`The free radical theory of ageing matures' systematically reviewed the status of the 
free radical theory by categorizing the literature in terms of the various types of 
experiments that have been performed. They reported that a large body of consistent 
data had been generated to convince scientists that oxidants play an important role in 
ageing and the aetiology of many degenerative diseases. In the same year, Diplock et al 
(1998) also published an extensive review critically evaluating the science base that 
underpinned the argument that oxidative damage is a significant causative factor in the 
development of human disease and that antioxidants are capable of preventing or 
ameliorating these disease processes. Diplock et al (1998) concluded that there was 
sufficient evidence that mechanisms which involve free radicals are implicated at some 
stage of the development of human diseases, and that maintenance of well-being and 
health depends on the supply through the diet of antioxidants which modulate free 
radical processes in vivo. With the general acceptance of the theory that many diseases 
are related to oxidative stress, current research has mainly focused on the role of free 
radicals and antioxidants in specific diseases such as atherosclerosis (Maron, 2004; 
Cherubini et al 2005) and Alzheimer's disease (Engelhart et al 2002; Behl, 2005) and 
the protective effects of various groups of natural antioxidants further outlined in this 
review. 
After a period of flourishing research on oxidants and antioxidants, Azzi et al (2004) 
suggest that it is now time to critically re-evaluate the evidence. Speculation that many 
diseases are related to oxidative stress still needs to be supported by more secure data 
and the hope that antioxidants can prevent or cure a number of pathological situations 
also requires reconsideration. Azzi et al (2004) propose that antioxidants may only be 
useful if the molecular mechanism of the oxidative stress situation or imbalance is 
known especially since antioxidants can protect, or increase injury, depending on the 
situation. There is still insufficient knowledge on the pro-oxidant, oxidant and 
antioxidant properties of the various antioxidant supplements and growing evidence that 
free radicals are not only by-products, but also play an important role in cell signal 
transduction, apoptosis and infection control (Bonnefoy, 2002; Halliwell, 2005). Such a 
review has yet to be published. 
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1.1.2 Reactive oxygen species and free radicals 
1.1.2.1 Origins and targets of free radicals 
Much has been written over the last twenty years about the origins and nature of free 
radicals. To summarise, free radicals are atoms or molecules with unpaired electrons 
which are capable of independent existence. The unpaired electron creates an unstable 
and highly reactive molecule which, to stabilise itself, will take an electron away from a 
stable molecule. On the loss of an electron, this previously stable molecule becomes 
damaged (a free radical), setting up a destructive chain reaction, i. e. one radical 
begetting another (Fig. 1.1. ). 
ADDITION 
HYDROGEN ABSTRACTION 
ELECTRON DONATION 
ELECTRON TRANSFER 
ELECTRON REMOVAL 
TERMINATION 
X+Y -* [x-Y] 
x' + yH-- xH+Y 
X+y -3 y+ X+ 
x'-+'y--+X+j; 
X +yýX. +y+ 
X+X --+ X2 
X+y -+ xy 
Figure 1.1 Free radical reactions: how radicals beget radicals (Halliwell et at, 
1992). Free radicals are signified by a superscript dot, which indicates the 
presence of one or more unpaired electrons (Halliwell, 1994). 
Damage is permanent. Even if the free radical regains its electron from a stable 
molecule it does not regain its original form and function (Halliwell et al, 1992). These 
free radicals are collectively known as Reactive Oxygen Species (ROS) or Oxygen 
Derived Species and encompass both oxygen radicals and certain non-radicals that are 
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oxidising agents, or are easily converted into radicals (Aruoma, 1993; Halliwell, 1996). 
ROS may oxidise cell components such as lipids, nucleic acids (deoxyribonucleic acid 
and ribonucleic acid), carbohydrates and proteins, changing their structure and causing 
them to malfunction (Halliwell, 1996; Diplock et al, 1998). 
Biological membranes comprise the most common target for auto-oxidative and 
oxidative tissue injury and disease. A free radical attacks membrane lipids by removing 
a hydrogen atom from a polyunsaturated fatty acid (PUFA) side chain, leaving a carbon 
centred radical (CH-). Since a hydrogen atom has only one electron, removing it leaves 
behind an unpaired electron on the carbon. This combines with molecular oxygen, 
yielding a highly reactive peroxyl radical (COO-). By abstracting a hydrogen, peroxyl 
radicals are capable of attacking adjacent fatty acids, generating new carbon centred 
radicals, resulting in a chain reaction, known as lipid peroxidation (Santanam et al, 
1998) (Fig. 1.2). The cell membrane is destabilised by the accumulation of lipid 
hydroperoxides (-COOH), leading to interrelated derangement of cell metabolism, 
including DNA strand breakage, alterations in gene expression, damage to membrane 
ion transporters (resulting in "free" iron and copper ions) and other specific proteins, 
plus further peroxidation of lipids. This results in the production of mutagenic products, 
which burden the immune system, whilst threatening it by compromising immune cell 
function by similar damage (Halliwell, 1984: 1994; Snowdon et al, 1996). The 
production of hydrophilic lipid hydroperoxides in the hydrophobic regions of 
phospholipids will increase the permeability of the membrane and a damaged 
membrane allows easy entrance to bacteria and viruses (Lin, 1993, p19). Trans metal 
ions are important catalysts of free radical reactions and the release of "free" metal ions 
from sequestered sites can promote the formation of hydroxyl radicals (Halliwell, 
1987). Peroxyl radicals can attack not only lipids but also membrane proteins. They 
may also oxidise cholesterol (Halliwell, 1994). 
There is growing evidence that excessive production of free radicals can cause or 
exacerbate many human diseases (Halliwell, 1992; McCall and Frei, 1999). 
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LIPID PEROXIDATION 
Figure 1.2 An outline of the mechanism of lipid peroxidation adapted from 
Halliwell (1994) 
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1.1.2.2 Sources of free radicals 
Free radicals emanate from the environment, from other free radicals in chain reactions 
and from many normal biological processes in vivo. 
Free radical reactions are initiated continuously in cells and tissues in the body from 
both enzymatic and non-enzymatic reactions. Enzymatic reactions serving as sources of 
free radical reactions include those involved in phagocytosis, prostaglandin biosynthesis 
and in the Cytochrome P450 system. Free radicals also arise in the non-enzymatic 
reactions of oxygen with organic compounds as well as those initiated by ionising 
radiation (Beckman and Ames, 1998; Diplock et al, 1998). 
Sources of free radicals from the environment include tobacco smoke, ozone derived 
from air pollution, automobile exhaust emissions, excessive radiation, pesticides, deep- 
fried foods, hydrogenated oils and toxic metals which we inhale or digest (Pryor et al, 
1995; Diplock et al, 1998). The destructive free radical nitrogen dioxide (NOZ) for 
example, which is the result of a reaction between nitric oxide (NO') and oxygen (02), is 
formed in cigarette smoke and vehicle exhaust and has been implicated in respiratory 
illnesses and irreversible lung damage (Pryor and Stone, 1993; Halliwell, 1994; Van de 
Vilet and Cross, 2000). 
1.1.2.3 Formation of reactive oxygen species and actions in vivo 
A number of ROS are responsible for oxidative damage in the human body. Some of 
the more physiologically relevant free radicals include hydroxyl (OH'), nitric oxide 
(NO-), superoxide anion (02' ), peroxyl (R02) and nitrogen dioxide (NOZ ), and the 
non-radicals, hydrogen peroxide(H202), hypochlorous acid (HOCI), singlet oxygen 
(102), ozone (03) and peroxynitrite (ONOO-) which, although not technically oxygen 
free radicals, are included in this family due to their radical-forming capacity. 
Superoxide anion radical (OZ -), the one electron reduction product of oxygen (Halliwell, 
1994), is the most important source of initiating radicals in vivo formed from the 
reduction of molecular oxygen by many physiological processes either deliberately or 
accidentally. Phagocytic cells like macrophages deliberately produce superoxide to help 
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inactivate viruses and bacteria (Babior et al, 1973; Halliwell, 1994). Accidental 
production appears to be a chemical accident of which leakage from the mitochrondria 
during electron chain transport is one of the most important sources (Halliwell, 1994). 
Another source is `autoxidation' (a spontaneous oxidation reaction in which a molecule 
reacts with oxygen via a free radical, self catalysed route). The development of 
rancidity in fatty foods is an everyday example. Superoxide radicals can damage red 
blood cells, cause lung damage and degrade synovial fluid, possibly leading to arthritis 
(Lin, 1993, p76; Halliwell, 1994). Superoxide can also produce other ROS by a variety 
of reactions in biological systems (Beckman and Ames, 1998). 
Hydrogen peroxide (H202), a non-radical derivative of oxygen, is present in tap water, 
expired air, tea and coffee and edible oil (Arumoa, 1993). It is continuously produced in 
vivo as a consequence of many physiological processes including phagocyte activity, 
peroxisomal fatty acid metabolism and as a result of normal aerobic respiration where 
mitochondria consume oxygen, reducing it by sequential steps to produce water (H20). 
Hydrogen peroxide (H202) and superoxide (02 -) are inevitable by products of this 
latter process due to leakage of partially reduced oxygen molecules (Ames, 1993). 
When superoxide (02*-) radicals react with hydrogen peroxide (H202) in metal catalysed 
processes (Fenton reaction: iron catalysed Haber Weiss reaction), the highly reactive 
oxygen centred hydroxyl radical (OH') is formed (Beckman and Ames, 1998). This is a 
deadly free radical that can attack all molecules in the human body. Damage includes 
cell membrane destruction and genetic mutation (Lin, 1993, p76; Snowdon et al, 1996). 
These radicals account for a large part of the damage done by ionising radiation 
(Halliwell, 1994). In vivo any OR produced reacts at or close to its site of formation. 
The extent of the damage done therefore depends on where it is formed (Halliwell, 
1984). 
Neither superoxide (02') nor hydrogen peroxide (H202) alone can attack DNA or 
initiate lipid peroxidation (Halliwell, 1994). Interest has been mainly focused therefore 
on the ability of superoxide (02') and hydrogen peroxide (H202) to generate the 
dangerous OR species. 
Singlet molecular oxygen (102), another highly reactive non-radical resulting from 
energy transfer, is thought to be formed in vivo for instance, from exposure to sunlight 
or ozone (03) (Beckman and Ames, 1998; Diplock et al, 1998). Singlet oxygen can 
damage lipids, DNA and RNA. P carotene is a known quencher of singlet oxygen and 
is often prescribed for people who are abnormally photosensitive (Pearson and Shaw, 
1982, p. 422). 
Nitric oxide (NO'), only recently recognised as a biologically significant free radical, is 
a messenger molecule, generated from the amino acid L-arginine that participates in a 
broad range of physiologic processes such as vasodilation, bronchodilation, 
neurotransmission and microbial-host defence (Moncanda and Higgs, 1993; Van de 
Vilet and Cross, 2000). Nitric oxide (NO') contributes to the tissue injury mechanism 
but in excess it is highly cytotoxic (Beckman and Ames, 1998). 
Peroxynitrite (ONOO-) a powerful oxidant which can cause lipid peroxidation is formed 
when Nitric oxide (NO') reacts with superoxide (02'), (Beckman and Ames, 1998; Van 
de Vilet and Cross, 2000). 
1.1.2.4 Oxidants generated in vivo via mitochondrial electron transport 
The mitochondria are a principal source of endogenous oxidants (Beckman and Ames, 
1998). Mitochondrial respiration utilises oxygen to produce ATP via several reactions 
including the electron transport system. It appears however, that mitochondria electron 
transport leaks a small amount of electrons and one-electron reduction of oxygen to 
form 02' occurs. The spontaneous and enzymatic dismutation of 02' produces H202, 
thus a significant by-product of the actual sequence of oxidation-reduction reactions 
may be the generation of 02' and H202 (Beckman and Ames, 1998). 
In regard to ageing, Harman postulated that mitochondria might be largely responsible 
for changes usually attributed to the intrinsic ageing process. He considered that ageing 
changes associated with the environment and disease can be viewed as resulting from 
varying degrees of interaction between the environment and free radical reactions of 
mitochondrial and non-mitochondrial origin (Harman, 1972). This theory is still under 
investigation with a great deal of uncertainty still remaining in regard to the 
mechanisms, quantity and meaning of mitochrondrial OZ' generation in vivo (Beckman 
and Ames, 1998; Nohl et al, 1996). The fact that mitochondria posses their own genetic 
material (mt DNA) and that they lack mt DNA repair enzymes and protective histones 
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makes them one of the prime targets for the ROS generated continuously by the 
mitochrondria (Sastre et al, 1999). Collins, (1999) in a review on oxidative DNA 
damage, antioxidants and cancer states however, that the amount of mitochondrial DNA 
(mt DNA) is so small relative to the DNA of the nucleus that its contribution to the 
whole is negligible (Collins, 1999). The mitochondrial damage caused by ROS and 
concomitant decline in ATP synthesis seems to play a key role not only in ageing but 
also in the fundamental cellular process of apoptosis (Miquel, 2002). Scientists appear 
to be in agreement that as the site of respiration, mitochondria must have a particularly 
high concentration of reactive oxygen and damage to their DNA might have important 
consequences in cellular ageing (Kowald, 2001; Wei et al, 2001). 
1.1.2.5 Transition metals 
Transition metal ions are important in the production of ROS. The ability of metal ions 
to donate and accept single electrons is the basis for the formation and propagation of 
many ROS. Both copper and iron gain or lose electrons during redox reactions, cycling 
from reduced to oxidised forms and back. Most iron in the body is stored in the oxidised 
(ferric form). 
Fe 2+ (reduced iron) 41 Fe 3+ (oxidised iron) 
Cu+ (reduced copper) -4 = Cu2+ (oxidised copper) 
In the presence of transition metal ions H202, which is continuously produced in vivo, 
easily breaks down to produce the OR radical. This is known as the Fenton reaction, 
which can also occur with copper and some other metal ions and is usually written as 
follows (Halliwell et al, 1992). 
H202 + Fe 2+ -3 OR + 01-1- + Fe 3+ 
Many antioxidants, including vitamin C and some flavonoids can provide the electron 
source for the redox recycling of transition metal ions which can lead to the formation 
of OR by the Fenton reaction (Boik, 2001, p. 168). 
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Transition metal ions such as iron and copper can also participate in the production of 
the OR radical by catalysing the steps in the Haber-Weiss reaction shown below, an 
interaction between H202 and 02 - (Boik, 2001, p. 169). 
02" -+ H202 Fe -* 02 + OH* + OH- 
Metal sequestration is an important part of extracellular antioxidant defence. As much 
iron or copper as possible in the human body is bound to transport proteins or functional 
proteins such as transferrin or haemoglobin (iron) and ceruloplasm and albumin 
(copper). Metals bound to these proteins are inactive or only weakly active in 
catalysing OH' production. Although the availability of iron and other transition metals 
to stimulate radical reactions in vivo is very limited, cellular injury appears to increase 
the availability of metal ions by possibly interfering with their storage vacuoles or by 
causing vacuole lysis thus exacerbating damaging radical reactions (Halliwell, 1984). 
There is established evidence for the occurrence of the Fenton and Haber Weiss 
reactions in vitro. Although there is evidence supporting these mechanisms in vivo 
variations in the actual chemistry is likely to occur (Boik, 2001, p. 169; Liochev, 1996). 
1.1.3 Endogenous protection 
Since free radicals are intermediates in many normal and necessary metabolic processes, 
we have evolved endogenous antioxidant defence mechanisms to protect us against their 
tissue-damaging effects. They include enzymes such as superoxide dismutase (SOD), 
catalase and glutathione peroxidases which metabolise superoxide, hydrogen peroxide 
and lipid peroxides, amino acids and proteins, e. g. glutathione, bilirubin, ubiquinol 
(coenzyme) and uric acid (Heng-long et al, 2000) and copper and iron transport to avoid 
Fenton chemistry (Ames et al, 1993; Halliwell, 1996). These are supplemented by 
repair antioxidants based on proteases, lipases, transferases and DNA repair enzymes 
which are able to repair the damage caused by unscavenged ROS (Pietta, 2000). 
Antioxidant nutrients like ß carotene (provitamin A), vitamin C and vitamin E and non- 
nutrient compounds like plant flavonoids, although not made in the body, contribute to 
its antioxidant defences (Knight, 2000). Trace elements from the diet like selenium, 
copper and zinc are essential co-factors of a number of enzymes with antioxidant 
function. Selenium is a vital component of glutathione peroxidase and zinc and copper 
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are components of SOD (Boik, 2001, p. 163-4 and p. 171). In healthy individuals the 
natural endogenous antioxidant defences are generally adequate to neutralise stray 
radicals, but with age, concentrations of these decrease, leading to increased amounts of 
free radical damage and chronic "age related" disease like atherosclerosis, Alzheimer's 
disease, arthritis, cataracts and cancer. Indeed, excessive oxidative stress may result at 
any age, causing serious damage to health when antioxidant defences are unable to cope 
with the production of free radicals from physiological stress or from the action of 
certain toxins (Halliwell, 1994; Spiteller, 2001 a/ b). 
1.1.4 Oxidative stress, age-related diseases and antioxidants 
There is now evidence that mechanisms that involve free radicals are implicated at some 
stage of the development of many human diseases (Diplock et al, 1998; Tiwari, 2001). 
The following are several of the chronic disease conditions associated with advancing 
age where research has implicated free radical involvement in their aetiology and 
pathogenesis. 
1.1.5 Cardiovascular disease 
Degenerative heart and blood vessel disease is one of the most common and serious 
effects of ageing. The gradual build up of atheromatous material in plaques in the walls 
of coronary arteries is initially asymptomatic but may lead to angina. The plaques may 
rupture and thromboses become superimposed. This is the usual basis for the acute 
syndromes of unstable angina and myocardial infarction. If these plaques calcify, 
arteriosclerosis occurs, plus the risk of cerebral infarction (stroke), leading to severe 
disability or death (Brown, 1996, p. 187-196). 
1.1.5.1 The role of lipid peroxidation in atherosclerosis 
A major development in cardiovascular disease was the finding that oxidation reactions 
played a central role in atherogenesis involving lipids in the arterial wall and serum that 
yield peroxides and other substances (Harman, 1992; Ames et al, 1993). Fatty streaks 
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formed in the subendothelial space by lipid deposits are one of the earliest lesions of 
atherosclerosis (Matsuoka, 2001). Lipids, as already outlined, are especially susceptible 
to free radical attack. Low-density lipoproteins (LDLs) comprised of lipids and proteins 
carry the majority of the cholesterol in the blood. ROS interact with the lipid component 
of the LDL particle, peroxidatively modifying it. Oxidised LDLs are cytotoxic and in 
quantity infiltrate and help to sustain an inflammatory reaction in the arterial vessel wall 
(Estubauer et al, 1991; Basu, 1999; Cherubini et al, 2005). Oxidised LDLs are more 
readily taken up by macrophages to form foam cells which play an important role in 
forming the atheromatous plaque. Foam cells may also come from medial smooth 
muscle cells that migrate to the intima of the arterial wall where they proliferate and 
contribute to the formation of the plaque, along with oxidation products including 
damaged lipoproteins and the cholesterol they are carrying. Much of the lipid in 
atheroscleroic plaques is composed of LDL particles (Mason, 1997; Diplock et al, 1998; 
Cherubini et al, 2005). The plaque continues to proliferate by a number of complex 
mechanisms that include large accumulations of extracellular lipids and connective 
tissue changes involving the deposition of collagen and elastin. Cholesterol, LDLs and 
other lipids deposited into the injured area become oxidised further increasing free 
radical activity and resulting in adherence of platelets to plaques (Kritchersky and 
Kritchersky, 1999). These attract red blood cells that haemolyse, leaking iron and 
copper, which are powerful autoxidation catalysts (Herbert et al, 1996; Parke, 1999). 
With the increase in size of the plaque, blood flow can become seriously compromised 
initiating thrombosis and aneurysm formation (Basu, 1999; Reed, 2002). 
1.1.5.2 Effects of antioxidants on cardiovascular disease 
Much research has been carried out in regard to the relationship between cardiovascular 
disease (CVD) and antioxidant status. Antioxidants may have a role to play in the 
atherosclerotic component of CVD by protecting both PUFAs and LDL cholesterol 
from oxidation. Epidemiological studies suggest preventive effects towards atherogenic 
lesions to be associated with an increased intake of lipophilic antioxidants such as 
vitamin E, which appears to inhibit the oxidation of LDL (Mason, 1997; Cherubim et al, 
2005). Low serum levels of antioxidant vitamins and minerals like selenium are 
inversely correlated with an increased risk for developing atherosclerosis (Kok, 1991; 
Diplock, 1993; 1998; Rimm et al, 1993). Established research carried out on the 
relationship between diet and disease has indicated that a large number of non-nutrient 
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components like plant flavonoids may also be contributing to antioxidant activity 
(Hirano et al, 2001; Vinson et al, 2001; Maron, 2004). However, because research has 
focused mainly on dietary sources of flavonoids, like fruit and vegetables, which 
contain other potentially protective antioxidant substances like micronutrients (vitamins 
and minerals), it has been difficult to state with certainty that flavonoids play a 
protective role against CVD. At least three studies however, have suggested a role for 
flavonoids in the prevention of coronary heart disease, (Hertog et al, 1993: 1995; Keli et 
al, 1996) and research on some medicinal plants have established positive anti- 
atherogenic effects due to their flavonoid constituents. (Miquel et al, 2002; Zhang et al, 
2001). 
1.1.5.3 Beneficial effects of flavonoids against cardiovascular disease 
The use of the plant Hawthorn (Crataegus oxyacantha) as a cardiovascular medicine is 
a modern herbal development that began with the discovery of a flavonoid-like complex 
of oligomeric procyanidins and other flavonoid compounds (Reweski and Lewak, 1967; 
Loew, 1994). Their potent antioxidant properties, which help to combat the damaging 
effect of free radicals on the cardiovascular system, assist the reduction of the risk of 
atherosclerosis (Hertog, 1997; Boughon, 1998; Fuhrman and Aviram, 2001). Two 
mechanisms have been proposed for their cardioprotective action; direct protection of 
human LDL from oxidation or indirect protection via the prevention of radical induced 
oxidation of a-tocopherol, a primary antioxidant known to protect human LDL from 
oxidative modification (Zhang et al, 2001; Maron, 2004). 
Turmeric (Curcuma longa), currently the subject of much research for a wide range of 
modern day health problems, although revered in India for its therapeutic properties for 
thousands of years, is a relative newcomer to Western herbal medicine. The anti- 
atherogenic effects of this plant have recently been demonstrated in vivo by the daily 
intake for 60 days of turmeric equivalent to 20mg of the phenolic antioxidant curcumin 
by 30 healthy volunteers ranging in age from 40 to 90 years, which resulted in a 
decrease in total blood lipid peroxides as well as reduced LDL and HDL lipid 
peroxidation, determined via the measurement of serum lipid peroxide levels from 
blood tests taken before and after the trial (Ramirez-Bosca et al, 1997). 
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1.1.6 Cancer 
Cancer is the uncontrolled virtually autonomous growth of abnormal cells that can arise 
in any organ or tissue of the body. A transformed neoplastic or cancerous cell is simply 
a once-normal cell which continues to grow and multiply without limitation. This may 
be due to a multiplicity of endogenous and exogenous factors, including oxidative 
stress, which initiate a change in the cell's DNA, resulting in a tumour. Only 
transformed cells that escape detection by the immune system have the opportunity to 
become tumours. The immune system usually isolates and destroys the abnormal cells 
before they proliferate enough to be noticeable as a tumour. Free radicals can 
compromise immune cell function reducing immune responses which can allow the 
abnormal cells to continue growing (Ames et al, 1993; Boik, 2001). The question of 
why the risk of cancer increases with age is an interesting one. Harman, (1993) 
suggests that this increase is probably due in part to the increased level of endogenous 
free radical reactions with advancing age and inadequate antioxidant defences resulting 
in an increased rate of mutations in proto-oncogenes (involved in normal cell growth 
and development) and tumour-suppressing genes (suppress cell proliferation) coupled 
with the progressive diminishing capacity of the immune system to eliminate 
transformed cells. 
1.1.6.1 The role of ROS in carcino eg nesis 
Carcinogenesis is a complex process with the in vivo generation of ROS leading to 
oxidative DNA damage being a significant contributory factor (Collins, 1999). 
A critical factor in mutagenesis is cell division. Cancer is rare in non-dividing cells. 
When the cell divides damage to the cell DNA can give rise to mutation. Oxidative 
damage to DNA has been demonstrated in vitro and in vivo showing that ROS damage 
to cells may contribute to carcinogenesis in a number of ways (Diplock et al, 1998). 
They may cause: - 
structural alterations in DNA such as gene sequence amplification (Halliwell, 
1996); 
" translocations and base pair mutations [the oxidised form of guanine has altered 
base-pairing properties (Collins, 1999)]; 
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" activation or inhibition of signal transduction pathways - over expression of a 
growth factor receptor is commonly involved in the majority of squamous cell 
carcinomas of the lung (Robbins, 1995, p112-3); 
abnormal cell-to-cell communication that allows unrestricted cell proliferation 
(Halliwell, 1996); 
" interference with genes that modulate cell growth preventing programmed cell 
death by apoptosis or necrosis (Robbins, 1995, p. 114); 
" damage to proteins such as DNA repair enzymes compromising repair of a 
mutation once it has occurred. (Wiseman et al, 1995; Wiseman and Halliwell, 
1996; Halliwell et al, 1996). 
The immune system keeps an ever-present vigil to protect us from invading organisms 
and remove damaged, aged or altered cells which have the potential to cause cancer. 
White blood cell membranes, like all cell membranes, are composed of lipids, which 
are highly susceptible to free radical attack. Numerous links have now been 
established between free radical reactions and altered immune cell function (Niki et al, 
1991). 
ROS can decrease the membrane fluidity of white blood cells, significantly reducing 
their function (Baker and Meydani, 1994). Loss of membrane fluidity has been directly 
related to the decreased ability of lymphocytes to respond to challenges of the immune 
system (Bendich 1994; 1999) Free radicals can also damage the DNA of immune cells 
resulting in mutations and reduced cell function (Fabiani et al, 2001). Ironically, free 
radical damage forms the basis of some chemotherapy drugs and radiation used in 
cancer treatment (Cottier et al, 1995). Well-documented side effects like hair loss, 
reduced immunity and gastro-intestinal disturbances result from the barrage of free 
radicals that indiscriminately destroy healthy cells as well as malignant ones (Buckman, 
1996, p. 305). 
1.1.6.2 Antioxidants and cancer 
Epidemiological data provides strong evidence of a cancer prophylactic effect of high 
intakes of vegetables, fruits and whole grains containing high levels of antioxidant 
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micronutrients and phytochemicals (Diplock et al, 1998; Eastwood, 1999; Kaur, 2001; 
Meydani, 2001). Some naturally-occurring phytochemicals such as phenolic/ 
polyphenolic compounds, e. g. epigallo catechin gallate from green tea (Bushman, 1998; 
Nie, 2002), curcumin from turmeric (Nagabhushan, 1992; Sriganth and Premalatha, 
1999), genestein from soy and red clover (Lian, 1999; Ren, 2001) and silymarin from 
milk thistle (Jiang, 2000), may reduce cancer risk according to initial trials (Weiner, 
1994; Lamson and Brignall, 1999). 
There have been a number of bioassay-guided searches for cytotoxic antitumour agents 
in plants especially those traditionally used in folk medicine for this purpose (Harborne 
and Williams, 2000; Williamson, 2001). Hartwell, (1971) in his survey, entitled `Plants 
against Cancer' catalogues hundreds of plants from around the world that have 
historically been used for treating cancer in various cultures. Many chemotherapeutic 
drugs currently in use were first identified in plants, including taxol, vinblastine and 
vincristine. 
1.1.6.3 A traditional herbal formula used by cancer patients 
One of the herbal products most widely purchased by cancer patients is `ESSIAC', 
originally developed as a folk medicine by the Native American Ojibway Indians which 
had particular application to auto-immune diseases. In the early 1920's a native healer 
passed the formula to a Canadian nurse called Rene Caisse (Essiac is Caisse spelled 
backwards) who successfully, it is claimed, used it to treat cancer. Nurse Caisse reduced 
the original formula to what she considered the most important ingredients: burdock 
root (Arctium lappa), turkey red rhubarb (Rheum palmatum), slippery elm bark (Ulmus 
rubra) and sheep sorrel (Rumex acetosella). No in vivo studies or clinical trials using 
the whole tonic have been reported to date. Evidence of anticancer activity for the 
Essiac formula is limited to anecdotal reports gathered from people who have used it 
during the decades of its popularity. In vitro, this formula has been shown to have 
strong antioxidant action and contains trace elements, minerals, and phytoestrogens 
(Flora Manufacturing & Distributing Ltd., cited in Tamayo, 2000). 
Quite a body of in vitro studies exists on the individual herbs in ESSIAC or the isolated 
components of these herbs. Burdock root in particular, contains five flavonoid-type 
antioxidants and several polyphenols that are more effective as antioxidants than 
vitamin C (Maruta et al, 1995; Tamayo et at, 2000). Slippery elm bark is reported to 
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contain high concentrations of antioxidants and sheep sorrel contains several 
anthraquinones including emodin, rhein, alizarin and aloe emodin which are effective 
antioxidants and radical scavengers in vitro (Malterud et at, 1993). Proponents of the 
Essiac formula claim that its effect is dependent of the herbs being present in the correct 
proportions in accordance with the original formulation and that, although difficult to 
demonstrate, its efficacy may be the synergistic interaction of all four herbal 
constituents used together that contribute to the treatment effect (Tamayo et al, 2000). 
Although there are no data on the possible synergistic effect of individual herbs in the 
final formula, research on the individual herbs may not be applicable to the whole 
preparation (Snow and Klein, 1999). Several new in vitro studies showing the effect of 
Essiac on a selection of cancerous cell lines indicate that this formula may be able to 
inhibit tumour growth while enhancing immune response to antigenic stimulation 
making it especially valuable for immune-suppressed individuals. Further research is 
still urgently required however, to elucidate in vivo activities (Ottenweller et at, 2004; 
Tai et al, 2004). 
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1.1.7 Neurode2eneration (Alzheimer's disease 
Alzheimer's disease (AD), one of the 21st century's growing health threats, is a 
neurogenerative disorder which causes progressive and irreversible decline in the ability 
to remember, learn, think and reason. Alzheimer's disease is the most common 
neurological disorder in old age and despite extensive research there still remains no 
effective treatment or prevention for it (Newton, 1998). 
1.1.7.1 The role of ROS in Alzheimer's disease 
Due to the economic implications for the Health Care System of the increase in our 
elderly population, with 1 in 5 over the age of 80 currently affected by Alzheimer's 
disease, research into the aetiology and pathogenesis of this disease has intensified over 
the last 15 years. There is now a better understanding of the pathogenesis of this tragic 
condition and possible areas of research into its prevention (Ferry, 1996). 
In the histopathology of AD many signs of oxidative reactions, including lipid 
peroxidation, can be found leading to an oxidative stress hypothesis (Zhou et al, 1995). 
Neuropathologically the dementia of Alzheimer's disease is associated with senile 
plaques, neurofibrillary tangles and loss of nerve cells from the cerebral cortex. There 
is also a change in the brain's chemistry, i. e. neurotransmitter deficits resulting from the 
neuronal degeneration. 
Senile plaques are spherical structures with a dense core of a protein called ß-amyloid, 
surrounded by the decaying remains of nerve cell terminals (Murphy, 1992). 
(3-amyloid can be neurotoxic and this toxicity is mediated by peroxides and by the lipid 
peroxidation of membrane lipids leading to lysis of the cell, thus generating an overall 
oxidative microenvironment for the nerve cells resulting in neuronal loss (Behl, 1999). 
ß-amyloid has been isolated, sequenced and found to be a variable length protein of 40 
- 42 amino acids which has a tendency to aggregate into insoluble fibrils which in turn 
form the basis of plaques (Murphy, 1992; Glenner et al, 1994). Studies have shown that 
it is a breakdown product of a much larger protein, amyloid precursor protein (APP), 
which is inserted into the cells outer membrane so that a short sequence protrudes into 
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the cell and a much longer sequence is left outside. This outside segment is cleaved by 
enzymes into a number of small segments, later broken down by proteases. One of 
these segments is ß- amyloid, which for unknown reasons is not broken down, but 
accumulates into plaques (Murphy, 1992; Selkoe, 1998). From his very early studies on 
mice Harman (1993) postulated that APP was one of the unknown substances from cell 
surface origin inhibited by antioxidants implicating an oxidative process. He surmised 
that by slowing down the rate of formation of fibrils they had more time to be 
proteolysed before aggregating to form amyloid (Harman, 1993). The generation of 
free radicals by ß-amyloid has now been directly demonstrated during research 
supporting the oxidative stress hypothesis (Harris et al, 1995; Martins et al, 1999). It is 
considered likely that one or more free radical reactions are involved in the 
pathogenesis of AD. 
1.1.7.2 Antioxidants and Alzheimer's disease 
Antioxidant supplementation has naturally formed the basis of much research, with 
preliminary evidence suggesting that antioxidants may have a protective effect against 
the development of AD (Flynn and Ranno, 1999; Behl, 2005). The antioxidant herb 
Ginkgo biloba and vitamin E have both demonstrated the ability to help relieve some of 
the symptoms of AD in the early stages and slow its progression (Wolff, 2001; 
Grundman, 2000). Several studies involving the daily administration of Ginkgo biloba 
to mildly-demented patients resulted in measurable improvements in memory, attention 
and mood according to caregivers compared to those taking a placebo (Hofferberth, 
1994; Kanowski et al, 1997; Le Bars et al, 1997; Kanowski and Hoerr, 2003). Due to 
the nature of AD, Ginkgo biloba may be able to slow the progression of early stage 
disease, but it is considered unrealistic to expect significant results in more advanced 
patients (Wolff, 2001). 
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1.1.8 Osteoarthritis 
Osteoarthritis, a joint disease strongly associated with ageing and probably one of the 
commonest disorders to affect homo sapiens, continues to baffle scientists as to its 
precise causation and pathophysiology. 
The modern view of OA is that it is neither a disease nor a single condition. It is now 
viewed as the dynamic repair process of synovial joints triggered by a variety of 
mechanical, metabolic or constitutional insults (Doherty et al, 2001). Sometimes a clear 
cause such as trauma may be apparent (secondary OA) but more often these insults 
remain unclear (primary OA). All the tissues of the joint such as cartilage, bone, 
synovium, ligament and muscle, depend on each other for health and function. Insult to 
one impacts on the others, resulting in a common OA phenotype affecting the whole 
joint (Doherty et al, 2001). 
1.1.8.1 The role of ROS in osteoarthritis 
Free radicals are now being considered as one of the contributory factors to the 
development of OA (Ames et al, 1993; Tiku et al, 2000). ROS and the products of their 
reactions were shown by early research to decrease the fluidity of synovial fluids, 
consequently reducing their function (Merry et al, 1989: Merry, 1991). Excessive free 
radicals in the synovial fluid can destroy the synovium, causing loss of joint fluid and 
support between bones. The resulting inflammation can trigger an inflammatory 
response resulting in the generation of more free radicals exacerbating the disease 
process (Henrotin et al, 1992). 
More recent studies report high levels of superoxide radicals in the exudates of patients 
with active synovitis, and evidence of oxidative DNA damage to cartilage and lipid 
peroxidation of chrondrocytes, fuelling the current suggestion that free radical damage 
may be the molecular mechanism of OA (Zhu et al, 1998; Kucera et al, 1998; Tiku et at 
2000). Tiku et al (2000) suggests that naturally occurring radicals like superoxide and 
nitric oxide, shown to be produced by chrondrocytes, could combine, resulting in the 
formation of peroxynitrite, a powerful oxidant known to initiate lipid peroxidation. 
Collectively, chrondrocyte lipid peroxidation plays both a physiological and 
pathological role in cartilage. Thus, a state of uncontrolled oxidative stress leading to 
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unbridled oxidation of cartilage collagen could make it more brittle and prone to 
mechanical fatigue failure, thereby instituting osteoarthritis. 
1.1.8.2 Antioxidants and osteoarthritis 
The role for dietary antioxidants in the prevention of OA is still unclear. In the 
Framington knee OA cohort study, vitamin C was shown to reduce the progression and 
development of knee pain, but there was no evidence to suggest that increased dietary 
intake of antioxidants is generally protective against the incidence of knee OA (Felson 
et al, 1995; McAlindon et al, 1996). 
Herbal remedies have a long history of use in the treatment of `arthritis' (Meletis, 1999; 
Aleves-Avela, 2001). The efficacy of many of these traditional remedies such as devil's 
claw (Harpagophytum procumbens), turmeric (Curcuma longa) and ginger (Zingiber 
officinale) on both the progression and pain associated with OA are now being 
confirmed by research. Proposed mechanisms of action all include antioxidant activity 
(Grant, 2000; Leblan, 2000; Marcus and Suarez-Almazor, 2001). 
OA is not exclusive to humans. It can also affect other animals including dogs. A large 
pharmaceutical 
for arthritic dog 
longa and Curc 
in vitro (Grant and Schneider, 2000; Phytopharm, 2001). Although evaluation of 
treatments for canine OA is difficult, results of a randomised, double blind, placebo- 
controlled study using this remedy to treat 61 dogs, reported an improvement in at least 
56% of those treated with turmeric extracts (Phytopharm, 2001). 
1.1.9 Reactive oxygen species and human disease 
As research into the role and involvement of oxygen and nitrogen-generated free 
radicals in the pathogenesis of many human diseases advances, a greater body of 
evidence is being established in regard to the number of essential biological functions 
associated with these species and their specific contribution to disease pathology. A 
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fine biological balance exists between the normal physiological formation of ROS/RNS 
and their removal. An excess of oxidative stress can lead to the oxidation of lipids, 
proteins and nucleic acids which is associated with cell injury. The biochemistry of 
oxidative pathobiology is complex. Some disease processes like carcinogenesis can be 
directly caused by ROS damage to biological molecules, whereas in others, like 
rheumatoid arthritis and ulcerative colitis where the disease process is characterized by 
inflammation, oxidative stress is not the cause of, but may be a contributory factor to 
the disease pathology by perpetuating tissue injury (Halliwell et al, 1992). 
Besides playing a role in the pathogenesis of many `age related' disorders, recent 
research suggests that free radicals may be implicated in a considerable number of other 
disorders. The following is a short representative list of human diseases in which 
oxidative mechanisms has been suggested may play an important role. 
Table 1.1 Range of human diseases in which oxidative damage have been claimed 
to play a role in the pathogenesis 
Category: Examples: 
Visual disorders Cataract and age-related macular degeneration (Diplock et al, 
1998) 
Neuronal diseases Parkinson's disease (Jenner et al, 1992), schizophrenia 
(Smythies, 1998; Reddy and Yao, 1999) 
Shock Septic, haemorrhagic and burnshock are all associated with 
severe oxidative stress and depletion of antioxidant defences 
(Goode and Webster, 1993) 
Respiratory diseases Asthma, lung cancer, cystic fibrosis, especially during 
exacerbations, exposure to environmental pollutants (03, NO2, 
SO2, auto exhaust), emphysema (Van der Vliet and Cross, 2000) 
Digestive system Inflammatory bowel disease, ulcerative colitis (Grisham, 1993) 
diseases 
Muscular Skeletal Rheumatoid arthritis (Halliwell et al, 1992) 
Infectious diseases AIDS, malaria (Halliwell and Gutteridge, 1999; Mollace et al, 2001) 
Endocrine disease Diabetes (Paolisso et al, 1995) 
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1.2 THERAPEUTIC USE OF ANTIOXIDANTS 
1.2.1 Introduction 
The accepted definition of an antioxidant is a molecule which, when present in small 
concentrations compared to the biomolecules they are supposed to protect, can prevent 
or reduce the extent of oxidative destruction of biomolecules (Halliwell 1990). In 
recent years there has been an increased interest in the application of antioxidants to 
medical treatment as information is constantly gathered linking the development of 
human diseases to oxidative stress. Because free radicals play many important 
physiological functions however, if antioxidants were stored in the body in such levels 
that all free radicals were neutralized many important body functions might fail. 
1.2.2 Mechanisms of action 
Two principle mechanisms of action have been proposed for antioxidants (Vaya and 
Aviram, 2001). The first is a chain-breaking mechanism, by which the primary 
antioxidant donates an electron to the free radical present in the system (e. g., lipid 
radical) forming a new radical, more stable than the initial one. Primary antioxidants 
include compounds such as flavonoids, tocopherol and ascorbic acid. The second 
mechanism involves removal of ROS initiators (secondary antioxidants) by quenching 
chain-initiating catalysts. This second mechanism can be accomplished by deactivation 
of high-energy species like 02, -, absorption of UV light, chelations of metal catalysing 
free radical reactions, or by inhibition of peroxidases, such as xanthine oxidase or 
lipoxygenases (Vaya and Avrim, 2001). Any compound that can react with the 
initiating radical, inhibit the initiating enzyme, or reduce the 02 level without generating 
ROS, can be considered as a secondary antioxidant. 
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1.2.3 Antioxidants and lifespan 
Scientists have revealed an interesting relationship between longevity and factors of 
ageing in humans and other mammals. The level of antioxidants detected in different 
mammals is directly related to the species' expected life spans. Humans, who were 
found to have the highest level of antioxidants, had the longest life expectancies of all 
mammals (Cutler, 1991). 
Experimental studies have also shown that the life span of laboratory animals can be 
prolonged with antioxidants (Short et al, 1997). In some of his early studies involving 
mice, Harman, (1968) demonstrated that by feeding weaned mice on diets containing 
0.5 - 1% antioxidants their life span was increased 30-40%. He equated this in human 
terms to raising the human life span from 73 to 95 years (Harman, 1968; Pearson and 
Shaw, 1982, p. 116). He used synthetic antioxidants such as Sevitoquin (commonly 
used as a stabiliser in chicken food) and butylated hydroxy-toluene (BHT) an 
antioxidant food additive. His choice of these substances led to some scepticism 
towards the relevance of his work. At this time Harman's free radical theory of ageing 
was still a relatively new concept and his initial research with synthetic, rather than 
recognised dietary antioxidants did not achieve a convincing outcome. It has also been 
suggested that the taste or smell of the synthetic antioxidants may have reduced the 
animals' food intake, which is known to retard ageing in mammals (Scott, 1995). 
Harman (1987) observed quite early on that an antioxidant capable of inhibiting 
essential free radical reactions would become toxic beyond some level of intake, e. g. 
BHT is toxic in the mouse when added to the diet at levels above about 0.5% by weight 
(Horrum, Harman and Tobin, 1987). Studies on the lifespan of mice receiving various 
supplement antioxidants have continued. Unfortunately, no lifespan studies appear to 
have been carried out on popularly available antioxidants such as proanthocyanins, 
lycopenes, bioflavonoids and other antioxidants from plant sources (Donaldson, 2005). 
1.2.4 Epidemiological studies 
Research to date has centred on diet-derived antioxidants such as vitamins C and E and 
carotenes. In a review by Diplock et al, (1998) it was concluded that although 
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epidemiological studies generally support the hypothesis that these vitamins may play a 
beneficial role in reducing the risk of several chronic age-related diseases, findings for 
human intervention studies are inconsistent. Many synthetic antioxidants, although 
more efficient in vitro than biological antioxidants of the body defence system, produce 
unwanted side reactions unrelated to their biological functions (Rekka and Kourounakis, 
1991). P carotene for example can both inhibit or exacerbate the growth of cancer cells, 
depending upon dosage (Lowe et al, 1999; Wang and Russell, 1999). A large human 
intervention trial carried out on smokers to investigate the efficacy of ß carotene and 
alpha-tocopherol supplementation in reducing the incidence of lung and other cancers 
produced unexpected results. Not only did the smokers show no benefit, but also an 
18% increase in the incidence of lung cancer was observed among those who only 
received ß carotene (Omenn et al, 1994: 1996; Collins, 1999). P carotene in its 
unoxidized form appears to be an anti-carcinogen, but its oxidised products appear to 
facilitate carcinogenesis. The carcinogenic response in lung tissue to high dose ß 
carotene observed in the trial is thought to be caused by the instability of ß carotene in 
the ROS rich environment of the lungs, particularly in cigarette smokers (Crayhon, 
2001; Wang and Russell, 1999). This is especially possible because smoke decreases 
tissue levels of other antioxidants such as ascorbic acid and alpha-tocopherol, which 
normally have a stabilising effect on the unoxidised form of ß carotene (Crayhon, 
2001). 
Dr. Jeff Evans oncologist, Cancer Research Campaign, University of Glasgow points 
out that even in successful human trials using ß carotene supplementation, protection 
lasts only as long as the supplement continues and ends on its discontinuation (Evans, 
2001). In respect of cancer therefore, for which there is a large body of research, it 
would seem that antioxidant vitamins used alone especially in doses considerably higher 
than normal dietary intake can produce beneficial, detrimental or insignificant results 
depending on the circumstances (Boik, 2001, p. 189). 
Results from epidemiological studies involving increased fruit and vegetable intake are 
generally more conclusive, appearing to confirm their protective function against 
various diseases such as cardiovascular disease and cancer and their contribution to the 
promotion of good health generally (Eastwood, 1999). This protective effect may be 
attributed to a variety of constituents, including not only a combination of vitamins, 
29 
minerals and fibre, but numerous phytochemicals, including flavonoids (Aruoma, 1993; 
Eastwood, 1999). 
The electron transfer studies carried out by Anderson et al., (2000) support the 
possibility that dietary flavonoids, in addition to being effective scavengers of free 
radicals, can repair a range of oxidative radical damage sustained by DNA by a 
mechanism of H atom transfer from the flavonoids to free radical sites on DNA which 
result in the fast chemical repair of some of the oxidative damage resulting from OR 
radical attack. As oxidative DNA damage is considered to be a pathogenic event in the 
induction of many cancers for example, a reduction in the rate of such damage would 
probably result in a reduced risk of cancer, postulating the beneficial protective role of 
fresh fruit and vegetables. 
1.2.5 Dietary supplementation with antioxidant enzymes 
The therapeutic benefits of oral supplementation with isolated antioxidant enzymes are 
mixed. For example, SOD (superoxide dismutase) taken as a nutritional supplement is 
ineffective due to the destruction of the enzyme during the digestive process 
(Dev-Marderoscan, 2001, p. 605-6). The results for Coenzyme Q10 [2,3 dimethoxy-5 
methylbenzoquinone (often abbreviated to CoQ 10)] a naturally occurring fat soluble 
quinine taken as a food supplement, are more promising (Lamson and Brignall, 1999; 
Dev-Marderoscan, 2001, p. 605-6). Morton et al, (1957) introduced the name 
ubiquinone, meaning the ubiquitous quinone because it is ubiquitous in eukaryotic cells. 
Mellors and Tappel, (1966) showed that in its reduced form, in vitro it was an effective 
antioxidant against lipid peroxidation in membranes. Ubiquinone is found in foods, 
particularly organ meat, but cooking and processing methods tend to destroy it and, 
whilst it can be made in the body, production declines with age. Professor B. Ames 
from the Department of Chemistry, University of California, Berkeley suggests that 
optimal levels of dietary ubiquinone/ubiquinol could be important in many of the 
degenerative diseases of ageing (Ames et al, 1993; Burke et al, 2001). 
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1.2.6 The synergistic approach 
Single nutrient therapy has comprised the bulk of all nutrient intervention studies 
because generally the aim of research is to isolate the activity of nutrients so that their 
individual roles in deficiency states and disease prevention can be established. 
Clinically however, it is now being established that when synergistic nutrient 
interventions are compared to single nutrient interventions, the combined nutrient 
approach is both more effective and safer (Crayhon, 2001). 
Intriguing results from some studies suggest that combinations of synergistic 
antioxidants acting by complementary mechanisms are more effective than individual 
antioxidants (Scott, 1995). For example Vitamin E alone is relatively ineffective 
without ascorbic acid (Scott, 1995). Vitamin C and other antioxidants are known to 
enhance iron absorption (Yang et al, 1999) and zinc is a nutrient that can be considered 
as synergistic with almost every other nutrient. A lack of zinc can lead to a lack of 
absorption of other nutrients especially fat soluble vitamins like ß carotene and alpha- 
tocopherol. 
The effect of the carotenoid lycopene when used alone or in association with other 
antioxidants on the growth of two different human prostate carcinoma cell lines 
(androgen insensitive DU-145 and PC-3) has been studied (Pastori et al 1998). 
Lycopene alone was not a potent inhibitor of prostate carcinoma cell proliferation 
however, in combination with alpha-tocopherol at physiological concentrations (> I µM 
and 50µM respectively) exhibited a strong inhibitory effect on prostate carcinoma cell 
proliferation, which reached values close to 90% inhibition (Crayhon, 2001; Pastori et 
al, 1998). Supplementation with a single antioxidant therefore may be counter- 
productive because it could result in less efficient control of oxidation. 
Based on this knowledge it could be postulated that medicinal plants, which contain a 
multiplicity of chemical compounds possibly working synergistically, could help in 
alleviating some of the problems associated with ageing processes linked to free radical 
damage. Although there is little documented evidence of plant synergy, one example 
comes from investigations on the anti-malarial herb Qing Hao (Artemisia annua) which 
suggest that the flavonoids it contains, especially casticin and artemitin, can enhance the 
in vitro activity of the main anti-malarial constituent, artemisinin (Williamson, 2001). 
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1.2.7 Phenolic compounds as antioxidants 
1.2.7.1 Introduction 
Though in its infancy, there is now a growing research interest in the role of plant 
phenolics, especially flavonoids, as antioxidants in vitro (Bohm et at, 1998). As well as 
being widely distributed in the fruits and vegetables of our diet flavonoids now seem to 
be the active constituents in numerous medicinal plants used in herbal medicine 
traditions throughout the world. 
Clearly a better understanding of the role played by free radicals in the pathogenesis of 
disease will lead to a better understanding of the way to control excessive free radicals 
with antioxidants. The tissue specificity of certain antioxidant compounds in medicinal 
plants is already being established indicating a need for more research and the 
development of more specific antioxidant treatments, e. g. Milkthistle (Silybum 
marianum) and the liver (Morazzoni and Bombardelli, 1995). 
The Naturopath Leon Chaitow, proposes that taking antioxidant supplements which the 
body should be producing itself may just result in the down regulation of production, 
thereby defeating the object of supplementation (Chaitow, 1993). Thus, the author 
feels that antioxidants from medicinal plants may provide the vital key to unlocking the 
preventive and therapeutic potential for antioxidants that researchers are still seeking. 
Further, if the body does not recognise the unique plant antioxidants as part of its 
normal metabolism, it may still continue to manufacture its own antioxidants, which 
will work alongside the plant antioxidants to control free radical reactions. 
1.2.7.2 Flavonoids 
Although the interest in flavonoids from a physiological viewpoint was first initiated 
over 60 years ago, the full potential of this diverse group of compounds is still to be 
realised, particularly from non-nutrient sources like medicinal plants. Resurgence of 
interest in holistic medicine and media-generated `scare stories' about drug side effects, 
coupled with scientific evidence that diets rich in fruit and vegetables may be protective 
against some chronic diseases, has rekindled interest in `herbal medicines' with terms 
like `bioflavonoids', `proanthocyanins' and ' high potency flavonoids' being touted 
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commercially as panaceas for ageing and disease prevention. Little research has been 
published on specific flavonoids such as proanthocyanins or on studies related either to 
absorption or antioxidant activity of these compounds in vivo in man. Most 
manufacturers' claims are extrapolations of the general benefits of flavonoids and 
proanthocyanins, one of which may be antioxidant activity. 
1.2.7.3 History and origins 
The flavonoids were first isolated in the 1930's by Albert Szent-Gyorgyi, the Nobel 
Laureate who discovered Vitamin C. From his dietary experiments on guinea pigs, fed 
with a scorbutogenic diet, he discovered that by feeding them daily with an additional 
supplement isolated from lemons which he called `citrin' they could be kept alive 
longer (Fairbairn, 1959). `Citrin' was subsequently found to consist of a mixture of the 
flavanones hesperitin and eriodictyol glucoside, compounds belonging to a group of 
substances known as bioflavonoids or just flavonoids (Evans, 1996). Szent-Gyorgyi 
found that `citrin' decreased capillary permeability and fragility in ways Vitamin C 
alone could not and the name vitamin P was proposed (Fairbarn 1959). This term was 
subsequently dropped because the flavonoids ultimately did not meet the definition of a 
vitamin, as no deficiency symptoms could be provoked. 
Flavonoids are a class of phenolic compounds present in most plants concentrated in the 
seeds, fruit skin or peel, bark and the flowers. They are the products of secondary plant 
metabolism biosynthesised via the shikimic, mevalonate and phenylpropanoid pathways 
(Duthrie and Crozier, 2000) that assist the plant's survival against harmful threats such 
as microbial invasion, insect and mammalian herbivory and UV radiation. Flavonoid 
pigments give plants their characteristic flower colour which acts as a vital attractant for 
pollinating insects. Protection however, particularly to UV-B (280-315nm) radiation, is 
conferred by the leaf flavonoids located at the upper surface of the leaf in the epidermal 
cells hidden by chlorophylls that have UV absorbing properties and are able to scavenge 
UV-generated ROS (Harborne and Williams, 2000). The intracellular flavonoids are 
thought to filter out UV-A (315-350nm) radiation (Harborne and Williams, 2000). The 
flavonoid content of plants can vary considerably and is influenced by many factors, 
including species, variety, light, and degree of ripeness, processing and storage. There 
can be surprisingly wide variations in the flavonol content of seeming similar produce 
(Duthrie and Crozier, 2000). 
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In resisting UV-A radiation and other insults such as wounding or infection, plants show 
significant increases in flavone or flavonol synthesis, constituents which are capable of 
free radical scavenging, a phenomena currently being investigated by scientists, who by 
stressing the plants during growth, hope to increase the levels of these constituents in 
medicinal plants to increase their pharmacological potency (Harborne and Williams, 
2000). 
1.2.7.4 Structures and properties 
The flavonoids are characterized by a basic C6-C3-C6 (flavan) carbon skeleton: two 
benzene rings (A and B) linked through an oxygen-containing pyran or pyrone ring (C) 
[Fig. 1.3a]. The various flavonoids differ in regard to the number and position of 
hydroxyl, or substituted hydroxyl groups in the aromatic rings, and the extent and 
character of oxidation in the middle C3 portion of the molecule (Fairbairn, 1959). 
Individual compounds within a class differ in the pattern of substitution of the A and B 
rings. Six main groups of flavonoid aglycones are recognised based on the flavan 
skeleton, these are chalcones [Fig. 1.3b], flavonols [Fig. 1.3c], flavones [Fig. 1.3d], 
flavanones [Fig. 1.3e], isoflavonoids [Fig. 1.3f] and anthocyanins [Fig. 1.3g] and they 
are found in a wide variety of fruits, vegetables and many medicinal plants (Evans, 
1996). Other flavonoid classes of particular interest to this study include 
dihydroflavonols and proanthocyanidins (condensed tannins). 
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(a. ) Basic Flavonoid Structure 
3, 
.' 
S' 
(b 
(d 
(c. ) Flavonol 
000, 
(e. )1 
(g. ) Anthocyanidin 
Zýý Alo, 
H 
Figure 1.3 Examples of flavonoid types based on the structure of the basic 
flavonoid nucleus as shown in (a. ) 
(f. ) Isoflavone 
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Flavonoids usually occur in actively metabolising plant tissues in combination with 
sugars as glycosides (a sugar portion linked to a non-sugar molecule called the 
aglycone) with a changeable spectrum of glycosidation. Although all glycosides 
contain a sugar unit, generally the pharmacological action of the glycoside is due to its 
aglycone, which varies widely in their chemical constituents. The sugars found in 
glycosides are mainly monosaccharides such as glucose, rhamnose, galactose and 
xylose (Rice-Evans et al, 1996). A glycoside molecule may contain just one, several of 
the same, or several different monosaccharide units. The glycoside rutin for example 
contains one rhamnose and one glucose molecule called rutinose. When there are two 
or more monosaccharides in a glycoside molecule, the sugars are mainly linked together 
in a di-, tri- or polysaccharide chain linked directly to the aglycone. The preferred 
glycosylation site on the flavonoids is the 3 position and less frequently the 7 position 
(Rice-Evans et al, 1996). The most common linkage between the sugar and the 
aglycone is a hemiacetal bond formed between the sugar and hydroxyl group of the 
flavonoid aglycone. Most of the plant glycosides known are of this type and are 
designated as O-glycosides. Other glycosides do occur however, whereby the sugar is 
linked to the thiol (suifhydryl) group (S-glycosides); an amino group (N-glycosides); or 
by a carbon-to-carbon bond (C-glycosides). Quite a number of C-glycosylated 
flavonoids occur naturally. The flavone apigenin can occur with glucose at C6 
(isovitexin); C8 (vitexin) or at both C6 and C8 (vicenin). The nature and number of 
saccharide-units in the sugar- portion of a glycoside affect the degree of polarity of the 
glycoside and consequently its solubility in and partition between different solvents. 
Glycosides are generally only very slightly soluble in water, but are more soluble in 
ethanol, methanol, or a mixture of water with ethanol or methanol. 
The most common flavonoid found in food is the flavonol quercetin, present in onions, 
olives, tea, wine, apples and many other fruits and vegetables (Noroozi et al, 2000). It 
is also found in medicinal plants like Hawthorn, Ginkgo and German Chamomile 
(Barnes et al, 2002). Any one flavonoid aglycone can occur in a single plant in several 
glycosidic combinations. Over one hundred different glycosides of quercetin are known, 
the commonest of which are the 3-0-glycosides quercetrin containing rhamnose as its 
sugar-portion and rutin that contains the disaccharide rutinose. Most flavonoids are 
glycosylated in their natural dietary form (Formica and Regelson, 1995) but due to this 
structure they cannot be absorbed from the small intestine. No enzymes that can split 
the glycosidic bonds are secreted into the gut or present in the intestinal wall. 
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Hydrolysis only occurs in the colon by cecal microflora that are capable of releasing the 
aglycone from its sugar. Furthermore, the aglycones can then undergo further 
breakdown by a process known as C-ring fission to give a variety of phenolic products. 
The manner in which the aglycone or its breakdown products transfer across the gut 
wall is still unclear and research on the metabolism of flavonoids particularly in humans 
is still sparse (Hollman, 1997). In a normal diet flavonoids are routinely consumed 
daily, with an estimated total consumption varying from 20mg tol g (Hertog et al, 1993). 
Table 1.2 shows a representative list of some other well known flavonoids and their 
dietary sources. 
Table 1.2 Sources of some well known compounds found in the different classes 
of flavonoids 
Compound: Type: Occurrence: 
Naringenin, Hesperidin Flavanones Citrus fruits (Rice-Evans, 2001). 
Taxifolin Dihydroflavonol Milkthistle (Barnes et al, 2002). 
Apigenin, Luteolin Flavones Parsley, celery and Roman 
chamomile (Evans, 1996). 
Cyanidin, Malvidin Anthocyanidins Dark red fruit berries such as 
strawberries, cherries, purple 
grapes and hawthorn (Rice- 
Evans, 2001). 
Catechin, Epicatechin, Proanthocyanidin Barks such as willow and 
Epigallocatechin cinnamon. 
Lime and hawthorn 
flowers. Green tea and red wines 
(Hertog and Katan, 1998). 
Genistein, Daidzein Isoflavonoids Legumes, soya beans and red 
clover (Evans, 1996). 
Quercetin, Kaempferol, Flavonols Various fruits and vegetables 
Myricetin, Isorhamnetin 
(mainly found in the skin). Green 
and black tea and red wine 
(Duthrie and Crozier, 2000). 
Flavones and flavonols represent about 80% of known flavonoids (Bruneton, 1995, 
p. 268). Flavones occur most frequently as glycosides located within the vacuole of the 
plant cells. Flavonols are a class of flavones in which the 3-position of the pyran ring is 
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occupied by a hydroxyl group. Flavones typically occur as 7-glycosides, whereas 
flavonols are usually present as 3-glycosides. For identification purposes flavonols 
absorb ultraviolet at higher wavelengths than flavones. Flavanones are formed 
biosynthetically from chalcones. They occur in a range of glycosidic forms with the 
sugar usually being attached to the 7 hydroxyl. Only a limited number of flavanones are 
currently known (Harborne and Baxter, 1999). Dihydroflavonols, often referred to as 
flavanon-3-ols, are formed by oxidative addition of a hydroxyl group to the 3-position 
of a flavanone. Taxifolin (dihydroquercetin), one of the commonest dihydroflavonols, 
is closely related in structure to the common flavonols (Harborne & Baxter, 1999). 
Anthocyanidins are coloured sap pigments related in structure to flavones. The 
anthocyanidin aglycone is referred to as an anthocyanidin which in plants is almost 
always found as the more stable glycosylated derivative known as an anthocyanin. The 
sugars are commonly at the C3 position or more rarely the C5 position. These sugars 
may be modified by acylation with acids such as p coumaric, caffeic and acetic acid 
(Bruneton, 1995, p. 303). Proanthocyanidins also known as condensed tannins, are 
colourless substances with polymeric flavan-3-ol structures (catechins) and/ or flavan- 
3,4-diols (leucoanthocyanidins) linked by carbon-carbon bonds usually from the 8- 
position of one unit to the 4-position of the next unit (Harborne and Baxter, 1999). The 
term proanthocyanidin is derived from the acid catalysed oxidation reaction that 
produces red anthocyanidins on hot acid treatment. Production of anthocyanidins in this 
way is the main method of detecting these colourless substances in plants (Walker, 
1975; Harborne, 1984). 
1.2.7.5 Flavonoids as antioxidants 
Plant flavonoids are multifunctional and may exert cell protective mechanisms by more 
than one biochemical mechanism. They can act as reducing agents, hydrogen donating 
antioxidants and singlet oxygen quenchers and, in some cases, metal-chelating 
properties have been proposed (Boik, 2001, p. 255; Rice-Evans et al, 1996). Many 
flavonoids have been shown in studies to be potent antioxidants capable of quenching 
HO' radicals, superoxide anions, and lipid peroxidation (Duthrie and Crozier, 2000). 
They may also however, exert a number of other biological affects including 
vasodilatory, antibacterial, antihepatotoxic, anti-allergenic, anti-inflammatory, anti- 
spasmolytic and anti-tumour activities which may be relevant to their overall effects on 
human health (Harborne and Williams, 2000). It is considered that the value of most 
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flavonoid medicinal plants rests not on the flavonoid fraction alone but on a complex 
mixture of chemically different compounds. Other components may either directly 
contribute or play an adjuvant role that strengthens the action of the flavonoids (Pietta, 
1998). 
Several pathways whereby flavonoids and other plant phenolics may exert their 
antioxidant effects on chemical oxidation have now been identified, the most important 
of which is likely to be their free radical scavenging capacity to halt the domino effect 
of a free radical chain reaction in lipid peroxidation by donating an electron to the 
peroxyl radical of a fatty acid, and thus halting propagation (Bors et al, 1998; Terao and 
Piskula, 1998). They may work synergistically with other vitamin antioxidants 
potentiating their actions. For example, in vitro studies have shown that rutin 
potentiates vitamins C and E when used in combination, yielding a more potent radical 
scavenging action (Negre-Salvayne et al, 1991). Flavonoids may act as antioxidants by 
influencing enzyme systems such as superoxide dismutase, catalase and glutathione 
peroxidases in various tissue sites (Weiner, 1994). Animal studies using silymarin and 
silybin extracts from Silybum marianum have demonstrated a stimulatory effect on 
superoxide dismutase activity and increase in the amount of total glutathione in the 
liver, intestines and stomach of normal healthy rats (Valenzuela et al, 1989; Morazzoni 
and Bombardelli, 1995). Further, they may also prevent the generation of the highly 
reactive hydroxyl radical by Fenton type reactions via their ability to sequester 
transition metal ions (Halliwell et al, 1995; Diplock et al, 1998). In vitro studies 
involving this final pathway have led to possible concerns of pro-oxidant effects in vivo 
whereby flavonoids could also generate free radicals in reactions with some free 
transition metal ions (Halliwell and Gutteridge, 1986; Halliwell, 1996; Cao et al, 1997). 
Flavonoids can reduce CU2+ to CU+ and Fe 3+ to Fe 2+ hence allowing the formation of 
initiating radicals. Although metal ions in the body are largely sequestered in forms 
unable to catalyse free radical reactions, injury to tissue may release iron or copper 
(1-lalliwell et al, 1992) and catalytic metal ions have been measured in atherosclerotic 
lesions (Smith et al, 1992) leading to concerns that under certain circumstances 
flavonoids could also generate free radicals in reactions with free transition metal ions. 
Most antioxidants i. e. isolated compounds like vitamin C and quercetin that have been 
tested, exhibit both antioxidant and pro-oxidant effects in vitro, depending on conditions 
that include the concentration of the antioxidant, the presence of other antioxidants, and 
the presence of iron and copper ions (Boik, 2001, p. 189). In an in vitro study the 
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flavonoid compounds apigenin and luteolin acted as antioxidants at low iron 
concentrations but as pro-oxidants at high iron concentrations (Sugihara et al, 1999). 
There is much in vitro evidence to support the antioxidant activity of flavonoids, but 
their effects in vivo are still unclear and mainly speculative. The in vivo antioxidant 
activity of flavonoids is largely dependent on their bioavailability. This in turn is 
dependent on a number of factors including their release and stability in the gut, 
glycosylation, absorption through the intestinal wall, liver metabolism and accessibility 
to the tissue target site. 
Taking current knowledge into account, i. e. that flavonoids may exert antioxidant 
protection by more than one biochemical mechanism, the use of total extracts or 
combinations of herbs in formulations may provide an important advantage, the 
possibility of additive or synergistic interactions that could target a range of cell 
protective antioxidant mechanisms. Safety is a further advantage, because the use of 
combinations allows lower and safer doses of each compound to be used. 
Synergy is comparatively difficult to measure and documented examples are scarce. 
Implicated instances, however are becoming more common. In a recent study, workers 
reporting the unnaturally high antioxidant activity of a liquorice extract compared to 
isolated compounds from the plant suggested that the activity of licorice extracts is due 
to the contribution from a number of components, especially flavonoids (Gordon and 
An, 1995). 
Various studies have established the structure-antioxidant activity relationships of the 
flavonoids, the chemistry of which is fully outlined in Bors et al, (1990). To briefly 
summarise, the structural features of flavonoids necessary for the optimum free radical 
scavenging are as follows illustrated in Fig. 1.4. (Bors et al, 1990). 
1. The presence of two adjacent hydroxyl groups on the B ring. The O-dihydroxy 
(catechol) structure for electron delocalisation is the obvious radical target site for 
all flavonoids with a saturated 2,3-bond. 
2. The 2,3 double bond in conjugation with a 4-oxo function in the C-4 position 
providing electron delocalisation from the B-ring. 
3. The presence of an OH group at positions C-3 and C-5 to provide hydrogen bonding 
to the keto group for maximum radical scavenging potential and strongest radical 
absorption (kinetically, the 3- and 5- OH groups are equivalent owing to their H- 
bonds with the keto group). 
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1. Two adjacent hydroxyl groups on the B-ring 
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Figure 1.4 The major determinates for effective radical scavenging of flavonoids 
(Bors 1990) 
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Rice-Evans et al, (1996) shows that the flavonol quercetin satisfies all the above criteria 
and is a more effective antioxidant than catechin for example, a proanthocyanidin that 
only satisfies requirement 1. 
1.2.7.6 Flavonoids in human health 
In addition to the potential health beneficial properties of the flavonoids and 
polyphenolic compounds found in dietary fruit and vegetables, more recent research has 
discovered rich sources of antioxidant compounds from medicinal plants, which exert 
valuable tissue-specific effects. 
The seed of milk thistle (Silybum marianum) for example, contains a number of 
flavonolignans including silymarin (a mixture of silybin, silychristin and silydianin) 
with antihepatoxic properties which, among other mechanisms, inhibit liver damage by 
scavenging free radicals and increasing glutathione levels (Fraschini et al, 2002). 
Preliminary in vitro studies indicate that in addition to its hepato-protective qualities 
milk thistle may also have an application in the prevention and treatment of certain 
cancers (Jiang, 2000). A number of flavonoids and other compounds have been isolated 
from the leaves of Ginkgo biloba which are believed to work synergistically as free 
radical scavengers (Kleijnen, 1992; Miller, 1998b). An important area of research 
relates to Ginkgo biloba in the prevention and treatment of vascular diseases and brain 
function. Excessive oxidation and cell damage is associated with Alzheimer's disease, 
as already outlined in section 1.1.7. In an intent-to-treat analysis Of 2020 patients with 
various stages of dementia, Ginkgo biloba was found to decrease the Alzheimer's 
disease assessment scale (cognitive subscale score 1.4 points better than placebo), 
suggesting that Ginkgo biloba was capable of stabilising and perhaps improving 
cognitive performance in patients with dementia (Le Bars et al, 1997). The diterpene 
ginkgolides and sesquiterpene bilobalides isolated from Ginkgo appear to be exclusive 
to this species, possessing a structure unique in the vegetable kingdom. These 
compounds may work synergistically with the Gingko flavones (Kleijnen, 1992). As 
plants such as these do not constitute a normal part of the diet, they would need to be 
taken as supplements. 
Hundreds of plants have been studied and found to have antioxidant activity in vitro. 
However, very few tissue-specific effects for plant based medicines containing 
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flavonoids have been established. Many herbal medicines traditionally used to provide 
protection against chronic diseases contain flavonoids, but their antioxidant potential 
has yet to be investigated. In herbal medicine the term herbs is used loosely to refer not 
only to herbaceous plants as defined by the botanical term, but also to bark, roots, 
leaves, seeds, flowers and fruit of trees, shrubs and woody vines. 
Flavonoids have become a priority of herbal medicine research, the current focus of 
which is their antioxidant activity for the development of defence strategies against 
ROS induced illness and preventive measures for maintaining and improving overall 
health. 
1.2.7.7 HYdroxycinnamic acids 
In addition to the flavonoids, further phenolic compounds with antioxidant activity of 
potential interest in this study are derivatives of cinnamic acid; e. g caffeic acid and 
chlorogenic acid (Rice-Evans and Miller, 1996b). Known as hydroxycinnamic acids 
these compounds are a group of phenylpropanoid (C6-C3) derivatives present in our 
daily diet in fruit and vegetables and many plants used in phytomedicine. They are 
essentially present as combined forms, usually esters, of four basic molecules: p- 
coumaric, caffeic, ferulic and sinapic acids [Fig. 1.5] (Macheix and Fleuriet, 1998). 
Caffeic acid occurs regularly as the quinic acid ester chlorogenic acid (3-caffeoylquinic 
acid). Hydroxycinnamic acids frequently esterify the hydroxyl group of many 
secondary metabolites such as flavonoids and anthocyanins (Bruneton, 1995, p. 214). 
The antioxidant activity of hydroxycinnamic acids has been fully established and may 
contribute to the protective function of increased fruit and vegetable intake against the 
incidence of diseases such as cardiovascular disease and cancer, as found in 
epidemiologic studies (Radtke et al, 1998). Due to the abundance and diversity of the 
hydroxycinammic acid derivatives, they are almost ubiquitous in plants with p-coumaric 
acid being the most widely distributed (Harborne, 1984, p. 46). Phenolic acids are rarely 
listed in food composition tables and there is no dietary intake data available (Radtke et 
al, 1998; Firuzi et al, 2003). 
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+(R) 
Caffeic acid (R) = OH as shown 
p-coumaric acid (R) =H 
Ferulic acid (R) = OCH3 
Figure 1.5 Chemical structures of some common hydroxycinnamic acids. 
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1.3 MEASUREMENT OF ANTIOXIDANT ACTIVITY 
1.3.1 Introduction 
In order to investigate the antioxidant potential of the selected plant extracts, the current 
literature was reviewed for established methods used for the in vitro measurement of the 
products of oxidation associated with the pathological processes outlined in sections 
1.1.4-1.1.8. Various methods using animal tissue or chemical assays have been 
developed for measuring the antioxidant activity of plants in vitro, mainly by the food 
industry seeking safe effective antioxidants from natural sources to prevent deterioration 
of foods. For this purpose antioxidants are classified into two groups; primary or chain- 
breaking antioxidants and secondary antioxidants, depending on their mechanism of 
action. Primary or chain-breaking antioxidants (free radical inhibitors) and peroxide 
decomposers react with lipid peroxy radicals to convert them to stable products. 
Secondary antioxidants, like oxygen scavengers, remove ROS/RNS initiators by 
quenching chain-initiating catalysts (Duh, 1998). As already outlined in section 1.2.2, 
antioxidants may have more than one mechanism for their effect on biological systems. 
Antioxidant function in vivo is much more complicated than a single free radical 
scavenging process and the interpretation of results obtained from in vitro 
measurements of antioxidant activity of a compound or crude plant extract must be dealt 
with caution as their antioxidative effect may vary considerably with the method and 
conditions used. Selection of the assay to be used should be based on the intended 
application of the antioxidant. 
1.3.2 Methods to examine antioxidant activity in vitro 
Methods to examine antioxidant activity of a sample can generally be divided into two 
major categories: 
1. Measuring its ability to donate an electron or hydrogen atom to a specific ROS or 
other electron acceptor. 
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2. Testing its ability to remove any source of oxidative initiation such as chelation of 
transition metal ions or inhibition of enzymes. 
The presence of lipid peroxides in certain tissues has been demonstrated in association 
with several pathological conditions associated with ageing in 1.1.4. Due to its 
biological significance, assays to assess lipid peroxidation are the most appropriate to 
determine the antioxidant activity of the crude plant extracts and herbal preparations in 
this study. The assays most commonly used for measurements of lipid peroxidation will 
be briefly reviewed. 
1.3.3 Measurement of peroxides 
Many in vitro methods for detecting antioxidant activity use the ability of an antioxidant 
to retard the oxidation of a PUFA such as linoleic acid (C18H3202) exposed to oxidative 
stress, determined by exposing the linoleic acid to heat, oxygen, light or free radical 
generators. Several products are generated from each PUFA during lipid peroxidation. 
Measurement of these oxidation products enables assessment at different stages of the 
oxidative pathway. 
1.3.4 Products of lipid peroxidation 
The mechanism of lipid peroxidation (further outlined in Chapter 3) can be divided into 
three phases, initiation, propagation and termination. Initiation usually involves 
hydrogen abstraction from aC-H bond on carbon atoms adjacent to double bonds in a 
PUFA, forming a carbon-centred radical. During the propagation stage this carbon 
radical is rearranged to a conjugated diene followed by reaction with oxygen to produce 
a highly reactive peroxyl radical (LOO) which simultaneously propagates the reaction 
by hydrogen extraction from another PUFA to form a lipid hydroperoxide (LOOH). 
Lipid hydroperoxide is the first, comparatively stable, product of the lipid peroxidation 
reaction (Abuja and Albertini, 2001). 
In the presence of transition metal ions such as copper, iron or cobalt (Barber and 
Berheim, 1967) the rate of lipid peroxidation can be increased or re-initiated by radicals 
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generated from LOOH which breaks down to form a lipid alkoxyl radical (RO) that is 
more reactive than the initial hydroperoxide. Alkoxyl radicals can continue the chain 
reaction of lipid peroxidation, or it can be hydrolysed to form aldehydes. Lipid 
hydroperoxides in the presence or absence of catalytic metal ions (M) give rise to a 
variety of aldehydes many of which can be used to assess the degree of lipid 
peroxidation. The general equation suggested for the metal catalysis of the initiation 
reaction is as follows: - 
MN+ + 02 -- M 
(M+1)+ + 02 
The 02 - can act as initiator of the autoxidation reaction by several different 
mechanisms. 
Two mechanisms are proposed for the metal catalysed breakdown of hydroperoxides: - 
MN+ + LOON -> M(N+I)+ + RO' + OH- 
M (M+i)+ + LOOH -a MN+ + R02'+ H+ 
1.3.5 Current in vitro methods for the measurement of antioxidant 
activity in lipid peroxidation 
The following assays are commonly used to measure the antioxidant activity of natural 
and synthetic antioxidants. 
1.3.5.1 Conjugated diene assay 
During the propagation stage of lipid peroxidation the carbon radical is usually 
stabilized via an allylic shift to form a conjugated diene which strongly absorbs light at 
a wavelength of 234nm (Abuja and Albertini, 2001). 
This method allows dynamic quantification of the formation of conjugated dienes 
during linoleic acid oxidation by measuring the absorbance of fight at 234nm. The 
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amount of conjugated dienes produced is directly proportional to the amount of 
hydroperoxides formed as the major initial product of the lipid peroxidation reaction. 
1.3.5.2 Lipid peroxide assay 
Conceptually, one of the simplest methods is the measurement of lipid hydro-peroxides 
formed during linoleic acid oxidation. This can be measured by various colorimetric 
methods involving either a colour change brought about by the oxidising action of the 
peroxide directly on the chromogen, or by the oxidising action of the peroxide on some 
intermediate that then reacts with the chromogen to affect a colour change (Barber and 
Berheim, 1967). Several of the more widely used methods involve some modification 
of the iodometric procedure which is based on the ability of peroxides to oxidise iodide 
salts and liberate the iodine quantitatively (Lea, 1931). Alternatives include the use of 
thiocyanate (Glavind and Hartmann, 1955) which involves the oxidation of ferrous iron 
to ferric and xylenol orange (FOX) which also involves ferrous oxidation in the 
formation of a coloured adduct (Wolff, 1994; Nourooz-Zadeh, 1999). The amount of 
lipid hydroperoxides accumulated first reaches a maximum and declines thereafter 
while forming aldehydes. 
1.3.5.3 Thiobarbituric acid reactive substances assay (TEARS) 
The thiobarbituric acid test is one of the oldest and most frequently used tests for 
measuring lipid peroxidation. Lipid hydroperoxides in the decomposition phase give 
rise to a variety of products including aldehydes such as hexanal, malondialdehyde 
(MDA) and 4-hydroxynonenal. This assay is based on the detection of a stable product 
which is formed between aldehydes and thiobarbituric (TBA) in the aqueous phase 
(Halliwell and Chirico, 1993). 
1.3.5.4 Quantitative measurement of lipid hydroperoxides 
The most direct method for the quantitative determination of lipid hydroperoxide 
products is HPLC. This method is specific and does not require any derivatization, 
unlike the more sensitive GC-MS methods which involves esterification and silylation. 
HPLC determination is best achieved following partitioning of the hydroperoxide into 
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polar solvent, which achieves a primary separation between the less polar 
triacylglycerol and cholesterol hydroperoxides and the more polar free fatty acids and 
phospholipid hydroperoxides (Rice-Evans et al, 1991). 
Chemiluminescence is a collective term, which includes the emission of light by 
molecules which have been excited to a higher energy level as a result of a chemical 
reaction (Abuja and Albertini, 2001). Chemiluminescence-based detection is gaining 
popularity as a very sensitive analytical tool particularly for monitoring the process of 
lipid peroxidation (Diplock et al, 1998; Abuja and Albertini, 2001). 
1.3.5.5 Reaction with 1,1-Diphenyl-2-picryl-h ddrazl (DPPH) 
The DPPH assay measures the free radical scavenging capacity of a compound. 
Because DPPH is known to abstract the labile hydrogen atom of chemical compounds 
the antioxidant that can scavenge the DPPH radical is expected to depress lipid 
peroxidation. 
In the presence of an antioxidant which can donate an electron to DPPH, the purple 
colour which is typical to free DPPH radical decays, and the change in absorbancy at 
517nm is followed spectrophotometrically (Blois, 1958). This assay is useful for 
comparing the reduction potential of unknown materials like plant extracts. 
1.3.6 In vitro assays for the general measurement of antioxidant 
activity 
1.3.6.1 Cyclic voltametry 
This technique developed to measure the antioxidant activity of tissue or plasma has 
been adapted by Chevion et al (1999) for evaluation of the antioxidant capacity of 
edible plants as reflected by their low-molecular-weight antioxidants (LMWA). The 
method is based on measurement of the reductive capacity of the various LMWA 
components of a plant extract either singly or as mixtures of compounds, indicating 
their ability to donate electrons. The total reducing power of a plant, without the 
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necessity to measure the specific antioxidant capacity of each component alone, can be 
evaluated. 
1.3.6.2 Reaction with 2,2'-azino-bis(3-ethyl benz-th iazol ine-6-su I fonic 
acid) (ABTS) 
This technique for the measurement of total antioxidant activity measures the relative 
abilities of antioxidants to scavenge the ABTS radical cation (ABTS'+) in comparison 
with the antioxidant potency of standard amounts of Trolox, a water soluble vitamin E 
analogue, Results are expressed as "Trolox equivalent antioxidant activity" (TEAC). 
The TEAC reflects the ability of hydrogen-donating antioxidants to scavenge the ABTS 
radical cation ABTS'+, a blue/green chromogen with characteristic absorption maxima 
at 645nm, 734nm, and 815nm, compared with that of Trolox . Antioxidants suppress 
absorbance at 734nm to an extent and on a time scale dependent on antioxidant activity. 
TEAC is defined as the concentration of Trolox solution with equivalent potential to 
1Mm concentration of the compound under investigation (Rice-Evans and Miller, 
1996a). 
1.3.6.3 Ferric reducing antioxidant power assay (FRAP) 
This assay uses antioxidants to reduce ferric ion in a complex with tripyridiltriazine 
(Fe3 -TPTZ) to an intense blue ferrous (Fe2) complex that develops an absorption 
maximum at 593nm. FRAP values are obtained by comparing the absorbance change at 
593nm in test reaction mixtures with those containing ferrous ions in known 
concentrations. Hence, this test measures the ability of a sample to reduce ferric ion 
complex. Absorbance changes are linear over a wide concentration range with 
antioxidant mixtures and with solutions containing one antioxidant in purified form 
(Benzie and Strain, 1996). 
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1.4 CONCLUSION 
In view of diverse and multitudinous evidence regarding the sources of free radicals, 
both environmental and endogenous and their destructive effect upon the human body, 
future research should be weighted towards their prevention. Greater emphasis is 
needed upon research into environmentally-generated free radicals and how they enter 
into and affect the body, and also how and if they, in some way, exacerbate the 
endogenous and possibly benign free radicals, conceivably making them more 
damaging. 
As the greater therapeutic efficacy of many plant extracts over single isolated 
constituents is recognised, research on isolated phytochemicals may not be the way 
forward, since the use of individual compounds may not reflect the synergistic action of 
the whole plant. Future research therefore, should be directed at investigating the 
therapeutic properties of the whole plant as used traditionally, rather than with isolated 
plant constituents which in some instances have been shown to cause toxicity, e. g. beta 
carotene and more recently, the reported hepato-toxic effects of concentrated 
standardised extracts of Piper methysticum (Kava Kava) (Whitton et al, 2003). 
Research needs to be conducted into the possible benefits of synergy in vitro on whole 
plant extracts and combinations of plant extracts as opposed to isolated constituents. 
Furthermore, there is a need for more information regarding the therapeutic roles of 
medicinal plant constituents, particularly tissue specificity, where the majority of 
evidence of their efficacy is anecdotal, i. e. Silymarin marianum and the liver, Ginkgo 
biloba and the brain and cardiovascular system; Crataegus spp. and the heart/circulatory 
system. Most flavonoid research has been carried out on dietary flavonoids with very 
few studies on medicinal plants. 
A number of different evaluation methods have been developed for assessing the in 
vitro antioxidant effects of flavonoids making comparison of the various studies very 
difficult. The reason for this is flavonoids do not specifically react with a single ROS, 
but may act as scavengers of various oxidizing species. Results obtained from in vitro 
measurement of antioxidant activity of a crude plant extract may vary considerably with 
the conditions and the methods used. Thus, selection of the appropriate assay to be used 
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should be based on the intended application of the antioxidant. Concentration of the 
plant extract used in the assay must be consistent for comparison of the antioxidant 
activity of several different plant samples. The ability of flavonoids to react with metal 
ions may also render them pro-oxidant. In an in vitro study by Cao et al (1997) using 
three different oxidation systems, flavonoids had potent antioxidant activity against 
peroxyl radicals and hydroxyl radicals, but were pro-oxidant in the presence of Cue+. It 
was presumed that the flavonoids reduced the Cu 2+ to Cu+, hence allowing the 
formation of initiating radicals. Studies have also shown that some antioxidants have the 
potential to act as pro-oxidants depending on final concentration. Thus, a greater degree 
of standardisation of method is desirable in the future. 
The antioxidant activity of a plant in vitro may not correspond with effects in vivo. 
Since there is a paucity of information on the bioavailability, absorption and metabolism 
of flavonoids, this could be due to differences in pharmacokinetics particularly between 
the different groups (Hollman, 1997; Wiseman, 1999). Most flavonoids enter the diet as 
glycosides, but the extent of absorption from the diet is largely unknown and may 
depend on the glycoside present (Bone, 2001). The metabolism of flavonoids is 
determined by the hydroxylation pattern, thus the final products of digested flavonoids 
absorbed in the bloodstream may not bear any resemblance to the original crude plant 
extract, giving conflicting results in vitro and in vivo. 
Moreover, there are very few human intervention studies using antioxidant 
supplementation, especially in regard to medicinal plants (individual or in combination) 
that establish cause-and-effect relationships. It is still unclear whether individual 
antioxidants from dietary or medicinal plants, working alone or in synergy, will improve 
human health and also at what level of intake. A relationship has been established 
between dietary intake of fresh fruit and vegetables and lowered risk of cancer 
(Eastwood, 1999) but no conclusive proof exists of specific antioxidants or exclusive 
medicinal plant constituents lowering disease-incidence to date. 
Finally, in order to facilitate the formulation of prophylactic herbal counter-measures to 
help maintain and improve good health, a greater understanding of the pathogenesis of 
certain diseases is required. 
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CHAPTER 2: THE BASIC PRINCIPALS OF 
HERBAL MEDICINE AND THE SELECTION OF 
HERBS FOR THIS STUDY 
2.1 THE MEDICINAL USE OF PLANTS 
2.1.1. Introduction 
Plants have played a significant role in maintaining the health and improving the quality 
of life for humans over thousands of years. The WHO estimate that 80% of the world's 
population rely on traditional medicine for their primary health care needs, and most of 
this therapy involves the use of plant extracts or their active components (Craig, 1999). 
Many Western drugs were originally derived from plants. Atropine, digoxin, colchinine, 
taxol and vincristine are examples of isolated plant constituents that have found their 
way into the prescription drug inventory (Craig, 1999). 
There are a number of healthcare approaches involving the use of plants. Medical 
herbalism, one of the primary complementary approaches to medicine in the U. K., 
encompasses the use of plant extracts for treatment and prevention of disease within a 
complete holistic framework of healing. One of the basic principles of herbal medicine 
is that all the constituents in the whole plant extract work collectively to achieve 
therapeutic efficacy. There is however, limited experimental and clinical evidence 
relating to the remedies traditionally used by herbalists or the synergistic interactions of 
combinations of herbs. As previously outlined, the aims of this study were to 
investigate a small selection of plants traditionally used by herbalists, including tincture 
extracts, the most widely-prescribed form of plant medicine in the U. K. 
2.1.2 Plants as medicine 
Herbal medicine refers to the use of whole plant remedies in the promotion of healing 
and maintenance of health. Herbal remedies can be made from a combination of herbs 
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or from a single herb and can be administered to a patient in a variety of forms 
including tinctures, infusions, oils, flower waters, poultices, suppositories, syrups, 
liniments and salves. Preparations of single chemicals contained in a plant are not 
classified as herbal medicines (Ernst, 2004). Although the salicylates from the bark of 
Sal ix alba (white willow) provided the natural product model for Aspirin, neither 
synthetic salicylate (acetylsalicylic acid) from which Aspirin is produced, nor the 
original active principal salicylic acid, a metabolite of salicin can be referred to as 
Herbal medicines. Isolating the active principals from a plant or synthetically 
reproducing them may alter the specific mode of action or produce unwanted side 
effects (Gilbert and Alves, 2003). For example, it has been found that at the doses 
necessary to produce the desired analgesic effect, willow bark extract containing salicin 
does not inhibit the cyclooxygenase COX-1 and does not cause gastro-intestinal 
irritation, both of which are observed with acetylsalicylic acid (Gilbert and Alves, 2003; 
Vane and Bolting, 2003). 
2.1.3 Isolation of biologically active constituents 
In some cases research has shown that by isolating the pharmacologically active 
compounds, less activity may be produced than when they are retained in the whole 
plant extract (Houghton, 2000). Cott and Misra, (cited in Gilbert and Alves, 2003) 
reported that, in the field of psychotherapeutic plants, substances isolated from 
Hypericum perforatum and PassWora incarnata did not reproduce the activity of the 
crude extracts of the plants at comparable doses of the isolates, either alone or in 
combination. The authors concluded that a synergistic effect was involved in which 
some substances present in the plants could enhance the activity of the so called active 
principles. These results contribute a scientific basis to the empirical beliefs of Medical 
Herbalists that not all constituents are medically active, but in many cases are adjuvant 
substances that may enhance or influence their efficacy. For scientific research the 
isolation of an active substance is preferred in order to provide an exact dosage and for 
ease of measuring bioactivity. In many cases the plant preparation as a whole may be 
traditionally reported as being clinically effective but the pharmacologically active 
moieties may not be known even if the chemical composition of the plant extract has 
been elucidated (Wuthold et al, 2004). Examples include Crataegus spp., Vitex agnus- 
castus and Passiflora incarnata (Williamson, 2005). 
54 
2.1.4 Formulations and synergy 
Traditional herbal practice in many part of the world involves prescribing combinations 
of herbs with a wide range of actions that concurrently cover several treatment 
strategies. Rather than focusing on a specific disease pathology, Herbal Practitioners 
treat holistically with individualised herbal formulae (Williamson, 2001). 
Combinations provide multiple active constituents working together which may produce 
additive, or synergistic interactions. Both Chinese Herbal Medicine and Ayuvedic 
Medicine (the ancient healing system of India) have been using combinations of natural 
compounds for centuries, if not millennia. Chinese records go back more than 4000 
years (Gilbert and Alves, 2003). The value of using combinations is not now confined 
to herbal medicines and the use of small drug combinations is now routinely used in 
cancer chemotherapy and the treatment of HIV and hypertension (Wagner, 2004). 
These combinations usually comprise 3-5 agents. Larger combinations are not tested 
because as the size of the combination increases so does the expense, technical 
difficulty, potential adverse effects and the difficulty of statistical analysis (Boik, 2001, 
p. x). 
In the field of pharmacology, the study of interactions between constituents of a single 
herb, between herbs in combination and between herbs and pharmaceutical agents is 
increasing. An interesting series of studies looking at the combined effects of plant 
extracts and xenobiotics on liposomal lipid peroxidation was carried out by Popovic et 
al (1999; 2001). Two of the studies involved the industrial chemical pyralene, a lipid 
soluble polychlorinated biphenyl (PCB) environmentally damaging to human health and 
a commonly prescribed antimicrobial drug Ciprofloxacin in combination with either 
extracts of Calendula officinalis (Marigold) or Taraxacum officinalis (Dandelion). 
Various extracts of Calendula officinalis or Taraxacum officinalis alone or in 
combination with different doses of Ciprofloxacin or pyralene were used to study their 
effect on lipid peroxidation induced by Fe 2+ and ascorbic acid. All the plant extracts 
tested individually showed antioxidant activity. Pyralene alone exerted a pro-oxidant 
action which was decreased by combining with both the dandelion and marigold 
extracts. At lower concentrations, ciprofloxacin alone did not affect lipid peroxidation 
but at higher concentrations it acted as a pro-oxidant. Both the dandelion and marigold 
extracts in combination with ciprofloxacin showed a protective effect by decreasing its 
pro-oxidative action which for marigold was also dose dependent. Wagner (2004) 
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comments that the gradual renunciation in mainstream medicine of the long-standing 
reliance on monosubstance therapy in favour of multidrug therapy is one of the new 
paradigm shifts in current healthcare. Phytomedicines, he postulates, have a good 
chance of contributing to this strategy. 
2.1.5 Evaluating synergy in herbal medicine 
The term synergy, as understood by Medical Herbalists in the U. K., applies to the 
formulation of whole herb combinations, the potency of which either by additive or 
synergistic interactions is increased. The skill and practice of combining herbs in this 
way is an expertise that has evolved over many generations. Since synergy can be 
extremely difficult to prove this knowledge is mainly without scientific basis. Current 
models for testing synergy are mainly based on the combination of pure compounds. 
Unlike pharmaceutical drugs where an exact dose of the active principal can be 
measured, the active principal in a whole plant extract is notoriously variable. To try 
and eliminate as many variables as possible, the use of plant extracts standardised to 
known active constituents are generally preferred for scientific validity. Controlled 
double-blind studies, still widely regarded as the most reliable evidence of objective 
drug reactions, depend upon consistency. Studies of herbal medicines face fundamental 
problems of external validity that are less obvious than those for the synthetic drugs that 
generally can be subjected to much more stringent standardisation because many 
different types of product can be made in different ways from raw plant material that 
may itself be inherently variable, for reasons that include geography, geology, weather 
and genetics, (Chrubasik et al, 2003). In addition, raw plant material may also vary with 
different harvesting procedures, time of harvest and storage conditions. Different 
manufacturing methods, i. e. methods of extraction, generate differing constituent 
profiles with subsequent variations in biological response. The use of isolated 
constituents and standardised plant extracts does not reflect the ethos of Herbal 
Medicine practice which is that of wholism, individualised treatment and herbal 
formulae based on whole plant extracts. This level of complexity presents a challenge 
to any research carried out into herbal medicine. 
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2.1.6 Herbal extracts 
Tinctures used as herbal medicines are the most widely used form of plant extract 
traditionally used by Medical Herbalists in their prescribing (Bilia et al, 2001). A 
tincture is a preparation containing the soluble constituents of a medicinal plant, most 
often the result of macerating or percolating the plant parts with alcohol/water solutions. 
Fluid extracts (liquid extracts) are highly concentrated preparations; one part by volume 
of the preparation is equivalent to one part by weight of the original plant material (1: 1). 
Tinctures are commonly made to a concentration of 1: 3,1: 4,1: 5,1: 8 or 1: 10. For 
example, a 1: 4 tincture has 1 kg plant material to 4 litres alcohol/water. The strength of 
alcohol in water also varies depending on the type of constituent to be extracted. Four 
strengths are used in the British Herbal Pharmacopoeia (1996), 45%, 60%, 70% and 
90%. In everyday practice where water alone would be sufficient to extract the 
medicinal compounds but alcohol is required to preserve the extract, 25% alcohol is 
often used. Both the British and European Herbal Pharmacopoeias (1996; 1997) 
contain general monographs about tinctures in which their modes of preparation and the 
amounts of herbal drugs in the tinctures are specified. The amount of alcohol required 
to facilitate extraction of the phytocomplex from individual herbs however is not 
specified, resulting in commercially available tinctures that contain different amounts of 
alcohol that may produce varying phytochemical profiles. 
2.1.7 Defining and demonstrating synergy 
Medical herbalists are taught to use polypharmacy, i. e. formulation of a preparation by 
combining a range of actions using a mixture of herbal tinctures. The synergistic 
interactions between the numerous constituents are believed to be a vital part of their 
therapeutic efficacy. It is not known, however, whether potentiation of the active 
principals, enhanced bioavailability, cumulative effects of the medicine or simply the 
additive properties of the constituents are responsible for any perceived enhancement of 
activity (Williamson, 2001; Gilbert and Alves, 2003). 
From a scientific view the fundamental problem with synergy is that the concept, by its 
very definition, lies outside of the current belief that wholes can be understood by the 
isolation and analysis of their parts. Plant synergy is not considered a rational approach 
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to the combination of molecules. Numerous mathematical models have been proposed 
in the quest for a quantitative measurement of synergy, the definition of which tends to 
be defined by the precise mathematical method used to demonstrate it. Berenbaum, 
(1989) and Greco et al, (1995) review these methods which, because they were mainly 
designed to assess the interaction of pharmaceutical drug combinations, do not take into 
account the multiple compounds, actions, interactions and effects of whole herb 
preparations and formulae. Williamson (2001) in a review on plant synergy cites the 
isobole method as proposed by Berenbaum (1989) as the current method of choice. 
Wagner and Steinke (2004) have successfully employed this method to assess synergy 
between various mixtures of ginkgolide A and B (constituents of Ginkgo biloba) 
measured using the thrombocyte aggregation assay. Synergy was indicated by the 
concave-up isobole curve obtained i. e. in the construction of the iso-curve, if the point 
representing a combination of two substances forms a straight line with single points on 
the x-y axis which are the doses of the individual substances, there is no interaction. If 
the point representing the effect of the combination lies below this line, the curve will 
be concave-up indicating that synergy is present. A point above this line produces a 
concave-down isobole indicating antagonism (Fig. 2.1). Wagner (2004) comments 
however, that although this method may be suitable for dose-response investigations 
with two-component containing mixtures, it is not a plausible method to be applied to 
herbal extract mixtures which would require detailed in vitro or in vivo comparative 
investigations with single constituents or mixtures and extract fractions or whole 
extracts to be performed. 
B1 
4NTAGONISM 
ADDITIVITY 
Dose of B SYNERGY 
DoseofA Al 
Figure 2.1 Isobologram illustrating additivity, synergy, and antagonism 
(Berenbaum 1989). Al and Bl are the doses of the constituents A and B 
respectively, which produce an equal effect. The concave up isobole represents 
synergy. The concave down isobole represents antagonism. 
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The idea that the nature of an interaction might be decided by analysing the mechanism 
of action of the agents and on this basis calculating the expected effect of the 
combination, was the original approach to the measurement of synergy. This 
presupposes however that the mechanisms of action are fully understood and entirely 
depends therefore on the current state of knowledge. Berenbaum (1989) cites the 
following example. If two compounds have common receptor sites and an equation for 
their expected efficacy in combination is derived on this basis and if the combination is 
observed to be more effective than the equation predicts, then synergy is thought to 
have occurred. If however, it is subsequently found that the binding sites are in fact 
different, leading to the derivation of a different equation and the data fits this new 
equation, the two compounds will now be said to show zero interaction. Thus, as new 
knowledge about mechanisms of action have expanded, interactions defined in this way 
are no longer valid, so that an interaction initially said to be synergistic could 
subsequently be thought to be antagonistic although the observed data remained the 
same. Berenbaum, (1989) has suggested that observed effects of the agents and their 
combinations without reference to mechanisms may be a better approach to the 
assessment of synergy. Such an approach would be just as applicable to agents of 
which the modes of action are completely unknown as to those which are well 
understood and even to agents that are unidentified. He states that the requirements of a 
mechanism free model are analogous to those of a nonparametric statistical test such as 
Mann-Whitney or the Kolmogorov-Smirnov test that calculates the probability that two 
sets of values come from populations with the same distribution and to decide this 
question no information is required about what the values represent, nor about the real 
distribution of the populations from which the sets of values come. Many mechanism 
free models analogous to these requirements have been developed like the isobole 
method mentioned above, but to date none have been identified for reliably interpreting 
reactions between complex herbal mixtures. As a precursor to more complex 
investigations, statistical analysis using a nonparametric statistical test would at least 
indicate whether or not two or more plant extracts interact, simply on the basis of 
observed effects. For the preliminary assessment of any plant interaction the Mann- 
Whitney test is the preferred method of analysis in this study. 
Three classes of interaction will be referred to in this study; zero interaction, in which 
the effect of a combination is the same as that expected from their effects alone; 
synergy, in which the effect is greater than expected; and antagonism, in which it is less. 
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2.2 SELECTION OF PLANTS 
2.2.1 Introduction 
The use of herbs to augment good health and to help in the treatment of some conditions 
associated with ageing such as circulatory disorders and joint disease are traditionally 
known to be effective. There is a growing need however to establish a scientific 
evidence base for the practise of herbal medicine. Conditions such as osteoarthritis that 
may respond poorly to orthodox treatment will possibly do better with appropriate 
herbal therapy (Long et al, 2001; Hoffman, 1993 p. 1 I). Herbs commonly used by 
herbalists in their treatment of OA formed the basis of this study, with research into 
their reported efficacy focused on the establishment of a possible therapeutic link 
between the chemical constituents contained in these plants, and one of the pathological 
processes associated with OA, namely lipid peroxidation. 
2.2.2 Osteoarthritis 
Osteoarthritis is the most common degenerative disease affecting human articular 
cartilage, especially in the population over 65 years old (Heraud et al, 2000). Reactive 
oxygen species are implicated in both cartilage ageing and the pathogenesis of 
osteoarthritis (Tiku et al, 2000); see Chapter 1 of this thesis. Since micronutrient 
antioxidants provide defence against tissue injury, high dietary intake of these 
micronutrients it has been suggested could protect against osteoarthritis. Lane et al, 
(1999) found that high levels of vitamin D protected against both incident and 
progressive hip osteoarthritis. Herbal remedies have a long history of use in the 
treatment of `Arthritis' generally. The word `arthritis' means joint inflammation 
involving either inflammation of connective tissues or non-inflammatory degeneration 
of these tissues. Conclusions from a systemic review (Long et al, 2001) on herbal 
medicine used for the treatment of osteoarthritis and a pilot study (Bell et al, 1999) 
investigating herbal treatment outcomes present promising evidence for the effective 
use of some herbal preparations in the treatment of this condition. When considering the 
large number of people suffering from osteoarthritis, together with the known adverse 
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side effects associated with conventional drug treatments, he concluded that this area 
had been under researched (Long et al, 2001). 
2.2.3 The Herbalists approach to `Arthritis' 
Western Herbal Medicine advocates a broad holistic approach to the treatment of 
`arthritis' by selecting herbs with a wide range of actions, primarily anti-rheumatic, 
anti-inflammatory, circulatory stimulant effects, plus enhancement of elimination, 
particularly for the improvement of liver function (Mills, 1991, p. 61; Hoffman, 1993 
p. 139-156). The term anti-rheumatic as used by Herbal practitioners refers to herbal 
remedies that have been traditionally observed to improve the patient's experience of 
rheumatic problems. It is a description of outcome rather than process that has 
anecdotally engendered herbal knowledge over many generations (Mills, 1991, p. 206- 
209; Hoffman, 1993 p. 139-156). The specific effect upon the disease or upon the 
musculo/skeletal tissue itself may not have been identified. Anti-inflammatory herbs 
ease symptoms overall by reducing inflammation; circulatory stimulants increase blood 
flow to muscles and joints and increase elimination through improved circulation; 
eliminative herbs, especially liver tonics, enhance the body's expulsion of toxic 
products of metabolism through the use of appropriate herbs. Supporting the liver to 
improve detoxification is considered an important focus of treatment in Western Herbal 
Medicine. Since many herbs fall into the above categories but may also have a wide 
range of other actions, the Herbal Practitioner's choice of one herb over another would 
be influenced by the botanical evidence-base in respect of both anecdotal and scientific 
evidence, the original preferences of the Practitioner's training Institution, and clinical 
experience. Osteoarthritis is a complex disorder and empirically it certainly seems that 
herbal remedies have qualities that lend themselves to the treatment of `arthritis' in a 
very different way from that of conventional medicines. As science unravels the 
multifactorial aetiology and pathogenesis of chronic diseases like osteoarthritis we may 
discover that herbs traditionally used to treat arthritic conditions have actions as yet 
unidentified that are contributing to their reported efficacy. 
61 
2.2.4 A pilot study investigating outcomes of herbal treatment for 
osteoarthritis 
A pilot study was undertaken by collaborators at Middlesex University and the 
Archway Clinic of Herbal Medicine to study patient outcomes following herbal 
treatment for osteoarthritis (Bell et al., 1999). Treatment was given from a choice of 
three herbal formulations generally based on the above approach to treatment [Table 
2.1]. Preliminary results suggest that the herbal treatment administered over the three 
month period of the study was of benefit to the patients, some of whom had been long 
term sufferers of the condition. The herbs used in the prescriptions for this pilot study 
formed the basis of the herbs selected for this study. 
Table 2.1 The list of herbs used by Herbal Practitioners in the pilot study by Bell 
et al (1999) for the treatment of osteoarthritis based on the following three 
presentations: - Metabolic/ Hormonal; Toxic/ Eliminative; Trauma/ Degenerative 
Common name Latin name Plant part used 
Celery Apium graveolens Seed 
White willow Salix alba Bark 
Liquorice Glycyrrhiza glabra Root 
Ginkgo Ginkgo biloba Leaves 
Dandelion Tarazacurn oJcinale Root 
Cramp bark Viburnum opulus Bark 
Black cohosh Cimicga racemosa Root 
Wild yam Dioscorea villosa Root and tuber 
Nettle Urtica dioica Ariel parts 
Meadowsweet Filipendula ulmaria Flowering tops and leaves 
Horsetail Equisetum arvense Ariel parts 
Hawthorn Crataegus spp. Leaves, flowers and berries 
Devil's claw Harpagophytum procumbens Root 
Angelica Angelica archangelica Root, leaves, stem, seeds 
Withania Withania somnifera Leaves, root, berries 
Ginger Zingiber officinale Rhizome 
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2.2.5 Method of plant selection for this study 
2.2.5.1 Practitioner consultation for the selection of herbs 
After consultation with clinic supervisors who were fully qualified and experienced 
Herbal Practitioners from a selection of specialist training clinics: - The Archway Clinic 
of Herbal Medicine, Westminster Poly clinic, The London clinic of Herbal Medicine 
and Dunboyne Herbs in Eire; a review of patients' case notes at the Archway clinic and 
a review of the existing literature, a list of 12 herbs most commonly used for the 
treatment of `arthritis' was compiled [Table 2.2]. 
Since the pilot study by Bell et al (1999), was carried out at The Archway Clinic of 
Herbal Medicine, patient case notes at this clinic strongly reflected the herbal treatments 
given in this trial. A more balanced view of Practitioner's prescribing for arthritis was 
thus achieved by additionally consulting with Practitioners from other training 
institutions viz Westminster Poly clinic, The London clinic of Herbal Medicine and 
Dunboyne Herbs in Eire. 
Key practitioners from all four training institutions were interviewed in regard to their 
general approach to the treatment of OA. All were specifically asked which single herb 
would be their primary choice in an herbal prescription for OA. They were then asked 
to indicate, which herbs from the list of those used in the pilot study by Bell et al (1999) 
they would include in this prescription plus any not on this list they would also routinely 
use. 
2.2.5.2 Results of Practitioner consultation: final selection of herbs 
As a result of all the data collated from the sources previously outlined, a list of twelve 
herbs most commonly used by Herbalists for the treatment of osteoarthritis was 
compiled as shown in Table 2.2. 
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Table 2.2 The 12 herbs identified as being those most commonly used by some 
Herbal Practitioners for the treatment of osteoarthritis. Herbs selected for study 
are marked with an asterisk (*). 
Common name Latin name Plant part used 
Devil's claw Harpagophytum procumbens Tuber 
Boswellia Boswellia serrata Bark, gum resin 
*Burdock Arctium lappa Root 
*Celery Apium graveolens Seed 
*Dandelion Taraxacum officinale Root 
*Milkthistle Silybum marianum Seed 
*Hawthorn Crataegus laevigata Leaves and flowers/ berry 
*Marigold Calendula officinalis Flower 
*White Willow Salix alba Bark 
Black Cohosh Cimicga racemosa Root 
Ginger Zingiber officinalis Rhizome 
Prickly Ash Zanthoxylum clara-herculis Bark and berries 
Seven of the twelve herbs shown in Table 2.2 were selected for study based on the 
criteria whereby the plant must be indigenous to Europe or the U. K. and that it could 
easily be grown and harvested from the Middlesex University herb garden. The seven 
herbs identified were Milkthistle (Silybum marianum), Marigold (Calendula officinalis), 
Dandelion (Taraxacum offtcinale), Celery (Apium graveolens), White Willow (Salix 
alba), Burdock (Arctium lappa) and Hawthorn (Crataegus laevigata). 
Those herbs not selected were Devil's claw (Harpagophytum procumbens) a native 
plant of Southern Africa, Ginger (Zingiber oJcinalis) that grows in India, China and 
Mexico, Black Cohosh (Cimicifuga racemosa) and Prickly Ash (Zanthoxylum clara- 
herculis) that are native to North America and Boswellia (Boswellia serrata) which is a 
traditional Ayurvedic herb from India. Marigold (Calendula officinalis) is not a 
traditional remedy for `arthritis' but since it was mentioned by several practitioners and 
there is a good evidence base for its anti-inflammatory action it was included in this 
study (Della Loggia, 1994; Akihisa, 1996). Although all of the selected herbs would 
have a role to play in the treatment of arthritis by a range of different actions, it is not 
known if they all possess the protective effects of antioxidant activity that could be 
postulated a part of the basis of their therapeutic effects. 
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2.3 PROFILES OF HERBS CHOSEN FOR STUDY 
2.3.1 BURDOCK 
Latin name: 
Arctium lappa (Linne) 
Family: 
Asteraceae 
Description 
Arctium lappa is a biennial plant native to Britain and Europe which grows wild along 
roadsides, hedgerows and on waste ground (Fig. 2.2). The root, seeds and leaves are all 
used as herbal medicines but for the purpose of this study only the root, which is the 
part traditionally used in the treatment of arthritic conditions, will be considered. 
Arctium lappa root is composed of the fresh or dried root, which is harvested from 
plants in their first year of growth, when they are large and fleshy (British Herbal 
Pharmacopoeia, 1996). 
Key constituents 
Phenolic acids For example, caffeic acid, chlorogenic acid (3-caffeoylquinic 
acid), isochlorogenic acid and other caffeolyquinnic acid 
derivatives) (Maruta et al, 1995; Bisset, 2001, p. 100; Barnes et al, 
2002, p. 95). 
Monocarboxcylic For example, isovaleric acid, acetic acid, butyric acid, proprionic 
acids acid, tiglic acid) (Barnes et al, 2002, p. 95). 
Fatty acids For example, lauric acid (dodecanoic acid), linoleic acid (9,12- 
octadecadienoic acid), linolenic acid (9,12,15-octadecadienoic 
acid), myristic acid (tetradecanoic acid), oleic acid (9- 
Figure 2.2 I. arg& licitrt-shaped 
foliage of Arctium lappa 
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Polyacetylenes 
octadecanoic acid), palmitic acid (hexadecanoic acid), stearic 
acid (octadecanoic acid) (Barnes et al, 2002, p. 95). 
Mainly trideca-1,11-dien-3,5,7,9-tetrayne and a number of 
sulphur-containing acetylene compounds (e. g. arctinone-a, 
arctinone-b, arctinol-a, arctinol-b, arctinal, arctic acid-b) 
(Washino, 1986a and 1986b; Bisset, 2001, p. 100; Barnes et al, 
2002, p. 95). 
Carbohydrates Inulin (gamma-glucoside-fructose ester), mucilage, pectin 
(Tamayo et al, 2000; Bisset, 2001, p. 100). 
Flavonoids Lignans (e. g. arctiin and its aglycone arctigenin) are thought to 
be present in the root (Bisset, 2001, p. 100; Cho et al, 2004). 
Bitter principals Sesquiterpene lactones of the germacranolide type (e. g. 
arctiopicrin); glycosidal bitter (e. g. lappatin) mainly found in the 
leaf, but also reported for the root. (Bruneton, 1995, p. 150-151; 
Barnes et al, 2002, p. 95). 
Other constituents Sterols (e. g. sitosterol, stigmasterol) (Yochkova et al, 1989; 
Barnes, et al, 2002, p. 95); essential oil containing more than 60 
identified substances including aldehydes (e. g. benzaldehyde, 
phenylacetaldehyde), 2-alkyl-3-methoxypyrazines, aliphatic/ 
aromatic acids and sesquiterpenes (e. g. costic acid) (Washino et 
al, 1985; Bradley, 1992, p. 48; Bisset, 2001, p. 99); minerals (e. g. 
calcium, cobalt, copper, chromium, iron, potassium, selenium and 
zinc (Duke, 1992). 
The term Arctium lappa is an umbrella term for several species e. g. Lappa minus, 
Lappa majus. The chemical composition of the root may vary between species (Barnes 
et al, 2002, p. 95). 
Current and traditional uses 
Arctium lappa is known foremost in Western Herbal Medicine for its alterative or 
`blood cleansing' properties. The term alterative is an expression used in herbal 
medicine to describe a concept, namely that certain herbs will gradually restore the 
proper function of the body by assisting with the elimination of waste materials that can 
66 
accumulate in the blood (Hoffman, 1990, p. 143). No scientific mechanism has 
been established to describe this action. Arclium lappa is also known for its anti- 
inflammatory, aperient, diuretic, cholagogue and depurative actions. Although the 
evidence for use is mostly anecdotal, Arclium lappa is valued by herbalists as a 
treatment for arthritis, gout, skin diseases and other inflammatory conditions. In vitro 
and animal studies on Arctium lappa root and some of its isolated constituents have 
shown the following properties, antibacterial (Moskalenko, 1986; Healy et al, 1999; 
Holetz et at, 2002), antifungal (Holetz et at, 2002), antiviral (Eich et at, 1996; Collins et 
at, 1997), anti-inflammatory (Iwakami et at, 1992; Lin et al, 1996), antitumour 
(Koshimizu et al, 1988; Cho et al, 2004) and hepatoprotective which may in part be 
attributed to its antioxidant activity, which decreases the oxidative stress of hepatocytes, 
or to other unknown protective mechanisms (Lin et at, 2002). 
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2.3.2 CELERY 
Latin name: 
Apium graveolens (Linne) 
Family: 
Apiaceae/ Umbelliferae 
Description: 
ý' 
i; 
} 
Native to Great Britain and other European countries, Apium graveolens is often found 
growing wild in ditches and marshy areas not far From the sea (Fig. 2.3). The dried ripe 
fruits (seeds) are used medicinally, usually harvested from cultivated plants (Bradley, 
1992, p. 56). 
Key constituents 
Flavonoids Flavones apigenin and glycoside apiin (apigcnin 7- 
apiosylglucoside) and luteolin as glycosides (e. g. luteolin 7- 
apiosylglucoside); Ilavonol glycoside isoquercitrin (Ilarborne and 
Williams, 1972; Bradley, 1992, p. 56; Duke, 1992). 
Phenolic acids Caffeic and chlorogenic acids (Bradley, 1992, p. 56). 
Coumarins For example, celerin, seselin, apigravin, umbellii'erone, osthenol 
(Garg, 1979; Bradley, 1992, p. 56). 
Furanocoumarins For example, bergapten, isopimpinellin, 9-hydroxy-5- 
methoxypsoralen; furanocoumarin glucosides (e. g. apiumoside, 
celereoside); dihydrofurocoumarins (e. g. rutaretin, apiumentin) 
(Garg, 1980; Bradley, 1992, p. 56; Lombaert et al, 2001). 
Volatile oils Many components including terpenes/sesquiterpenes (e. g. 
limonene, a-selinene, ß-selinene, nerolidiol, (1-pinene, d-carvone, 
ß-caryophyllene, a-eudesmol) (Duke, 1992; Rao et al, 2000). 
Figure 2.3 Flowering top of 
Apium graveolens 
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The phenylpropene apiole (Harborne, 1984, p. 52) and phthalide 
compounds (e. g. 3-n-butylphthalide, sedanolide) which determine 
the characteristic odour of celery (Zheng et at, 1994; Momin and 
Nair, 2002). 
Other constituents Fatty acids (e. g. lauric acid, linoleic acid, myristic acid, 
myristicic acid, oleic acid, palmitic acid, stearic acid); minerals 
(e. g. calcium, copper, iron, magnesium, zinc); ascorbic acid 
(Garg, 1979 Duke, 1992; Barnes et at, 2002, p. 118); 
sesquiterpenoid glucosides (celerioside A-E), phthalide 
glycosides (celephtalide A-C) (Kitajima et at, 2003). 
Current and traditional uses 
Traditionally, Apium graveolens seed is known for its antirheumatic, anti-inflammatory, 
diuretic, carminative and hypotensive effects and is used in the treatment of rheumatic 
disorders, arthritis, gout and urinary tract infections. It is also used by Ayurvedic 
physicians for ailments of the liver and spleen. There is limited research, especially 
with human subjects, to support the effectiveness of its traditional uses, however, some 
in vitro and preliminary animal studies suggest anti-inflammatory (Atta and Alkofahi, 
1998; Momin and Nair, 2002), antibacterial (Krishna and Banergee, 1999; Friedman et 
al, 2002), antifungal (Momin and Nair, 2001) and hepatoprotective (Singh and Handa, 
1995; Ahmed et al, 2002) activity. Studies in laboratory mice show that Apium 
graveolens seed may help prevent the formation of cancerous tumours (Zheng et al, 
1993; 1994; Sultana et al, 2005). 
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2.3.3 DANDELION 
Latin name: 
Taraxacum officinale (G. H. Weber ex F. G. Wigg) 
Family: 
Asteraceae 
Description 
V. 
- 
Taraxacum officinale is a common perennial plant native to Western Europe (Fig. 2.4). 
It grows wild in fields, along roadsides and on waste ground everywhere. Both the 
leaves and root are used medicinally but, for the purpose of this study, only the root will 
be considered since this is the part traditionally used in the treatment of arthritis. 
Taraxacum nfficinale root is composed of the dried root and rhizome which are 
harvested in the autumn when the roots are two years old (Chevallier, 1996, p. 140; 
Blumenthal 2000, p. 79). 
Key constituents 
Phenolic acids For example, caffeic acid, chlorogenic acid, p- 
hydrox yphenyl acetic acid) (Duke, 1992; Barnes et al, 2002, 
p. 171). 
Fatty acids For example, linoleic acid, linolenic acid, palmitic acid, oleic 
acid) (Duke, 1992; Barnes et al, 2002, p. 171). 
Terpenoids Sesquiterpene lactones of the eudesmanolide type (e. g. 
taraxacolide glucoside) and germacranolide type (e. g. taraxinic 
acid glucoside). Triterpenes (e. g. taraxol, taraxerol, Is-amyrin, 
faradiol) (Blumenthal, 2000, p. 81; Hagymasi et al, 2000). 
Phytosterols For example, sitosterol, stigmasterol, taraxasterol (Blumenthal, 
2000, p. 81; Hagymasi et al, 2000). 
Figure 2.4 Flower and foliage 
of Taraxacum officinale 
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Other constituents Bitter glycoside, taraxacin; carbohydrates, inulin, pectin, 
mucilage; choline (Barnes et al, 2002, p. 171; Blumenthal, 2000, 
p. 81); beta-carotene (Duke, 1992); minerals (e. g. calcium, 
chromium, cobalt, iron, magnesium, potassium, selenium, zinc); 
sugars (e. g. glucose, fructose, sucrose) and vitamins A, B, C and 
D (Duke, 1992; Hagymasi et at, 2000). 
Current and traditional uses 
Taraxacum of cinale is better known as a folk remedy than a conventional medicine. 
Its choleretic, diuretic, antirheumatic, anti-inflammatory, appetite-stimulating and 
laxative properties are well known anecdotally as a treatment for liver and gallbladder 
disorders, digestive complaints, arthritic and rheumatic disorders as well as eczema and 
other skin conditions. In folk medicine Taraxacum officinale is considered to be a 
`blood purifier' and is used as a detoxifying remedy (Chevallier, 1996, p. 140-1; 
Hagymasi et al, 2000). 
71 
2.3.4 HAWTHORN 
Latin name: 
Crataegus laevigala (Poiret) de Candolle I (syn. 
Cralaegus oxyacaniha (Linne)]; Cralaegus 
monogvna (Jaquin emend. Li ndman ). 
Family: 
Rosaceae 
Description: 
CrataeAII. c Spp. 
(haws) of Crataegus spp. 
Crataegus laevigata and Cralaegus monogyna are spiny trees or shrubs native to 
Europe and Great Britain. The traditional use by farmers of planting I lawthorn to form 
into thorny, stock-proof hedges has contributed to the patchwork appearance of the 
English landscape. In herbal medicine, hawthorn refers to the flowers, leaves and 
berries called `haws' from the two Craiaegus species above (Figs. 2.5a and b). The 
flowers which bloom in May and June, are harvested immediately after opening; the 
leaves when they are completely developed. The berries are collected in September and 
October. Herbal preparations are usually made from the dried plant parts (Blumenthal, 
2000, p. 185-8). Both the flowering tops and berries are to be used in this study. 
Figure 2.5a Flowering tops of 
Figure 2.5b Ripe berries 
72 
Key constituents 
Flavonoids are considered the most important constituents and primarily responsible for 
the pharmacological activity of this plant (Upton, 1999b). The flavonoid profile and 
proportions of active constituents varies within each species. Although the constituents 
for the berries and leaf with flower are similar, the relative amounts of the individual 
flavonoids and procyanidins is different. The berries consist primarily of oligomeric 
and polymeric procyanidins with lower levels of flavonoids than the leaf with flower 
(Upton, 1999a and b). The main flavonoids in the berries are hyperoside and rutin with 
small amounts of quercetin derivatives e. g. isoquercetin (Shahat et at, 1996; Zhang et at, 
2001). The primary flavonoids in the leaves are vitexin and vitexin-2"-O- rhamnoside 
with little or none present in the berries (Wagner, 1984, p. 178; Upton, 1999b). The 
predominant flavonoid in the flowering tops is hyperoside (Upton, 1999b). 
Flavonols Flavonols present in the berries, leaves and flowering tops 
include the flavonols quercetin and glycosides (e. g. hyperoside 
(quercetin-3-D-galactoside), rutin (quercetin 3-rutinoside), 
isoquercitrin (quercetin-3-0-ß-D-glucopyranoside), quercitrin 
(quercetin-3-0-rhamnoside), quercetin-3-0-rhamnogalactoside) 
and kaempferol and glycosides (e. g. 8-methoxykaempferol-3-O- 
glucoside, 8-methoxykaempferol-3-O-neohesperidoside, 
kaempferol-3-O-neohesperidoside) (Djumlija, 1994; Upton, 
1999a and b; Zhang et al, 2001). 
Flavones Glycosides of apigenin and luteolin (e. g. vitexin (apigenin 8-C- 
glucoside), isovitexin (apigenin 6-C-glucoside), vitexin-2"-O- 
rhamnoside (leaves), acetylvitexin-2"-O-rhamnoside (leaves), 
orientin (luteolin 8-C-glucoside), luteolin-7-O-glucoside, 
luteolin-3'7-diglucoside) (Djumlija, 1994; Rehwald et al, 1994; 
Upton, 1999a). 
Proanthocyanidins Procyanidins (constituents (+)-catechin and (-)-epicatechin). The 
dimeric procyanidin B2 and the trimeric procyanidin Cl are the 
primary constituents of both the berries and leaf with flower. 
Tetramers (e. g. D1) and oligomers that primarily consist of (-)- 
epicatechin units are also present. Polymeric procyanidins are 
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mainly present in the berries (Upton, 1999a and 1999b; 
Svedstrom et al, 2002a and 2002b). 
Triterpene acids For example, ursolic acid, crataegolic acid, oleanolic acid) 
(Djumlija, 1994; Zhang et al, 2001). 
Phenolic acids For example, caffeic acid, chlorogenic acid, cinnamic acid, 
protocatechuic acid) (Djumlija, 1994; Zhang et al, 2001). 
Fatty acids For example, lauric acid, linoleic acid, linolenic acid, palmitic 
acid) berries (Duke, 1992). 
Other constituents Amines (e. g. phenylethylamine, o-methoxyphenethylamine, 
tyramine) (Hobbs, 1990). These compounds are found mainly in 
the flowers. Leaves and fruit contain smaller amounts (Weiss, 
1988, p. 163). Sterols (e. g. beta-sitosterol) leaf with flower 
(Hobbs, 1990; Duke, 1992); minerals (e. g. calcium, cobalt, 
chromium, iron, magnesium, potassium, selenium, zinc) berries; 
vitamins (e. g. ascorbic acid, beta-carotene) (Duke, 1992; 
Djumlija, 1994); 
Current and traditional uses 
Crataegus spp. (monogyny or laevigata) leaves, tops and berries have traditionally been 
used for their cardiotonic, coronary and peripheral vasodilator, hypotensive, diuretic and 
antirrhythmic effects to treat conditions such as angina, arteriosclerosis, hypertension, 
cardiac failure and associated cardiovascular disorders. Both animal and human studies 
support the traditional use of these Crataegus spp. in treating various cardiovascular 
disorders (Djumlija, 1994; Miller, 1998a; Degenring et al, 2003). Based on the findings 
of a meta-analysis of randomized trials for the treatment of chronic heart failure (Pittler 
et al, 2003), Eaton and Kinkade, (2003) in The Journal of Family Practice concluded 
that Crataegus spp. could be recommended as an adjunctive therapy to improve the 
physical performance and ameliorate heart failure-related symptoms of patients with 
chronic heart failure. Research on individual constituents has shown that the therapeutic 
benefits of Crataegus spp. are only gained when a whole plant preparation is used 
(Upton, 1999a and 1999b). 
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2.3.5 MARIGOLD 
Latin name: 
Calendula ofcinalis (Linne) 
Family: 
Asteraceae 
Description 
rý ý 
Calendula officinalis is an old garden favourite also known as pot marigold, native to 
Southern Europe (Fig. 2.6) and commonly cultivated in Britain. For medicinal purposes 
either the dried flower-heads or the dried ligulate flowers (ray florets) are used 
(Blumenthal, 2000, p. 45). 
Key constituents 
Flavonoids Different flavonol glycosides have been identified in Calendula 
officinalis including rutin, narcissin (isorhamnetin-3-rutinoside), 
isorhamnetin-3-glucoside, isorhamnetin-3-neohesperidoside, 
isorhamnetin rutinorhamioside and isoquercetrin, plus the 
flavonol aglycones isorhamnetin and quercetin (Wagner, 1984, 
p. 176; Pietta et al, 1992; Bilia et al, 2001). 
Phenolic acids Caffeic acid, chlorogenic acid (Duke, 1992). 
Terpenoids Triterpene saponins, triterpene alcohols and their fatty acid esters 
(e. g. a -amyrin, [3-amyrin, lupeol, helianol, calendulosides C-H) 
(Pizza, 1987; Akihisa et al, 1996; Hamburger et al, 2003); 
triterpenoid acids (e. g. oleanolic acid) (Duke 1992). The 
triterpenoid esters (e. g faradiol 3-0-laurate, palmitate amd 
myristate) are reported to significantly contribute to the anti- 
inflammatory effects of C'alendula ofcinalis flowers (Della 
Loggia et al, 1994; Hamburger et al, 2003). 
Figure 2.6 Calendula 
officinalis flower 
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Phytosterols For example, cholesterol, sitosterol, sigmasterol, taraxasterol 
(Duke, 1992; Barnes et al, 1996, p. 103). 
Other constituents Carotenoid pigments (e. g. lutein) (Bako et al, 2002; Wei et al, 
2003); a bitter, calendine (Willuhnand and Westhaus, 1987); 
immunostimulant polysaccharides and volatile oils (Barnes et al, 
2002, p. ; Kaurinovic et al, 2003). 
Current and traditional uses 
Calendula officinalis has commonly been used in conventional as well as folk medicine 
for its anti-bacterial and antimycotic effects ( Dumenil et at, 1980; Tarle and Dvorak, 
1989); antiviral activity (De Tommasi et at, 1990; Kalvatchez et al, 1997), anti- 
inflammatory and antiphlogistic action (Della Loggia et al, 1994; Blumenthal, 2000, 
p. 44; Hamburger et al, 2003); immunostimulant, antitumorous and anti-lipidemic 
effects (Lansky, 1993; Golding, 1994; Isaac, 1994). 
Traditionally, Calendula officinalis is used externally as a lotion, ointment, oil or 
tincture for the treatment of diverse dermatological conditions such as wounds, ulcers 
eczema, bums, bruises and eruptions like impetigo. Infusions are used internally for 
indigestion and liver and gallbladder disorders (Kaurinovic et at, 2003). 
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2.3.6 MILKTHISTLE 
Latin name: 
Silybum marianum (L. ) Gaertner [Carduus 
marianus (Linne)] 
Family: 
Asteraceae 
Description 
1ý 
Figure 2.7 Flowerhead of 
Silybum marianum 
A spiny annual or biennial plant, native to the Mediterranean but found growing 
throughout Europe (Fig. 2.7). The part used in Herbal Medicine is the small, hard- 
skinned fruit (achene) known as h'ructus silybi that develops from the large purple 
flower head. Referred to commercially as Silybum marianum seeds, these fruits are 
used when they mature and are freed from the papus (a deciduous tuft of minutely 
barbed bristles that falls off the mature fruit) (Blumenthal, 2000, p. 260). 
Key Constituents 
Flavonoids Flavanone lignans collectively referred to as silymarin consisting 
of the flavanolignans silyhin (silibinin), isosilybin, silydianin, 
silychristin (Wagner, 1984, p. 190; Bilia et al, 2001; 
Campodonico et al, 2001). 
Dihydroflavonols (e. g. dehydrokacmpferol, dihydroquercetin 
(taxifolin); flavonols (e. g. quercetin, kaempferol); flavones, 
flavanones and their glycosides (e. g. apigenin, chrysoeriol 
(luteolin 3'-methyl ether), naringin (naringenin 7-0- 
neohesperidoside), eriodictyol (Wagner, 1984, p. 190; Morazzoni 
and Bombardelli, 1995; Duke, 1992; Bisset, 2001, p. 122; Barnes 
et al, 2002, p. 341). 
Lipids For example, linoleic acid, oleic acid, palmitic acid) (Bisset, 
2001, p. 122; Barnes et al, 2002, p. 341; El-Mallah et al, 2003). 
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Other constituents Phytosterols (e. g. cholesterol, campesterol, stigmasterol, 
0 sitosterol); mucilage (Bisset, 2001, p. 122; Barnes et at, 2002, 
p. 341; El-Mallab et al, 2003). 
Current and traditional use 
Historically, Silybum marianum has been used as a liver tonic. In Western Herbal 
Medicine it is the main remedy used to protect the liver and treat liver disorders such as 
hepatitis and jaundice, cirrhosis and alcoholic liver disease and problems associated 
with the gall bladder. Numerous biochemical and pharmacological studies carried out 
on Silybum marianum have provided support for its traditional use as a unique 
hepatoprotective agent (Sailer et al, 2001; Fraschini et al, 2002). Clinical trials using 
formulations of the active constituent silymarin have shown positive hepatoprotective 
effects in the treatment of liver diseases of different aetiology that include acute viral 
and chronic hepatitis, alcohol-related liver disease and poisoning by the highly toxic 
mushroom Amanita phalloides (Ferenci et al, 1989; Flora et al, 1998; Luper, 1998). 
Anti-inflammatory, anti-arthritic, antioxidant and anti-carcinogenic properties have also 
been documented (Morazzoni and Bombardelli, 1995; Gupta et al, 2000; Jiang et al, 
2000; Kang et al, 2001; Davis-Searles et al, 2005). 
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2.3.7 WHITE WILLOW 
Latin name: 
Sulix alhu (l, innc) 
Family: 
Salicaceae 
tree SaiLv a/ba 
Description 
Salix alha is a large deciduous tree indigenous to Britain, central and southern Furope, 
with a stout deeply furrowed trunk and smooth silvery grey branches, found growing 
beside streams and waterways (Fig. 2.8). The part used as medicine is the dried hark of 
young 2-3 year old twigs and branches harvested during the early spring (Blumenthal, 
2000, p. 409). 
Key constituents 
Plant chemistry varies between the many Sa/ix species (l Jpton. 1999c). The Ii llowing 
chemical profile is representative of the main constituents present: - 
Phenolic glycosides Salicin and esters of salicin (e. g. salicortin, 2'0-acetyl salicortin, 
fragil in (2'-()-acetyl salicin), tremulacin). 
Salicyl alcohol (saligenin) aglycone of salicin (Wagner, 1984, 
p. 282; Upton, 1999c, p. 7). 
Flavonoids Flavanones (e. g. eriodictoyl-7-glucoside, naringenin-5-glucoside, 
naringenin-7-glucoside); chalcones (e. g. isosalipurposidc) 
according to species (Upton, 1999c, p. 7; Du et al, 2004). 
Polyphenols Flavan-3-ol monomers, mainly (+)-catechin accompanied by 
traces of (-)-epicatechin; dimeric and trimeric proanthocyanidins 
(Kolodziej, 1990; Bradley, 1992, p. 224). 
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Ocher constituents Acids (e. g. caffeic acid, p-coumaric acid, ferulic acid, p- 
hydroxybenzoic acid, salicylic acid, syringic acid, vanillic acid); 
minerals (e. g. calcium, chromium, cobalt, iron, magnesium, 
potassium, selenium, zinc) (Duke 1992; Bisset, 2001, p. 438). 
Current and traditional uses 
The bark of Salix alba is an ancient remedy historically used for its anti-rheumatic, anti- 
inflammatory, antipyretic, analgesic and astringent properties for the symptomatic relief 
of arthritis and rheumatism, gout, fever and aches and pains of varying aetiology, 
particularly joint pain (Vane, 2000). Most of the research carried out on the bark of 
Salix spp. has isolated the salicylate compounds and shown these to have analgesic, 
anti-inflammatory and antipyretic activity that in principle support the herbal uses 
(Upton, 1999c). Since levels of salicylates in the bark may vary and can often be low, 
these findings are difficult to extrapolate to whole herbal extracts of Salix alba (Upton, 
1999c). 
Few studies have been carried out to evaluate the therapeutic efficacy of whole extracts 
of the bark of Salix spp. as opposed to isolated salicylates and their synthetic 
counterpart acetylsalicylic acid (aspirin). Two recent clinical studies investigating pain 
management with herbal anti-rheumatics as a replacement for conventional drugs, 
evaluated the effectiveness of Salix bark extracts for pain associated with osteoarthritis 
and lower back pain, with the common conclusion that it was a safe and effective 
remedy for the treatment of mild to moderate pain. In contrast to NSAIDS such as 
acetylsalicylic acid, no gastrointestinal side effects were observed at the 
pharmacologically active dose administered (Chrubasik et al, 2000; Schmid et al, 2000; 
Marz and Kemper, 2002). Using a similar Salix bark extract to that used in these trials a 
further in vitro study was carried out to investigate the mechanisms of its anti- 
inflammatory and analgesic actions (Fiebich and Chrubasik, 2004). The results 
indicated that the effectiveness of the extract i. e. inhibition of COX-2-mediated PGE (2) 
release, was through compounds contained in the extract other than salicin or salicylate. 
The authors suggest that the actions of Salix albs are only partly attributable to its 
salicylate content (Fiebich and Chrubasik, 2004). 
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2.3.8 Concluding comment 
A small selection of herbs that generally reflect practitioner prescribing for OA has been 
chosen for this study. Reasons for their choice are based mainly on anecdotal evidence 
and clinical observation. Since free radicals may now be implicated in the pathogenesis 
of OA, many of the herbs traditionally used to treat arthritis, all attributed with different 
properties such as anti-inflammatory, pain relieving or improving elimination, may all 
share a common underlying property, antioxidant activity. 
Based on the knowledge that many of the polyphenols present in plants, especially 
flavonoids, have antioxidant activity which has been fully recognised in both model 
systems and under in vitro conditions, the plants selected for study were extracted, 
separated and analysed for their polyphenolic content by a number of phytochemical 
methods as outlined in section one of the next chapter. Following phytochemical 
analysis, these extracts were then evaluated in vitro for any antioxidant propensity, 
including the ability to inhibit the pathological process of lipid peroxidation as 
described in section two. 
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CHAPTER 3: EXPERIMENTAL 
3.1 METHODS OF PLANT ANALYSIS FOR 
IDENTIFICATION OF FLAVONOIDS 
3 . 1.1 Selection, separation and extraction of plant material 
General methods for flavonoid identification are outlined in this section, whilst those 
used for assessment of antioxidant activity are included in section 3.2. 
The chemicals used were mainly purchased from Sigma-Aldrich Chemical Company, or 
Fisher Chemical Company, U. K. 
3 . 1.2 
Extraction of phenolic compounds from plant material 
3.1.2.1 Plant material 
Authenticated dried plant material provided by Proline Botanicals for the production of 
the crude plant extracts and extracts prepared as tinctures and commercial tinctures 
(liquid extracts) purchased from Rutland Biodynamics are described in Table 3.1. Dried 
herbs were all stored in sealed plastic bags at normal room temperature. Tinctures 
(liquid extracts) were supplied in brown glass bottles and stored at normal room 
temperature (approximately 20°C). 
3.1.2.2 Preparation and extraction methodology 
Solvent extraction was carried out by two different methods, Soxhlet extraction and 
cold maceration. Extracts produced by Soxhlet extraction are referred to as crude plant 
extracts. Extracts referred to as commercial tincture extracts (liquid extracts) and 
`extracts prepared as tinctures' were produced by cold maceration. In the text, where 
the term fresh tincture extract is used, this refers to the `extract prepared as tincture' 
which was freshly prepared by the author, using the same plant material as the crude 
plant extract in order to provide a better comparison of extraction methods. 
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Table 3.1 Plant material: dried herbs and commercially produced tinctures 
(liquid extracts) used in this study. 
Latin Common Plant part Dried herbs Tinctures Tinctures 
name name used (Proline (liquid (liquid 
Botanicals) extracts) extracts) 
Batch No. (Rutland final % 
and country Biodynamics) alcohol 
of origin Batch No. and content 
country of 
origin 
Silybum Milkthistle Seed B4433/ 030822-2/ UK 25% 
marianum France 
Calendula Marigold Flower B5157/ 010925/-1 UK 45% 
officinalis heads Egypt 
Apium Celery Seed B2044/ 020813-1 / UK 60% 
graveolens India 
Salix alba White Cut bark 134758/ 021211-1/ UK 25% 
willow Bulgaria 
Taraxacum Dandelion Cut root B5063/ 030723-1/ UK 25% 
officinale France 
Crataegus Hawthorn Berries B2934/ 011109-2/ UK 25% 
laevigata Bulgaria 
Crataegus Hawthorn Leaves and 135392/ 010601-6/ UK 25% 
laevigata flowers Bulgaria 
Arctium Burdock Cut root B4522/ 020627-3/ UK 25% 
lappa Hungary 
'- The final % alcohol content shown for the commercial tinctures is the alcohol content 
at the point of sale and not the alcohol/water solvent ratio used in the initial extraction 
process which for most plants is different and shown in Table 3.2. 
83 
3.1.2.2.1 Crude plant extracts 
Extraction was based on the methods of Markham (1982, p. 16), Harborne (1984, p. 5) 
and Waterman and Mole (1994, sec. 4.2.3). Dried plant material (30g) was ground to a 
fine power for solvent extraction carried out by continuous Soxhlet extraction for one 
hour at a temperature of 60°C. Flavonoid constituents are unaffected by heating at this 
temperature (Jodrell Laboratory, 2004). 
To separate the extract from plant material filtration was carried out using a filter funnel 
and filter paper (Whatman No. ]). The extract was filtered until clear and then 
concentrated to a final volume of about I ml under vacuum using a rotary evaporator. 
The residue was weighed and re-dissolved in the original solvent to give a stock 
solution of 100mg per 1 ml, which was stored at a temperature of -18°C. The ratio of 
1g dried plant material to 5ml solvent as recommended by Wagner (1984, p. 291), was 
used for all extractions in the proportion 30g powdered plant material to 150ml solvent. 
(30g of powdered plant material was the maximum volume that could be used in the 
`thimble' used for Soxhlet extraction, and increase in solvent volume above 150ml 
failed to increase the final yield). 
The above procedure was used for extraction of all dried plant material. Different 
solvents and solvent mixtures were experimented with as outlined below. The final 
extracts were assayed and the most appropriate adopted for use. 
3.1.2.2.2 Experimental procedure for the extraction of dried plant material 
Following the method of Markham, (1982, p. 16) the crude extract obtained from 
Soxhlet extraction using the recommended methanol: water (1: 1) solvent ratio was 
filtered and the methanol removed by rotary evaporation. The resultant aqueous extract 
was then further extracted in a separating funnel with chloroform, to remove low 
polarity contaminants such as chlorophylls and fats. This chloroform extract was then 
evaporated under reduced pressure as above (3.1.2.2.1). To simplify the method and 
avoid any further use of chloroform because of its hazardous nature, single solvent 
soxhlet extractions were carried out using 100% ethanol and 100% methanol, which 
were filtered and evaporated to dryness as outlined in (3.1.2.2.1) without further 
extraction. Although TLC analysis (3.1.3.1) of the two single solvent extractions 
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showed similar results, 1-IPLC analysis (3.1.6) showed that neither the ethanol nor 
methanol alone was extracting the full range of flavonoids. This was indicated by the 
absence of the flavonol quercetin aglycone and quercetin methyl ether (Grayer, 2003) 
which were present in the authentic silymarin standard [Fig 3.1; tR 17.47 and 1R 20.80], 
but not in the ethanolic or methanolic crude plant extracts from Silybum marianum 
[Figs. 3.2 and 3.3 visualised at 335 nm]. In accordance with a recommendation from 
the research team at the Jodrell Laboratory, Kew (2003) and review of the literature 
(Zhang, 2001), a soxhlet extraction of Silybum marianum was carried out with 80% 
aqueous ethanol, using the method outlined in (3.1.2.2.1). 11PLC analysis of this extract 
showed the presence of the quercetin aglycone and quercetin methyl ether at IR 17.39 
and tR 20.71 (Grayer, 2003) [Fig 3.4 visualised at 335 nm], suggesting that some 
flavonoid compounds may only be water soluble and that the composition of the solvent 
should therefore be a mixture of alcohol and water. All further experimental work was 
therefore carried out using the crude plant extracts from Soxhlet extraction with 80% 
ethanol. 
The procedure most suitable for flavonoid extraction depends on the type of flavonoids 
to be extracted and by whether the extraction is for qualitative or quantitative purposes. 
At the Jodrell laboratory, Kew, methanol (80: 20) or ethanol (80: 20) are traditionally 
used for extraction of flavonoid glycosides (Jodrell Laboratory, 2003). Ethanol is 
considered to be the less toxic of the two solvents and is also the solvent of choice for 
the production of herbal tinctures (Mills, 1991, p. 369). The method outlined in 
3.1.2.2.1 is for qualitative flavonoid analysis. Quantitative yields of the constituent 
flavonoid glycosides require several sequential extractions of the original plant material 
(Markham and Bloor, 1998; Jodrell Laboratory, 2003). 
3.1.2.2.3 `Extracts prepared as tinctures' 
Extracts were prepared in the laboratory as follows from the same dried plant material 
as the crude plant extracts (Table 3.1) and by the same method of cold maceration as 
that used in the production of the commercial tinctures (liquid extracts), to provide 
better comparability between the two types of extract i. e. crude plant and tincture 
extracts, produced by two different methods of extraction. The solvent ratios were the 
same as those used for commercial manufacture (Table 3.2). 
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Dried plant material (1g) was pulverised and macerated in an ethanol and water 
menstruum (100ml) in a covered airtight conical flask and agitated daily for three days. 
The ethanol-water solvent ratio used for the extraction of each plant is shown in Table 
3.2 [A]. The extract obtained was clarified by vacuum filtration using a Buchner flask 
and filter paper (Whatman No. 1). The filtrate was then concentrated under reduced 
pressure to a final volume of about l ml. Each plant extract was reconstituted with 
aqueous ethanol (5ml) to the same final ethanol content (%) as that of the commercially 
produced tinctures (liquid extracts) as shown in Table 3.2 [B]. Each extract (1 ml) was 
then filtered into an HPLC vial and stored at a temperature of 4°C ready for HPLC DAD 
analysis. 
Table 3.2 Alcohol-water ratios used in the production of the commercially 
produced tinctures (liquid extracts) from Rutland Biodynamics outlined in Table 
3.1. 
Plant Ethanol-water solvent 
ratios used in the 
extraction process of 
the commercial tincture 
(liquid extracts) [A] 
Final percent (%) ethanol 
content of the 
commercially produced 
tinctures (liquid extracts) 
[B] 
Silybum marianum seed 25% 25% 
Calendula ofcinalis flowers 90% 45% 
Apium graveolens seed 90% 60% 
Sal ix alba bark 50% 25% 
Taraxacum officinale root 45% 25% 
Crataegus laevigata berries 45% 25% 
Crataegus laevigata leaves 
and flowers 
45% 25% 
Arctium lappa root 65% 25% 
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3.1.2.2.4 Tinctures (liquid extracts) 
Using a rotary evaporator, the commercially produced tinctures (liquid extracts) (30m1), 
listed in Table 3.1, were prepared for study by concentrating to a final volume of about 
I ml. Each reduced extract was then weighed and reconstituted with aqueous ethanol to 
the same final ethanol content (%) as the original product (Table 3.2 [B]), to give a 
stock solution of 100mg per I ml, which was then stored at a temperature of -l 8°C. 
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3.1.3 Separation and identification of compounds from the extracts 
3.1.3.1 Thin Layer Chromatography (TLC) 
Thin layer chromatography provides a quick and simple means of separation and 
preliminary detection of plant compound from small samples. 
3.1.3.1.1 Materials and methods 
3.1.3.1.2 Standard compounds 
Caffeic acid (99%); rutin (95%); quercetin (98%); taxifolin (85%); chlorogenic acid 
(95%); hyperoside and silymarin purchased from Sigma-Aldrich Company Ltd. Where 
no percentages are quoted they were not specified by the manufacturer. 
3.1.3.1.3 Detection reagents 
Reagent A Natural products reagent (NP/PEG) 
The plate is sprayed with 1% methanolic diphenylboric acid-ß- 
ethylamino ester (NP) followed by 5% ethanolic polyethyleneglycol 
4000 (PEG) 
Reagent B The plate is sprayed with a mixture of I volume sulphuric acid and 9 
volumes of ethanol. 
Reagent C The plate is sprayed with 0.3g vanillin in 85 ml of methanol with 3 ml 
sulphuric acid added. 
3.1.3.1.4 Method 
TLC analysis was carried out on Macherey-Nagel TLC plates coated with fluorescent 
Kieselgel 60 F254 eluting with the appropriate solvent system as indicated in Table 3.3 
according to the methods described by Stahl (1974, p. 3-23) and Wagner (1984, p. 163- 
5). The compounds were detected by direct visualisation under shortwave UV light, 
developing the plates in spray reagent (see Table 3.3) and heating on a hot plate. The 
identified compounds were characterized by their Rf values. 
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The development distances on the chromatogram are expressed by the Rf value that is 
constant for a particular compound. TLC of each crude plant extract (3.1.2.2.1) was 
carried out using key reference compounds prepared as 0.1% solutions, as indicated by 
the literature (Wagner, 1984; Bisset, 2001). Where the specified reference compound 
was unavailable documented Rf values were used to aid interpretation (Wagner, 1984; 
Bisset, 2001). 
3.1.3.2 Thin layer chromatography (TLC) for the identification of 
salicylic acid derivatives in Salix alba (Willow bark) 
Willow bark contains numerous phenolic compounds that are hydrolysed to salicin 
(Upton, 1999c, p. 8). Hydrolyzed plant material was therefore used to detect the 
presence of salicin and its derivatives. 
3.1.3.2.1 Materials and method 
TLC was carried out according to the method given in the American Herbal 
Pharmacopoeia (Upton, 1999c, p. 8)). A solution of plant extract (sample A) was 
prepared by heating a mixture of powdered Willow bark (1 g) and methanol (20ml) on a 
water bath at a temperature of 50°C for 10 minutes. 'Ihre mixture was allowed to cool 
and then filtered using a filter funnel and filter paper (Whatman No. 1). 
Alkaline hydrolysis was performed by adding I ml of a solution of anhydrous sodium 
carbonate (50g/L solution) to an aliquot of the prepared plant extract (5ml) and heating 
in a 60°C water bath for 10 minutes. This solution (sample B) was cooled and filtered 
as above. 
TLC of samples A and B was carried out as outlined under 3.1.3.1.4 using the 
appropriate solvent system listed in Table 3.3. Documented Rf values for salicin were 
used to aid interpretation (Wagner, 1984, p. 282; Upton, 1999c, p. 8). 
93 
Table 3.3 Chromatography solvent systems and detection reagents for TLC 
analysis of selected plants (Wagner, 1984; British Pharmacopoeia, 1996; Bisset, 
2001). 
Plant Chromatography Solvent System Detection 
Silybum marianum chloroform: acetone: anhydrous Reagent A 
(Milk thistle seed) formic acid (3.1.3.1.3) 
(75: 16.5: 8.5) 
Apium graveolens ethyl acetate: anhydrous formic acid: Reagent A 
(Celery seed) glacial acetic acid: water (3.1.3.1.3) 
(100: 11: 11: 27) 
Arctium lappa ethyl acetate: anhydrous formic acid: Reagent A 
(Burdock root) glacial acetic acid: water (3.1.3.1.3) 
(100: 11: 11: 26) 
Calendula officinalis ethyl acetate: anhydrous formic acid: Reagent A 
(Marigold flower) glacial acetic acid: water (3.1.3.1.3) 
(100: 11: 11: 26) 
Salix alba ethyl acetate: methanol: water Reagent B 
(White willow bark) (100: 13.5: 10) (3.1.3.1.3) 
Taraxacum officinalis chloroform: ethanol Reagent C 
(Dandelion root) (95: 5) (3.1.3.1.3) 
Crataegus laevigata ethyl acetate: formic acid: glacial Reagent A 
(Hawthorn berries acetic acid: ethylmethyl ketone: (3.1.3.1.3) 
Leaf and flower) water (50: 7: 3: 30: 10) 
3.1.4 Column chromatography 
3.1.4.1 Materials and method 
Commercially prepared polyethylene tubes packed with 8g silica containing a 
fluorescence indicator were supplied by Fisher Chemicals and used for the isolation of 
compounds identified by TLC. 
The crude plant extract (3.1.2.2.1) was dissolved in the selected solvent mixture (Table 
3.3) and applied to the top of the column. The column was allowed to develop and then 
directly examined under UV light to visualize the separated compounds and the desired 
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portions cut out and extracted using the same selected solvent mixture. The resulting 
eluent was analysed using TLC as outlined in 3.1.3.1 
3.1.5 Assays for the detection or quantification of specific 
flavonoids 
3.1.5.1 Detection of plant proanthocvanidins 
Proanthocyanins or flavolans are mainly associated with woody plants and are rarely 
found in herbaceous angiosperms (Walker, (1975, p. 37). Three prepared extracts 
outlined under 3.1.2.2 of the plants identified by the literature to contain 
proanthocyanidins (Salix alba and Crataegus spp. berries plus leaves and flowers), were 
analysed for the presence of proanthocyanidins. 
3.1.5.1.1 Materials and method 
The standard method for acid hydrolysis used was adapted from I-larborne, (1984, 
sec. 283) and Walker, (1975, P. 52). An aliquot of each plant extract (Iml) was placed in 
a boiling tube with an equal volume of 2M HCl (I ml) and the colour of each extract 
recorded. These were then heated on a 100°C water bath for 30 minutes. The tubes 
were removed from the water bath, allowed to cool and any colour changes recorded. A 
red colour indicates a positive result. 
To further extract the anthocyanidins, ethyl acetate (I ml) was added to each tube which 
was shaken for 30 seconds. The top layer (ethyl acetate) was pipetted off and placed on 
labelled watch-glasses to dry in the fume cupboard. The bottom layers were discarded. 
The ethyl acetate layers were re-dissolved in 1 ml of 80% aqueous methanol then filtered 
into crimp top HPLC vials which were stored in the dark at a temperature of 4°C ready 
for analysis. The separated anthocyanidins may be tentatively identified from their 
colours but these only serve as a rough guide (Walker, 1975, p. 54; 1-larborne, 1984, 
p. 62-64). 
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3.1.5.2 Quantitative analysis bSpectroscopy 
The following two spectrophotometric assays quantitatively determine the concentration 
of the two principal flavonoids contained in the berries and in the flowers and leaves of 
Crataegus spp (Hawthorn). 
3.1.5.2.1 Spectrophotometric measurement of procyanidin content in 
Crataegus spp. (Hawthorn berries) 
3.1.5.2.1.1 Materials and method 
Acid hydrolysis of a flavonoid glycoside leads to the separation of the aglycone and the 
sugar moieties thereby enabling independent analysis of the separated portions 
(Markham and Bloor, 1998). The assay was carried out according to the method given 
in the American Herbal Pharmacopoeia, (Upton, 1999a, p. 11). A mixture of 2.5g 
powdered hawthorn berries and 30 ml aqueous methanol (70% v/v) were refluxed for 30 
minutes and then filtered. After 15ml hydrochloric acid and l Oml water were added to 
the filtrate the residue was then washed with 10 ml aqueous methanol and added to the 
acidified filtrate. The filtrate was then refluxed for a further 80 minutes and re-filtered. 
The remaining residue was washed with aqueous methanol and the resulting solution 
added to the filtrate. The final volume was adjusted to 250 ml with aqueous methanol. 
Using a rotary evaporator, 50 ml of this solution was concentrated to a volume of about 
3 ml and transferred to a separating funnel. The flask was rinsed with 15 ml water 
which was also transferred to the separating funnel and the combined solutions shaken 
with 45 ml butanol. The organic layer was diluted to a final volume of 100 ml with 
butanol and the absorbance of this solution measured at 545nm. 
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Total procyanidin available from hawthorn berries was calculated as percentage 
cyanidin chloride using the following formula cited in The American Pharmacopoeia, 
(Upton, 1999c, p. 11): - 
Total procyanidin available as percentage of mass =Ax 500/ 75 xm 
A= absorbance of the test solution at 545 nm 
The specific absorbance of cyanidin chloride is 75 
m= mass of substance to be analysed in grams 
3.1.5.2.2 Spectrophotometric measurement of hyperoside in Crataegus 
spp. (Hawthorn leaf and flower) 
3.1.5.2.2.1 Materials and method 
The assay was carried out according to the method given in the American Herbal 
Pharmacopoeia (Upton, 1999b, p. 14). A stock solution was prepared by heating a 
mixture of 40 ml aqueous ethanol (60%v/v) and 0.4g powered hawthorn leaves and 
flowers on a 60°C water bath for 10 minutes that was allowed to cool, and then filtered 
using a filter funnel and filter paper (Whatman No. 1) into a 100 ml volumetric flask. 
The extraction was then repeated as above by adding 40 ml aqueous ethanol to the filter 
paper and plant residue. The two filtrates combined were adjusted with aqueous ethanol 
to a final volume of 100 ml. 
To prepare the test solution, 5 ml of the above stock solution was evaporated to dryness 
and 8 ml methanol-acetic acid reagent (10 volumes methanol: 100 volumes glacial 
acetic acid) added to the dried extract. This solution was then transferred into a 25 ml 
volumetric flask and 10ml of boric acid-oxalic acid reagent (2.5g boric acid and 2g 
oxalic acid made up to 100 ml with anhydrous formic acid) added and the final volume 
adjusted to 25 ml with anhydrous acetic acid. 
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The blank solution was prepared as above replacing the boric acid-oxalic acid reagent 
with 10 ml anhydrous formic acid. Absorbance of both solutions was measured at 
410nm after standing for 30 minutes at room temperature. 
Concentration of flavonoids available in hawthorn leaf and flower was calculated as 
percentage hyperoside using the following formula cited in The American 
Pharmacopoeia, (Upton, 1999b, p. 14): - 
% available hyperoside =Ax D/M x 405 
A= absorbance of the test solution minus the blank at 41 Onm 
D= dilution factor = 100/5 x 25 
M= mass of powdered material in grams 
405 =E (1%) value of hyperoside at 41Onm 
3.1.6 Analysis of flavonoids and phenolic compounds by High 
Performance Liquid Chromatography (HPLC) 
3.1.6.1 Materials and methods 
3.1.6.1.1 Standard compounds 
Caffeic acid (99%); chlorogenic acid (95%); p-coumaric acid; ferulic acid; rutin (95%); 
quercetin (98%); taxifolin (85%) and silymarin prepared as 1 mg/mi and 0.1 mg/ml 
solutions in 80% ethanol or methanol, filtered into HPL, C vials. Where no percentages 
are quoted they were not specified by the manufacturer 
3.1.6.1.2 Equipment 
HPLC analysis was carried out using a Waters 600 HPLC pump with a 600E system 
controller and a Waters 717 plus autosampler coupled to a Waters 996 Photodiode array 
detector. The HPLC was controlled by a PC workstation (Elonex) running Millennium 
3.11 software (Waters Ltd. ) Compounds were separated on a 250mm x 4mm i. d., 51. tm 
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particle, LiChrospher 100 RP-18e capillary column, (Merck) maintained at 25°C. 
Helium was used for de-gassing solvents. 
3.1.6.1.3 Method 
Since retention times can vary between methods a standard method is used by many 
workers in the field (Grayer et al., 2000; Merken and Beecher, 2000). To separate the 
flavonoids present in the samples the mobile phase utilised a gradient solvent system 
prepared from methanol and water and containing acetic acid in order to avoid peak 
tailing (Table 3.4) (Grayer, 2000; l lostettmann and llostetttmann, 1981); the flow rate 
was I ml/min. Solvent A (100% methanol) was used to wash the column. A delay of 13 
minutes between each run was used to re-equilibrate the column. The UV-visible 
spectra were recorded on-line during the H PLC analysis in the range 210-400 nm for 
flavonoids and phenolic acids, 210-600 nm for acid hydrolysed anthocyanidins. The 
characteristic of each peak was ascertained at 254 nm and 335 nm for flavonoids and 
phenolic acids and 535 nm for anthocyanidins. Crude plant extracts (3.1.2.2.1) and 
tincture extracts (3.1.2.2.5) were diluted to l0mg/ml and filtered into HPLC vials prior 
to analysis. The volume of sample solution injected was 30µl. (Markham and ßloor 
1998). 
Table 3.4 HPLC conditions for the analysis of flavonoids in plant extracts 
Time (min) Solvent A Solvent C Solvent D Flow (ml/min) 
0 0 75 25 1.0 
20 0 0 100 1.0 
24 0 0 100 1.0 
25 0 75 25 1.0 
Solvent A= Methanol 
Solvent C= 2% Aq. Acetic acid 
Solvent D= Methanol: water: acetic acid 18: 1: 1 
3.1.6.1.4 Identification procedures 
The UV-visible spectra of phenolic compounds provide a valuable aid to their 
identification since the wavelengths of the absorption maxima are often characteristic of 
a particular class of compound. Flavonoids are easily detectable using UV detectors 
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since they possess a chromphore which allows them to absorb UV light (Waterman and 
Mole, 1994, p. 79-80). Flavonoids and hydroxycinnamic acids present in the extracts 
were identified where possible by retention times and by comparing the UV spectra of 
the peaks with those of the available standards. Where authentic samples were 
unavailable general identification of flavonoid types was made by interpretation of the 
general flavonoid spectrum which typically consists of two absorption maxima in the 
ranges 240-285nm (band 11) and 300-550 (band 1), (Markham, 1982, p. 37; Jodrell 
Laboratory, 2004). Band I absorption can be used as a guide to the type of flavonoid 
present. Flavones tend to absorb between 310 - 350nm, whilst flavonols absorb 
between 330 - 385nm. Flavanones tend to have the major hand 11 maximum in the 270 
- 295nm region. They also have a small shoulder in the 300 - 330nm region. 
Anthocyanins have a principal maxima at 475-550nm (Markham, 1982, p. 39; Markham 
and Bloor, 1998, p. 25). Caffeic acid and its derivatives have characteristic absorbance 
bands at 243nm and 326nm with a distinct shoulder at 300nm (Markham, 1982, p. 50- 
51). Documented ranges of absorption maxima for different flavonoid types were used 
to aid interpretation (Mabry, 1970; Markham 1982; Pietta, 1998). 
3.1.7 Analysis of plant compounds by Gas Chromatography/ Mass 
Spectroscopy (GC/MS) 
This technique, although not the chromatographic technique of choice for the 
identification of flavonoid compounds, was used to identify any volatile components in 
the crude plant extracts. Flavonoids have a molecular weight which is generally too 
high to volatilize and they may be best chromatographed as their trimethylsiloxy 
derivatives (Evans, 1996). After using a BPX5 column (SGE) which produced a poorly 
separated chromatogram, an attempt was made with a BPX20 column, which produced 
a very acceptable separation for all the plant extracts tested. 
3.1.7.1 Equipment 
GC analysis was carried out on a Fisons/Carlo Erba GC interfaced to a MassLab 
MD800 mass spectrometer. A medium polarity column (SGE BPX20) was used with a 
retention gap to provide protection for the column. 
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3.1.7.2 Materials and method 
Helium at 8 pounds per square inch was used as a carrier gas; the oven programme was 
set at 50°C for 2 minutes then increased by 10°C per minute up to 250°C where it was 
held for 7 minutes. A volume of lµl of the crude plant extract diluted to approximately 
1 mg per ml was injected onto the column via a splitless vapour rising injector at 270°C. 
3.1.7.3 Identification procedures 
The volatile components of the extract separate out at different times according to their 
affinity for the column coating. Although analytes show a characteristic retention time, 
only tentative identification of plant constituents could be made, because most of the 
compounds appeared to be absent from the system's database and reference compounds 
would have been required for positive identification. A characteristic fragment profile 
or mass spectrum was produced for each compound. The mass/charge ratio against 
relative abundance of the resultant ions for each GC peak gives a characteristic 
profile for each compound. Mass spectra for significant GC peaks were 
qualitatively analysed using the National Institute for Science and Technology database 
to allow identification of the type of compound present. 
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3.2. EVALUATION OF PLANT EXTRACTS AS 
ANTIOXIDANTS 
3.2.1 LIPID PEROXIDE ASSAY 
3.2.1.1 Introduction: the membrane structure 
The scope of this project was influenced by the existing knowledge that the plasma 
membrane forms the outer surface of a cell and protects it from harmful substances in 
its immediate environment. The basic structure of all membranes is a phospholipid 
bilayer containing both free-floating peripheral proteins and integral proteins embedded 
in the bilayer. The membrane lipids are distinct and separate from each other yet are 
tightly packed in order to form a flexible cell membrane. This unique structure allows 
the lipids to move laterally freely and rapidly, a process referred to as membrane 
fluidity (1.1.6.1). Proteins account for about 50% of the membrane mass, but there are 
around 50 lipid molecules for every protein molecule (Kingsland, 2000). 
Biological membranes are one of the major targets of reactive oxygen species, the attack 
of which affects membrane functions by inducing lipid peroxidation. The primary 
reaction site for lipid peroxidation is the polyunsaturated fatty acid moities, oleic, 
linoleic and linolenic acids. The rate of oxidation of these fatty acids increases with the 
degree of unsaturation (Mihaljevic et al, 1996). Monounsaturated and saturated 
fatty acids are much less reactive and are not usually affected. 
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3.2.1.2 Peroxidation of unsaturated lipids 
To expand on the process of lipid peroxidation outlined in chapter 1: (section 1.3.4), 
poly unsaturated fatty acids can become peroxidised according to the following scheme 
(Abuja, 2001). 
The initiator (free radical R') abstracts a hydrogen atom from a polyunsaturated fatty 
acid side chain (LH) leaving a carbon-centred radical (L' ). 
LH+R'-4 L'+RH 
The carbon-centred radical (U) combines with molecular oxygen yielding a highly 
reactive lipid peroxyl radical (LOO) 
L'+02-*LOO' 
The lipid peroxyl radical formed is capable of abstracting a hydrogen from an adjacent 
fatty acid to give a lipid hydroperoxide and a new carbon-centred radical (L') and thus 
propagating the chain reaction of lipid peroxidation. A single initiation event can result 
in conversion of hundreds of fatty acid side chains into LOON. The length of the 
propagation chain reaction depends on many factors including the oxygen 
concentration, composition of the fatty acid, and the presence within the membrane of 
chain breaking antioxidants. 
LH + LOO' -3 L' + LOOH 
A termination reaction limits the extent of lipid peroxidation by generating non-radical 
products, i. e. less reactive compounds with no free electrons. 
LOO' + LOO' --+ non-radical products. 
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3.2.1.3 Autoxidation of linoleic acid 
Based on the scheme outlined for the lipid peroxidation of unsaturated lipids, Figure 3.5 
below shows the oxidation of a typical unsaturated fatty acid, linoleic acid. 
Figure 3.5 Mechanism of linoleic acid peroxidation. Adapted from Vaya and 
Avriam (2001). 
Lipid peroxidation, an irreversible reaction, may be considered a result of a pathological 
process. The presence of lipid peroxides in certain tissues has been demonstrated in 
association with several pathological states (Chapter 1). Due to its biological 
significance therefore, assays to assess lipid peroxidation are the most appropriate to 
determine the antioxidant activities of the crude plant extracts and herbal preparations in 
this study. 
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3.2.2 EXPERIMENTAL PROCEDURES 
3.2.2.1 Principles of the lipid peroxide assay using the ferric 
thiocyanate method for the measurement of peroxides. 
The lipid peroxide assay is based on the use of linoleic acid that can undergo lipid 
peroxidation which in turn can be interrupted by antioxidants. Linoleic acid is widely 
reported in the literature as an oxidising substrate and although easily oxidised by air, 
requiring storage under an inert gas such as nitrogen, it is convenient and effective. 
Primary antioxidants such as flavonoids can halt chain reactions by donating an electron 
to the peroxyl radical of the linoleic acid and thus breaking the propagation chain. 
Assessment of antioxidant activity is based on the ability of the crude plant 
extract/herbal preparation to retard oxidation of the linoleic acid when exposed to 
oxidative stress, i. e. exposure to oxygen and heat (incubation). 
The products of lipid peroxidation can be measured by colorimetric methods. A 
convenient spectrophotometric method to measure lipid hydroperoxides is based on the 
oxidation of ferrous to ferric ion and subsequent complexation of the latter with 
thiocyanate. This method for the detection of peroxides was initially developed by the 
food industry to detect the presence of peroxides in the fat of such foods as butter and 
milk, to study the oxidative deterioration of these products (Loftus Hills and Thiel, 
1945). This method, in conjunction with the lipid peroxide assay, has now been 
adopted by a number of workers in the field to asses the antioxidant potential of crude 
plant extracts and phytochemicals against lipid peroxidation. The colour reagent 
thiocyanate permits the direct estimation of the amount of ferric iron formed and the 
sensitivity of the test is particularly high in a solvent of low dielectric strength such as 
ethanol-water mixture with high ethanol content. The ferric thiocyanate response is fast 
and, since only small amounts of sample are needed, the method is suitable for multiple 
sample analysis (Mihaljevic et al, 1996). The sensitivity of the method enables 
170pmol LOOH/ml in the analytical solution to be measured (Mihaljevic et al, 1996). 
The presence of antioxidants in the reaction solution does not interfere with formation 
of the ferric thiocyanate complex (Mihaljevic et al, 1996). 
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3.2.2.2 Ferric thiocyanate assay principle 
Peroxides will convert Fe 2+ ion to Fe3+ ion at acidic pH. Fe3+ ion will then form a 
coloured adduct with ammonium thiocyanate ((Fe(SCN)6)"3) which is observed at a 
wavelength of 500nm. 
The oxidation of ferrous to ferric is a consequence of the one-electron reduction of 
LOOH, followed by monolytic cleavage of LOOH, giving rise to lipid alkoxy radicals, 
LO' (Mihaljevic et al, 1996; Kolthoff and Medalia, 1951): 
LOOH + Fe 2+ --3 LO' + OH- + Fe 
3+ 
The alkoxyl radical is very reactive, and capable of further reacting with another ferrous 
ion: 
LO' + Fe 2+ + H+ -> LOH + Fe 
3+ 
3.2.2.3 Validity of the ferric thiocyanate assay for lipid hydroperoxides 
The preparation and concentration of reagents have previously been established 
(Mihaljevic et al, 1996; Glavind and Hartmann, 1955; Loftus Hills and Thiel, 1946). 
A 30% solution of ammonium thiocyanate has been established as the optimum 
concentration. Reducing the concentration noticeably reduces the colour intensity and 
an increase above 30% does not result in an increase in the colour intensity (Loftus Hills 
and Thiel, 1946). 
The optimum concentration of the ferrous chloride solution is established at 20mM. 
More concentrated ferrous solutions give higher blank values reducing the accurate 
quantification of lipid hydroperoxides (Loftus Hills and Thiel, 1946). 
Maximal colour intensity of the ferric thiocyanate complex formed has been found to be 
dependent on the hydrogen ion concentration (Loftus Hills, & Thiel, 1946; Kolthoff et 
al, 1951). Methods described in the literature use ferrous chloride dissolved in 3.5% 
hydrochloric acid. Ferric and ferrous chlorides are both prone to hydrolysis and the 
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hydrochloric acid is added to prevent this. By experimentation, it was established that 
the colour intensity of the ferrous thiocyanate assay in 75% ethanol was improved if the 
ferrous chloride reagent was made up using a 3.5% hydrochloric acid solution based on 
the actual hydrochloric acid content of the acid (35.45%). Experimentation established 
that this concentration of FeCl2 did not produce, at full oxidation of the ferrous ion by 
hydrogen peroxide, an absorbance beyond the range of the spectrophotometer after the 
thiocyanate was added. Lower concentrations were naturally less sensitive. Since 
ferrous chloride is prone to rapid oxidation, the use of ferrous sulphate acidified with 
sulphuric acid was substituted in the assay. This resulted in the production of a 
precipitate in the test solution and some cloudiness. It was therefore decided to revert to 
the use of ferrous chloride. The acid inhibits the formation of hydroxides (i. e. ferric 
hydroxide) which may add to the absorbance by causing turbidity. 
'4 o, FeC13 + 3H20 Fe (OH)3 + 3HC1 
Fe (OH)3 could form a precipitate without sufficient hydrochloric acid. 
3.2.2.3.1 Kinetics of the development response 
The complete response to micromolar concentrations of LOOH can be achieved within 
5 minutes irrespective of the structure of LOOH (Mihaljevic et al, 1996). Previous 
studies in which this technique is used to measure the antioxidant activity of plant 
material report recording results at 3 minutes after the addition of the ferrous chloride 
solution. 
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3.2.2.3.2 Absorption spectrum 
To establish optimum wavelength for the measurement of the red ferric thiocyanate 
complex, an absorbance curve was plotted using hydrogen peroxide as the oxidising 
agent. The ferric thiocyanate complex absorbs in the green part of the spectrum. 
Readings were therefore taken every 20nm between 400nm and 600nm. Results are 
shown in Fig. 3.6. Absorption maximum was found to be 500nm. 
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Figure 3.6. Absorption spectrum of ferric thiocyanate in 75% ethanol, using 
hydrogen peroxide as the oxidizing agent. 
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3.2.2.3.3 Stoichiometry 
The stoichiometry of the reaction of the hydroperoxy compound hydrogen peroxide 
with ferrous ions has previously been established as a 1: 2 stoichiometry (Mihaljevic et 
al, 1996). The ferrous thiocyanate assay was performed as outlined in section 3.2.2.4 
using different concentrations of hydrogen peroxide as the sample and a standard curve 
constructed to confirm the linearity of the response. Absorbance at 500nm was 
measured at the following concentrations of hydrogen peroxide, 1mM, 5mM, 10mM, 
and IM as these covered the expected experimental range. [Fig. 3.7] The absorbance 
reading for IM was outside the expected range and too high to register an accurate 
result. The 1: 2 stoichiometry relates to hydrogen peroxide only (Mihaljevic et al, 1996). 
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Figure 3.7. Absorbance of ferric thiocyanate complex in 75% ethanol at 500nm 
generated by hydrogen peroxide at concentrations of: 1mM; 5mM; 10mM as 
determined by the ferric thiocyanate assay method. 
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3.2.2.3.4 Sources of error 
In the presence of transition metal ions, Fenton's reaction, resulting in the production of 
additional Fe 3+ ions, would lead to an overestimation of LOOH. 
Autoxidation of Fe 2+ ions by atmospheric 02 may produce a small concentration of 
superoxide ion which could be subsequently involved in the production of additional 
Fe 3+ ions which could also lead to an overestimation of LOOH. 
3.2.2.4 Ferric thiocyanate assay procedure 
3.2.2.4.1 Materials 
Iron (II) chloride tetrahydrate and ammonium thiocyanate 97.5% ACS reagent were 
purchased from Sigma-Aldrich and hydrochloric acid (35.4%) and analytical grade 
ethanol from Fisher Chemical Co. 
3.2.2.4.2 Preparation of reagents 
Ammonium thiocyanate solution was made by dissolving ammonium thiocyanate (6g) 
in distilled water using a 20 ml volumetric flask and adjusting the volume with distilled 
water to 20 ml. 
Ferrous chloride (0.08g) was dissolved in 3.5% hydrochloric acid solution in a 20 ml 
volumetric flask. Small aliquots of the solution were then stored under liquid nitrogen. 
To maintain a low blank reading, several zinc pellets were added to the solution during 
use. The zinc reacted with the hydrochloric acid reducing all Fe 3+ to Fe 2+ (hydrogen ion 
takes an electron from Fe 3+ reducing it back to Fe2). It was observed that ferrous 
chloride solutions prepared with water used immediately from the laboratory two-stage 
still gave lower blank readings. This water was found to contain only traces of oxygen, 
which was determined by the use of a dissolved oxygen meter that showed the level of 
oxygen to be appreciably less than 5% at ambient temperature (20°C). Ferrous (Fe2+) 
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compounds are very readily oxidised to ferric (Fe3+) and this reaction appeared to be 
minimised by the low level of dissolved oxygen present in this water. 
Reagents were freshly prepared each time. 
3.2.2.4.3 Apparatus 
To ensure reproducibility, the same micropipettes were used each time and disposable 
plastic 30ml universal screw cap vials and cuvettes were used to perform the assay. A 
Spectronic 20 Genesys spectrophotometer with a wavelength range of 325 - 1100 nm 
was used to measure the absorbance of the ferric thiocyanate complex. 
3.2.2.4.4 Procedure 
To 10 ml of a 75% ethanol solution, 200µ1 30% ammonium thiocyanate, 200 µl sample 
solution and 200 µl ferrous chloride (20mM) in 3.5% hydrochloric acid were added 
sequentially and stirred immediately after the addition of the ferrous chloride. After 
three minutes the absorbance was read at 500nm. 
For each batch of tests, a blank containing no test solution measured against solvent 
(75% ethanol) was included to confirm the quality of the reagent and as an indication of 
the absence of ferric ions. High blank readings prevent accurate quantification of lipid 
hydroperoxides in samples containing lipids (Richards and Feng, 2000). Under the 
laboratory conditions used, the background absorbance reading varied between 0.007 - 
0.02. If the sample (crude plant extract) was coloured, the absorbance was measured 
against a different sample blank which had the same composition, except for the 
omission of the reagent solutions. The absorbance at 500nm was measured against this 
blank and the reagent blank subsequently subtracted. 
3.2.2.5 Lipid peroxide assay (linoleic acid system) 
3.2.2.5.1 Materials 
The Linoleic acid 97% used was purchased from Lancaster Synthetics Ltd. (Batch No. 
FA003793). Phosphate buffer (pH7) and analytical grade ethanol were obtained from 
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Fisher Chemical Company and n-Propyl gallate and caffeic acid were purchased from 
Sigma-Aldrich. 
3.2.2.5.2 Apparatus 
Oxidising substrate was incubated in 30 ml glass universal screw cap vials, double 
rinsed with distilled water prior to use. A standard temperature controlled 
microbiological incubator was used for incubation. 
3.2.2.5.3 Optimization of the method 
A reaction mixture containing varying proportions of 99.8% ethanol, distilled water, 
phosphate buffer (pH7) and a 2.5% linoleic acid solution was tested following the 
methods of Kikuzaki and Nakatani (1993); Osawa and Namiki (1981); Duh (1998); Ono 
et al, 1999); Kim et al, (2000) and Habash (2000). The amounts of 2.5% linoleic acid 
solution used in the assay mixture differed from author to author ranging from 130µ1 in 
a total volume of 25 ml (Duh, 1998) to 4 ml in a total volume of 20 ml (Habash, 2000) 
giving variable and inconsistent results. The following method was adapted from the 
literature and used to test oxidising substrates containing 2.5% linoleic acid solution in a 
range of concentrations for rate and hydroperoxide formation. 
3.2.2.5.4 Procedure 
A mixture of 2.5% linoleic acid in 99.8% ethanol in varying amounts made up to 8 ml 
with 99.8% ethanol, 8 ml phosphate buffer (p17), and 4 ml water were placed in screw 
top bottles and put in a microbiological incubator at 37°C. A total of 6 concentrations 
were tested: - 100µ1; 250µ1; 500µl; 1 ml; 2 ml and 4 ml. A blank sample containing the 
above mixture with no 2.5% linoleic acid solution was included. Commencing on the 
third day of incubation, absorbance values of each solution were measured by the ferric 
thiocyanate method at 500nm and then measured every 24 hours up to and including the 
11th day. 
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3.2.2.5.5 Effect of time and concentration on the rate of oxidation and 
hydroperoxide formation 
Figure 3.8 shows results over an eleven day period for the 6 concentrations tested. A 
volume of 4 ml of 2.5% linoleic acid in 99.8% ethanol in a total volume of 20 ml, was 
found to produce the highest absorbance readings. Absorbance readings for this sample 
on days 6,7,10 and 11 were outside the accurate measurement range of the instrument, 
although an indication of absorbance can be provided as shown in Fig. 3.8. Albeit these 
results may not be precisely accurate, it seems reasonable to assume that they are 
relative to each other and a trend of increasing absorbance is apparent. These results 
confirm that incubating the assay solution over a5 day period as recommended in the 
literature (Ono et al, 1999) generates hydroperoxides to the maximum level that can be 
accurately measured at the established wavelength of 500nm. 
A concentration curve for the 6 samples on day 5 was plotted and the results shown in 
Figure 3.9. Because of the general trend of the results, an exponential curve gave the 
line of best fit. It has previously been shown that peroxide values reach a maximum and 
then start to decline (Vaya and Avriam, 2001). This was confirmed with samples 
containing 2m1 and 4m1 2.5% linoleic acid in 99.8% ethanol in a total volume of 20m1, 
both showing a slightly reduced absorbance after the 10`h day [Fig. 3.8]. The blank 
sample (assay solution without linoleic acid) registered no increase in absorbance above 
the background blank. 
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Figure 3.8. Absorbance at 500 nm for different amounts of 2.5% linoleic acid in 
20 ml substrate measured by the ferric thiocyanate method over an eleven day 
period, to quantify the rate of oxidation and hydroperoxide formation (mean of 
two experiments). 
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Figure 3.9. Absorbance values showing the results for the generation of 
hydroperoxides, using a range of concentrations of 2.5% linoleic acid in 20m1 
substrate, measured by the ferric thiocyanate method on the fifth day of 
incubation (mean of two experiments) 
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3.2.2.5.6 Effect of incubation temperature on hydroperoxide formation 
The assay mixture found to produce the highest absorbance as described in 3.2.2.6.1 
(4ml 2.5% linoleic acid in 99.8% ethanol in a total volume of 20ml) was incubated at 
the following temperatures: - 4°C; 25°C; 37°C; 60°C and 85°C. Samples were 
measured by the ferric thiocyanate method at 500nm on the 5`h day of incubation. 
Results are shown in Figure 3.10. Maximum generation of lipid hydroperoxides was 
achieved by incubation at 37°C (body temperature). At 85°C no hydroperoxides were 
generated and a red precipitate was observed, indicating that the linoleic acid may have 
denatured. Results confirm that 37°C (body temperature) as recommended in the 
literature, is the most effective incubation temperature, providing the highest absorbance 
readings. 
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Figure 3.10. Effect of incubation temperature on the lipid peroxide assay, 
measured by the ferric thiocyanate method, on the fifth day of incubation (mean of 
two experiments). 
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3.2.2.6 Assessment of antioxidant activity 
The measurement of antioxidant activity is based on the ability of the test substance to 
donate an electron (or hydrogen ion) to the lipid peroxide radical (LOO'), halting 
propagation (chain breaking mechanism). Using the ferric thiocyanate test, antioxidant 
activity is reflected in a reduction in the absorbance of the sample (oxidising substrate 
with the test solution added), against the absorbance of the control [Fig. 3.11 ]. The test 
solution was prepared by diluting the stock solution (plant extract) to the desired 
concentration in 4 ml of 99.5% ethanol. 
Figure 3.11. Lipid peroxide assay. A dark red solution indicates a high level of 
lipid hydroperoxides (control). A paler reaction shows inhibition of lipid 
peroxidation (test solution). 
3.2.2.6.1 Assay protocol to measure antioxidant activity 
A mixture of 4 ml test solution, 4 ml 2.5% linoleic acid in 99.5% ethanol, 8 ml 
phosphate buffer (pH 7) and 4 ml distilled water was placed in screw top bottle and 
incubated at 37°C in a microbiological incubator for 5 days. On the fifth day of 
incubation, the absorbance of the reaction mixture (sample) was measured by the ferric 
thiocyanate method at 500nm as described above. For each crude plant/tincture extract 
different concentrations were tested. 
The synthetic antioxidant n-propyl gallate, a known chain-breaking lipid antioxidant 
(Halliwell et al. 1992) and caffeic acid, a natural antioxidant phenolic compound found 
in plants, were both selected to compare their antioxidant activity with that of the test 
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substances (Pharmaceutical Soc., 1979). To determine an appropriate concentration a 
literature search and brief programme of experimentation was conducted and 50pM was 
deemed to be the most suitable for use in this assay 
3.2.2.6.2 Calculation 
Antioxidant activity was expressed using the formula cited in Duh (1998). 
100 -[( absorbance of sample/ absorbance of control) x 100] 
(Absorbance readings are minus the blank). 
3.2.2.6.3 Pro-oxidant activity 
The antioxidant activity of Silybum marianum has previously been demonstrated in the 
inhibition of lipid peroxidation in rat hepatocytes (Farghali, 2000). This plant was 
therefore selected to use in the development of the lipid peroxide assay. During early 
development of this assay, results showed that the concentration of 2.5% linoleic acid in 
the reaction mixture compared with the concentration of the crude plant extract affected 
the antioxidant activity. Pro-oxidant results against the control were recorded for 
Silybum marianum at a final concentration of 0.02% w/v in a reaction mixture 
containing 250µ1 2.5% linoleic acid solution, compared with 62.7% inhibition in an 
assay containing 4 ml 2.5% linoleic acid solution at the same concentration. 
Furthermore, use of a 1% solution of the silymarin authentic standard produced pro- 
oxidant results when added to a reaction mixture containing 250gl 2.5% linoleic acid 
solution at a final concentration of 0.01% w/v. 
Since the ability of polyphenols to react with metal ions rendering them pro-oxidant has 
been shown in some studies (Cao et al, 1997), to gain further insight, ICP analysis of all 
the selected plant material was undertaken to ascertain the presence of transition metal 
ions capable of promoting the Fenton reaction. 
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3.2.2.7 Experimental design for evaluating the synergistic, additive and 
antagonistic interactions of pairs of crude plant extracts for antioxidant 
activity in the linoleic acid system. 
Synergy is defined as "the phenomenon whereby the effect of two substances acting 
together is greater than the sum of their individual effects" (Bailey, 1999). 
Measurement of synergy is a complex process and there is yet to be a universally 
accepted formula for its determination (Boik, 2001, p. 147). Either additive or 
synergistic interactions are sufficient to increase the potency of most natural compounds 
but there is no accepted definition of either process to distinguish between the two. 
The object of this test is to establish if the antioxidant activity of two herbs tested in 
combination is greater than the sum of both herbs tested singly. 
3.2.2.7.1 Procedure 
The eight crude plant extracts were tested in pairs (28 combinations), following the 
procedure outlined in 3.2.2.6.1. These tests were run in triplicate and the mean 
percentage inhibition for single extracts versus pairs of extracts analysed for antioxidant 
activity using the Mann Whitney test. The pairs of extracts were all tested at a final 
concentration of 0.01 mg/ml, i. e. each crude plant extract was used at a concentration of 
0.005 mg/ml. 
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3.2.3 INDUCTIVELY COUPLED PLASMA (ICP) ANALYSIS FOR 
SELECTED METAL IONS 
There is established evidence for the occurrence of the Fenton and Haber Weiss 
reactions in vitro involving transition metal ions that may catalyse a pro-oxidant 
reaction with flavonoids (1.1.2.5). In view of the pro-oxidant effects observed for 
Silybum marianum during the development of the Lipid Peroxide assay, the possibility 
that the Fenton or a similar reaction catalysed by the presence of transition metal ions 
was occurring was explored. ICP analysis was used to detect the presence of selected 
metal ions in each of the eight plant parts to be tested in vitro for antioxidant activity. 
Metal ions such as zinc and selenium are involved in protecting the body against 
oxidative stress. Selenium is an integral component of the enzyme glutathione 
peroxidase (Sunde and Hoeksra cited in Lentner, 1981, p239). Zinc combined with 
copper is found in the cytoplasmic form of the enzyme superoxide dismutase whereas 
zinc and magnesium occur in the mitochondrial enzyme. Plants containing important 
trace elements such as these may contribute to the plants in vivo antioxidant activity. 
3.2.3.1 Equipment 
ICP analysis was carried out on a Perkin Elmer Plasma 40 ICP with an AES (atomic 
emission spectroscopy) detector. Table 3.5 lists the metals used as standards and their 
characteristic wavelengths. 
3.2.3.2 Materials and method 
ICP analysis was carried out according to the method recommended by Professor Mike 
Revitt (verbal communication), Middlesex University. A weighed sample (20g) of 
dried plant material was ground to a fine powder and left for 24 hours to digest in a 
glass beaker using sufficient hydrochloric acid (4M) to cover the plant material. This 
extract, which had reduced to dryness, was then re-dissolved in 60% hydrochloric acid, 
filtered through Whatman filter No. I and made up to (250 ml) with double distilled 
water. The resulting solution was analysed by ICP at the appropriate wavelength as 
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shown in Table 3.5 to determine the presence of the listed metal ions. The use of 
hydrochloric acid instead of the more usual nitric acid was to dissolve only the easily 
dissolvable ionic components of the plant matrix and not the organically bound metals. 
A mixed aqueous standard solution (lppm) containing the metals listed in Table 3.5 
was prepared from 100ppm standard solutions and calibration curves plotted to quantify 
the levels of each metal ion present in the prepared plant material. The amount of each 
metal shown on the machine output copy is the amount present in the weighed plant 
extract. Integration was set at three times sequentially for each individual metal and 
each plant extract. A one point calibration was used because of the excellent linearity of 
the instrument. A high coefficient of variation, i. e. over-range readings, is normally a 
result of the ICP working at its limit of detection (LOD). The limit of detection can be 
calculated from the standard deviation obtained from analysis of the blank sample at a 
specified wavelength [Table 3.5] using the following equation: - Limit of detection 
(LOD: ppm) = standard deviation (s. d. : ppm) x 3. 
Table 3.5 Metals used as standards in ICP analysis of the selected plants and their 
detection wavelengths. 
Metal Wavelength (nm) 
Nickel (Ni) 221.647 
Iron (Fe) 238.204 
Copper (Cu) 324.754 
Cobalt Co 238.892 
Chromium (Cr) 205.552 
Selenium (Se) 196.090 
Magnesium (Mg) 279.553 
Zinc (Zn) 213.856 
3.2.3.3 Experimental procedure for ICP analysis of the selected plants 
To explore the pro-oxidant activity of Silybum marianum during the development of the 
lipid peroxide assay, ICP analysis was carried out to investigate if this plant contained 
iron or copper documented in the literature to catalyse free radical reactions with 
flavonoids (Cao et al, 1997; Sugihara et al, 1999). ICP analysis was initially carried out 
on the diluted crude plant extract but this solution was incompatible with the instrument. 
Following the above method (3.2.3.2) a nitric acid digestion of Silybum marianum dried 
plant material was performed and ICP analysis showed the presence of both iron and 
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copper. Since nitric acid completely breaks down the plant material releasing all forms 
of the metal, an acid digestion of Silybum marianum dried plant material was carried out 
using the less caustic hydrochloric acid (3.2.3.2) to dissolve only the easily dissolvable 
ionic components of the plant matrix. ICP analysis again showed the presence of iron 
and copper. Intensity counts however, which are directly related to the concentration of 
the target metals, were higher for iron and copper from the nitric acid digestion than that 
from the hydrochloric acid digestion, suggesting more metals were recovered using 
nitric acid. ICP on all the selected plant material was therefore carried out using 
hydrochloric acid digestion. 
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3.2.4 DPPH' SCAVENGING ACTIVITY 
3.2.4.1 Introduction 
DPPH' or a, a-diphenyl-ß-picrylhydrazyl (Fig. 3.12) is a stable free radical capable of 
abstracting the labile hydrogen atom of chemical compounds (Ratty, 1988). This assay, 
which measures the scavenging effect on DPPH, is a simple but effective method for 
investigating the potential free radical scavenging activity (FRSA) of crude plant 
extracts. 
N" ß-120 
02N p2 
NO2 
Figure 3.12 The structure of a, a-diphenyl-ß-picrylhydrazyl free radical (DPPH) 
Ethanolic solution of a known concentration of DPPH' /EtOH produces a deep violet 
colour, which shows maximum absorbance at 517 nm. To evaluate antioxidant activity, 
test compounds (TC-H) are added to the DPPH- solution which may reduce the DPPH' 
radical to the yellow-coloured diphenypicrylhydrazine resulting in a decrease in optical 
absorbency. Decolourisation is stoichiometric with respect to the number of electrons 
taken up (Blois 1958). 
(DPPH)' + TC-H -ý DPPH-H + TC' (Blois, 1958) 
The antioxidant compounds that can scavenge the DPPH' radical are expected to depress 
lipid peroxidation (Aniya et al, 1999). 
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3.2.4.2 Materials 
DPPH, IM Tris HCl buffer (pH 7.4), propyl gallate and caffeic acid were purchased 
from Sigma-Aldrich. Analytical grade ethanol was obtained from Fisher Chemical 
Company. 
3.2.4.3 Experimental procedure 
Methodology was adapted from the methods of Pieroni et al (2002) and Aniya et al 
(1999). The stable free radical DPPH' was dissolved in ethanol to give a 0.1 mM 
solution and the test solution was prepared by diluting the stock solution (plant extract) 
with ethanol to the desired concentration. For each test solution different concentrations 
were tested. The optical absorbency of DPPH is unaffected by pH except for highly 
alkaline solutions (Blois, 1958). A Tris HCl buffer (pH 7.4) was used in the reaction 
mixture to stabilise the pH of the test solutions. 
The reaction mixture added sequentially, consisted of 1 ml 0.1 mM DPPH, 1 ml Tris 
HCl buffer (pH 7.4) diluted to 0.05M and 1 ml test solution or ethanol/water at the same 
ethanol concentration as the test sample (control), mixed in a cuvette and shaken. The 
decrease in DPPH absorption was measured at 517 nm using a spectrophotometer 
exactly 30 seconds after adding the test solution and every 60 seconds for 30 minutes. 
Readings taken at 30 seconds showed the immediate reducing ability of the test 
solutions. At 2 minutes absorbance readings had stabilized. Subsequent readings 
showed only minimal change after 10 minutes. All results were therefore based on how 
much each test solution reduced the DPPH radical after 10 minutes. To measure the 
absorbance of the plant extract alone as a blank, DPPH was omitted from the reaction 
mixture and replaced by ethanol. All tests were run in triplicate and the mean values 
obtained used to calculate the "Free Radical Scavenging Activity" (FRSA) of the test 
solution. Propyl gallate and caffeic acid were used at a concentration of 100pm as 
positive controls (Pieroni et al, 2002; Yan et al, 1998). 
3.2.4.4 Calculation 
To calculate the DPPH radical scavenging activity (FRSA), the absorbance of the blank 
(crude plant extract alone) was subtracted from the absorbance of the reaction mixture. 
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The resultant figure was then subtracted from the absorbance of the control and 
expressed as the percent decrease in the absorbance of the reaction mixture compared 
with that of the control. The antioxidant activity of each test solution was also 
expressed as an IC50 value (concentration in mg/ml or µM/ml required to reduce the 
DPPH- radical by 50%), which was determined from the log dose-inhibition curve. By 
experimentation it was shown that this method, widely used in the literature, should be 
utilised, due to the non-linearity of the crude plant/tincture extracts. The co-efficient of 
correlation relating to the logarithmic curve was superior to that produced by the linear 
graph. 
3.2.4.5 Determination of the ICSo value 
The FRSA of each test compound was expressed as an IC50 value, determined 
graphically. This was obtained by calculating the correlation co-efficient from the log 
concentration of the test substances by linear regression analysis, i. e. FRSA of the test 
substance as calculated above was plotted for the concentration expressed as a 
logarithm. The IC50 was calculated by using the following equation: - 
IC50 = y50 - intercept / slope = log of IC5o (expressed as concentration in mg/ml or 
µM/m1) 
In figure 3.13 on the following page, the log dose-inhibition curve is shown for the 
crude plant extract of Apium graveolens. Using the equation above the IC50 value is 
found to be 0.024983 (0.025) mg/ml. 
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Apium graveolens (Celery seed) 
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Figure 3.13 The log dose-inhibition curve of Apium graveolens crude plant extract 
corresponding to percent inhibition of the DPPH' radical (FRSA) 
Because a linear response is not always obtained from work involving plant extracts the 
above method (3.2.4.5) is used by many authors in the field. Concentration against 
inhibition for Apium graveolens crude plant extract created a curve [Fig. 3.14] whereas 
the log dose against inhibition produced a straighter line [Fig. 3.13] and better 
coefficient of correlation. The IC50 concentrations calculated from these graphs, were 
0.024983 (0.025) mg/ml [Fig 3.13] and 0.044931 (0.045) mg/ml [Fig. 3.14]. Tests 
based on these results established 0.024mg/ml as the exact IC50 confirming the use of 
linear regression analysis based on the log dose of the test substances in this study. 
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Figure 3.14 The linear dose-inhibition curve for Apium graveolens crude plant 
extract corresponding to percent inhibition of the DPPH' radical (FRSA) 
The concentrations (mg/ml) of crude plant extract and commercial tincture extract used 
to calculate the IC50 value of each of the extracts from all the selected plants are shown 
in Table 3.6 on the following page. The IC50 value of each extract was calculated using 
linear regression analysis for the logarithm and interpolation as outlined for Apium 
graveolens (celery seed), Figure 3.13. 
0 20 
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Table 3.6 Concentrations (mg/ml) used to calculate the IC50 value i. e. the 
concentration in mg/ml required to reduce the DPPH' radical by 50%, which was 
calculated using linea regression analysis for the logarithm and interpolation. 
PLANT DPPH Assay: concentrations DPPH Assay : concentrations 
(mg/ml) used to calculate the (mg/ml) used to calculate the 
IC50 value of the crude plant IC50 value of the commercial 
extracts tinctures (liquid extracts) 
Apium graveolens 0.1: 0.05: 0.01: 0.005 0.5: 0.1: 0.05: 0.01 
(Celery seed) 
Taraxacum 0.1: 0.05: 0.01: 0.005 0.5: 0.25: 0.1: 0.05 
officinale 
(Dandelion root) 
Arctium lappa 0.05: 0.01: 0.005; 0.001 2.5: 1.0: 0.5; 0.1 
(Burdock root) 
Crataegus laevigata 0.01: 0.005: 0.001: 0.0005 0.1: 0.05: 0.025: 0.01 
(Hawthorn leaves 
and flowers) 
Crataegus laevigata 0-1: 0.05: 0.01: 0.005 0.05: 0.025: 0.01: 0.005 
(Hawthorn berry) 
Silybum marianum 0.1: 0.05: 0.01: 0.005 0.5: 0.25: 0.1: 0.05 
(Milkthistle seed) 
Salix alba 0.01: 0.005: 0.001: 0.0005 0.025: 0.01: 0.005: 0.001 
(White Willow bark) 
Calendula officinalis 0.5: 0.1: 0.05: 0.01 0.1: 0.01: 0.005: 0.001 
(flower) 
3.2.4.6 Experimental design for evaluating the synergistic, additive or 
antagonistic interaction of the crude plant extracts for antioxidant activity 
in the DPPH assay 
In order to evaluate any synergistic, additive, or antagonistic interactions in the DPPH 
assay, ICSO values for the crude plant extracts were all tested to establish exact 
percentage inhibition (IC50 is only an estimation). 
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By experimentation, it was shown that by using half the IC50 concentration to reduce the 
DPPH radical by 25%, variable results were achieved, i. e. they did not display linearity. 
The log dose-inhibition curve was shown to be unsuitable for calculating IC25 
concentrations. Exact percentage inhibition (FRSA) of the crude plant extracts at half 
the IC50 values was established and the crude plant extracts were tested in pairs, by 
using half the IC5o value for each herb. The FRSA of the combination of two individual 
herbs was compared with the combined FRSA's of the same herbs tested singly. 
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CHAPTER 4: RESULTS and DISCUSSION 
4.1 METHODS OF PLANT ANALYSIS FOR 
IDENTIFICATION OF FLAVONOIDS 
The flavonoid content of the plant samples used in this study has been investigated 
using various chromatographic techniques. The results for each plant are presented 
individually. A typical set of chromatograms is shown for Silybum marianum (Milk 
thistle). In HPLC analysis, only compounds showing a distinct peak are reported. 
4.1.1 Extraction 
Extraction of the compounds from the dried plant material listed in Table 3.1 by two 
different solvents is shown in Table 4.1. 
Table 4.1 Yield and description of the crude plant extracts obtained from the 
selected plant parts extracted with 100% MeOH and 80% EtOH from 30g dried 
plant material 
Yield (g) 
Plant Yield (g) 100% Extract 80% Extract 
methanol ethanol 
Silybum 3.5g Deep russet brown 2g Dry brown 
marianum separating into a solid brown extract 
layer and yellow oil. 
Arctium lappa 4g Deep brown 4g Dry deep 
brown 
Cralaegus 6.5g Brown 6g Solid 
laevigata (berries) maroonish- 
brown extract 
Crataegus 0.5g Dark green 3g Dark green 
laevigata (leaves syrupy liquid 
and flowers) 
Apium graveolens 0.5g Bright green 3g Green and 
syrupy 
Taraxacum 4.5g Dark brown 5g Dry golden 
officinale brown 
Salix alba 2g Dark woody brown 1g Solid woody 
brown 
Calendula 4.5g Sticky bright orange- brown 4g Bright orange- 
officinalis brown and 
stick 
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The results indicated that the extract yields for most plants were similar, but the nature 
of the extracts differed in that the 80% ethanol solvent generally produced a drier 
extract. 
4.1.2 Chromatographic analysis 
4.1.2.1 Silybum marianum (Milkthistle) 
4.1.2.1.1 Thin Layer Chromatography 
TLC analysis of the crude plant extract (sec. 3.1.2.2.1) carried out using the reference 
compounds silymarin and taxifolin gave Rf values which were consistent with those 
reported in the literature (Wagner 1984, p. 190). Three spots were observed for the 
extract, each corresponding to the appropriate reference compound, Fig. 4.1. Silymarin 
was resolved into two yellow spots identified as silybin (Rf 0.6) and silychristin (Rf 
0.35). Taxifolin appeared as a pinky orange spot at Rf 0.4. Silydianin appeared as a 
pale yellow fluorescent zone between taxifolin and silybin (Wagner, 1984, p. 190). 
4.1.2.1.2 Column Chromatography 
Silymarin has been shown to consist of a number of related flavonoid compounds 
including silybin, silydianin, silychristin, isosilybin and dehydrosilybin (Bilia et al, 
2001; Campodonico et al, 2001). Column chromatography of the crude plant extract of 
Silybum marianum was used to ascertain if this new technique achieved a better 
separation of the silymarin compounds than TLC. Using a newly developed 
commercially prepared polyethylene column gave no better separation and TLC 
analysis of the extracted fractions were the same as reported above. Glass column 
chromatography was slow and unsuccessful in separating the components. As a result 
of this no further analysis was carried out using this technique. 
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Components: 
Silybin 
Taxifolin 
Silychristin 
Figure 4.1. TLC chromatogram of Silybum marianum (Milkthistle) 
(Solvent system A/ Detection reagent A, pages 89 and 91). 
1. Methanol extraction 
2. Ethanol extraction 
3. Reference compound silymarin 
4. Reference compound taxifolin 
5. All samples 1-4 
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4.1.2.1.3 High Performance Liquid Chromatograph 
High performance liquid chromatography (HPLC) was carried out on three different 
extracts of Silybum marianum (secs. 3.1.2.2.1; 3.1.2.2.3; 3.1.2.2.4). Typical 
chromatograms of an extract viewed at two characteristic wavelengths i. e. 254nm and 
335nm (Jodrell laboratory, 2004) are shown in Fig. 4.2 (254nm) and Fig. 3.4 (335nm) 
previously shown in Chapter 3. The flavonoid/phenolic acid compounds identified in 
these three extracts are listed in Tables 4.2 and 4.3. HPLC analysis of the crude plant 
extract confirmed the presence of the flavonoids, in particular the flavolignans, reported 
in the literature (Bilia et al, 2001; Campodonico et al, 2001). Compounds comprising 
the silymarin complex were identified in the three extracts by comparing their tR values 
and UV spectra with the corresponding authentic silymarin standard previously shown 
in Chapter 3 [Fig. 3.1]. The peak at tR 10.7 min when compared with an authentic 
sample gave a spectrum typical of taxifolin [Fig. 4.2/ 3.4 and Table 4.2]. Compounds 
appearing at wavelength maxima of 285/290 nm in all three extracts were identified by 
their UV spectra as flavanones (Jodrell laboratory, 2004). Neither the tincture extract 
nor the extract prepared as tincture however contained compounds that equated with the 
authentic silymarin standard, possibly due to a slight shift in retention times, resulting 
from the difference in alcohol concentration of the two types of injected samples, i. e. 
80% MeOH (silymarin) and 25% EtOH (tincture extracts). A flavonol glycoside was 
identified by its UV spectrum in all three extracts (tR 15.31 min) and the flavonol 
quercetin aglycone (previously identified in the crude plant extract; sec. 3.1.2.2.2) was 
again identified in this extract (tR 17.39 min), but could not be identified in the two 
tincture extracts. Quercetin methyl ether plus its aglycone (tR 20.71 min and 21.36min) 
were also only identified in the crude plant extract (Grayer, 2004). Hydroxycinnamic 
acids in all three extracts i. e. caffeic acid derivatives, p-coumaric acid and ferulic acid 
were identified by comparing the UV spectra of the peaks with authentic standards. 
As illustrated in Table 4.2 the differences in the phytochemical profiles of the two types 
of extracts, crude plant extract (sec. 3.1.2.2.1) and tincture extract (sec. 3.1.2.2.4) are 
quite significant. Although an extraction as tincture (sec. 3.1.2.2.3) prepared in the 
laboratory using the same plant material as the crude plant extracts [Table 3.1] 
recovered more flavonoid compounds than the commercially produced tincture, none of 
these compounds appeared to belong to the silymarin complex. Thus it would appear 
that both the composition of the solvent mixture and method of extraction had a 
significant effect on the flavonoid profile of the two types of extract. 
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Table 4.2. Results of HPLC-DAD analysis of Silybum marianum showing the 
flavonoid/phenolic acid profiles of the commercial tincture extract and crude plant 
extract used in the testing of antioxidant activity. 
Compounds detected at 254nm and 335nm 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(25/25%EtOH) 
CRUDE PLANT EXTRACT 
(80% EtOH) 
Retention Time 
(Minutes) 
3.29 Caffeic acid derivative 
4.71 Chloro enic acid 
10.71 Dihydroflavonol (taxifolin)* 
-coumaric acid derivative 10.78 
11.34 Dihydroflavonol sil marin * 
Ferulic acid 11.48 
12.11 Caffeic acid derivative 
13.18 Dihydroflavonol sil marin * 
13.78 Dih droflavonol(sil marin)* 
14.1 Flavanone 
14.34 Dihydroflavonol sil marin * 
Flavanone 14.40 
14.91 Dih droflavonol (silymarin)* 
Flavonol 1 coside 15.31 Flavonol glycoside* 
15.51 Dihydroflavonol (silymarin)* 
16.11 Dihydroflavonol (silymarin)* 
16.28 Flavanone 
16.69 Dihydroflavonol sil marin * 
16.94 Dihydroflavonol sil marin * 
17.39 Quercetin a1 cone** 
17.66 Dihydroflavonol sil marin * 
17.79 Flavanone 
18.04 Flavanone 
20.71 Quercetin methyl ether** 
21.36 Quercetin methyl ether 
a1 cone** 
* Compounds identified by direct comparison with the authentic Silymarin standard. 
** Compounds identified by their retention times and on-line UV spectra in 
collaboration with experienced staff at the Jodrell laboratory, Kew (Grayer, 2004). 
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Table 4.3. Results of HPLC-DAD analysis of Silybum marianum showing the 
flavonoid/phenolic acid profiles of the commercial tincture extract and extract 
prepared as tincture. Compounds detected at 254nm and 335nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(25/25% EtOH) 
EXTRACT PREPARED AS 
TINCTURE (25/25% EtOH) 
Retention Time 
(Minutes) 
5.51 Caffeic acid derivative 
5.80 Caffeic acid derivative 
8.41 Caffeic acid derivative 
8.83 p-coumaric acid derivative 
8.90 p-couman acid derivative 
-coumaric acid 10.78 
Ferulic acid 11.48 
11.6 Flavanone 
11.7 p- coumaric acid 
12.6 Ferulic acid 
12.9 Caffeic acid derivative 
13.8 Flavanone 
Flavanone 14.1 Flavanone 
14.8 Flavanone 
15.5 Flavanol glycoside 
16.6 p-coumaric acid derivative 
16.9 Flavanone 
17.8 Flavanone 
18.8 -coumaric acid derivative 
p-coumaric acid derivative 19.1 p-coumaric acid derivative 
4.1.2.1.4 Gas Chromatography/Mass Spectrometry (GC/MS) 
GC analysis of the authentic reference sample of silymarin was unable to detect any 
compounds, indicating the non-volatile nature of this flavonoid complex. Results of 
GC/MS analysis of the crude plant extract (sec., 3.1.2.2.1) and tincture extract (sec., 
3.1.2.2.4) are shown in Fig 4.3 and Table 4.4. Using the chemical database, tentative 
analysis of the two extracts showed the presence of several fatty acids and components 
consistent with the literature (Bisset, 2001, p. 122; El Mallah et al, 2003): - lauric acid 
ethyl ester (tR 20.7 min), glycerol (IR 21.4 min, tincture extract) a basic component of 
nearly all complex lipids (Bailey, 1999), lauric acid OR 22.6 min, tincture extract), ethyl 
pentadecanoate OR 22.8 min, tincture extract), palmitic acid (tR 27.3 min), stearic acid 
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(tR 31.1 min, crude plant extract), palmitoleic acid (tR 32.0 min, crude plant extract) and 
arachidic acid (tR 37.16 min, crude plant extract). The following compounds were also 
tentatively identified using the database: - 
9 Acetic acid (tR 11.5 min, crude plant extract), an essential primary metabolite 
particularly as acetyl- CoA (Evans, 1996) 
"A heterocyclic 4H pyran-4-one compound (tR 21.0 min, crude plant extract), 4H 
pyran-4-one derivatives are widely distributed in nature. 
A furan compound possibly 5-(hydroxymethyl) furfural at tR 23.2 min (crude 
plant extract) 
7 dodecanol, an unsaturated long chain aliphatic alcohol at tR 33.5 min. 
"A high peak at tR 23.3 min (tincture extract) whose identity could not be 
established from the database but was identified by the mass spectrum to most 
likely be an unsaturated alcohol, probably C 18 with 2 double bonds. 
Acquisition of pure samples of all the above compounds to verify retention time 
equality would be necessary for positive identification. Since no flavonoid compounds 
were detected in any of the plant samples, no further results for GC/MS are reported. 
This method was used as an exploratory exercise to ascertain the nature of some of the 
other constituents present. Results for all the selected plants were similar to those 
reported for Silybum marianum. 
Sample ID: Milk Thistle Seed Extract 
BP2 
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Figure 4.3. GC analysis of the separations of Silybum marianum showing 1) crude 
plant extract (BP23) and 2) commercial tincture extract (BP24). 
Table 4.4. Results of GC-MS analysis of Silybum marianum showing the volatile 
components of the commercial tincture extract and crude plant extract used in the 
testing of antioxidant activity. 
TINCTURE EXTRACT 
(Liquid extract 25/25% EtOH) 
CRUDE PLANT EXTRACT 
(80% EtOll) 
Retention Time 
(Minutes) 
11.5 Acetic acid 
Dodeconoic (lauric) acid ethyl 
ester 
20.7 Dodeconoic (lauric) acid ethyl 
ester 
21.0 2 methyl-3,5-dihydroxy (4H) 
pyran-4-one 
Glycerol 21.4 Glycerol 
Dodecanoic (lauric) acid 22.6 
Pentadecanoic acid, ethyl ester 
(ethyl pentadeconoate) 
22.8 
23.2 5 (h drox meth l) furfural 
Unsaturated aliphatic alcohol 23.3 
Hexadecanoic (palmitic) acid 27.3 Hexadecanoic (palmitic) acid 
31.1 Octadecanoic (stearic) acid 
32.0 Palmitoleic acid 
7 dodecanol 33.3 7 dodecanol 
37.16 Eicosanoic (arachidic) acid 
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4.1.2.2 Taraxacum officinale radix (Dandelion root) 
4.1.2.2.1 Thin Layer Chromatography 
Bisset (2001, p. 488) considers that methods for TLC analysis of dandelion root are 
questionable. Using the method outlined in the British Pharmacopoeia (1996, p. 69) 
however found the major bands relative to the solvent front matched the literature 
values for the crude plant extract (sec. 3.1.2.2.1) as follows, red Rf 0.85, purple Rf 0.6 
and red Rf 0.5 and Rf 0.45 in accordance with the composition of a typical dandelion 
root extract. No reference compounds are specified. 
4.1.2.2.2 High Performance Liquid Chromatography 
High performance liquid chromatography was carried out on three different extracts of 
Taraxacum officinale radix (secs. 3.1.2.2.1; 3.1.2.2.3; 3.1.2.2.4). The phenolic 
compounds identified in these three extracts are listed in Tables 4.5 and 4.6. HPLC 
analysis of the crude plant extract confirmed the presence of caffeic acid derivatives the 
main phenolic compounds reported in the literature (Barnes et al, 2002, p. 171). Identity 
of these compounds was established by confirming their UV spectra with those of the 
corresponding standards. The peak at tR 4.71 min, when compared with a known 
sample, was indicative of chlorogenic acid. No phenolic compounds were identified in 
the commercial tincture extract. This was in contrast to the extract prepared as tincture 
[Table 4.6] which presented a similar profile to the crude plant extract [Table 4.5], 
although fewer caffeic acid compounds were identified in the extract prepared as 
tincture. It is possible that the difference in alcohol concentration of the two different 
injected samples, i. e. 80% EtOH (crude plant extract) and 25% EtOH (tincture extracts), 
caused a slight shift in retention times of the two types of extract, resulting in their 
apparent disparity. 
Since the two methods of extraction (sec. 3.1.2.2.1; sec. 3.1.2.2.3) produced similar 
phytochemical profiles, the absence of phenolic compounds from the commercial 
tincture extract (sec. 3.1.2.2.4) could be postulated to be attributable to storage 
conditions, sample preparation or methods of harvesting and drying (sec. 2.1.5; 2.3.3). 
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Table 4.5. Results of HPLC - DAD analysis of Taraxacurn officinale showing the 
flavonoid/phenolic acid profiles of the commercial tincture extract and crude plant 
extract used in the testing of antioxidant activity. Compounds detected at 254nm 
and 335nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(45/25% EtOH) 
CRUDE PLANT EXTRACT 
(80% EtOH) 
Retention time 
(minutes) 
No flavonoid compounds or 
phenolic acids could be detected 
in this sample 
3.31 Caffeic acid derivative 
4.71 Chlorogenic acid 
4.85 Caffeic acid derivative 
6.56 Caffeic acid derivative 
8.85 Caffeic acid derivative 
9.60 Caffeic acid derivative 
11.88 Caffeic acid derivative 
12.18 Caffeic acid derivative 
12.51 Caffeic acid derivative 
12.85 Caffeic acid derivative 
13.55 Caffeic acid derivative 
13.70 Caffeic acid derivative 
13.93 Caffeic acid derivative 
Table 4.6. Results of HPLC - DAD analysis of Taraxacum officinale showing the 
flavonoid/phenolic acid profiles of the commercial tincture extract and extract 
prepared as tincture. Compounds detected at 254nm and 335nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(45/25% EtOH) 
EXTRACT PREPARED AS 
TINCTURE (45/25% EtOH) 
Retention time 
(minutes) 
No flavonoid compounds or 
phenolic acids could be 
detected in this sample 
4.60 Caffeic acid derivative 
6.90 Caffeic acid derivative 
7.65 Caffeic acid derivative 
8.43 Caffeic acid derivative 
11.27 Caffeic acid derivative 
11.67 Caffeic acid derivative 
11.95 Caffeic acid derivative 
13.48 Caffeic acid derivative 
16.73 Caffeic acid derivative 
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4.1.2.3 Arctium lappa radix (Burdock root) 
4.1.2.3.1 Thin layer Chromatography 
Standard methods given for TLC analysis of Arclium lappa provide only a fingerprint 
chromatogram for authentication of the plant material (British Herbal Pharmacopoeia, 
1996, p. 49; Bisset, 2001, p. 101). Using the method outlined in section 3.1.3.1, TLC 
analysis of the crude plant extract (sec. 3.1.2.2.1) found the following major bands 
relative to rutin (Rf 0.32), matching the literature values as follows: - a whitish blue band 
(Rx 2.1) and two pale blue bands (Rx 1.74 and Rx 1.4). A narrow intense blue band 
indicated by the literature at Rx 2.35 could not be identified (British Herbal 
Pharmacopoeia 1996, p. 49). Chlorogenic acid at Rf 0.45 (Rx 1.4) was identified by 
comparison with the standard Rf value cited for chlorogenic acid in this solvent system 
(Wagner, 1984, p. 176). 
4.1.2.3.2 High Performance Liquid Chromatography 
HPLC was carried out on three different extracts of Arctium lappa root (secs. 3.2.2.1; 
3.1.2.2.3; 3.1.2.2.4). The polyphenolic compounds identified in these extracts are listed 
in Tables 4.7 and 4.8. The presence in the crude plant extract of the principal 
components of Arctium lappa, namely the caffeylquinic acids composed of polyphenols 
such as chlorogenic acid, caffeic acid and derivatives reported in the literature (Bisset, 
2001, p. 100; Maruta et al, 1995) was confirmed by HPLC analysis. The identity of these 
compounds was established by comparing their UV spectra with those of the 
corresponding standards. No phenolic compounds were identified in the tincture 
extract, while the extract prepared as tincture [Table 4.8] presented a similar profile to 
the crude plant extract [Table 4.7]. Although chromatographic results of the extract 
prepared as tincture and crude plant extract were broadly similar, it is possible that the 
comparative differences in retention times may be due to the difference in alcohol 
concentration of the two types of injected samples, i. e. 80% EtOH (crude plant extract) 
and 25% EtOH (tincture extracts). The peak at tR 17.63 min [Table 4.7] and 17.5 min 
[Table 4.8] with a major absorption peak (band 11) at 275.8nm gave a UV spectrum 
typical of a flavanone in both the crude plant extract and tincture extraction. 
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Since the two methods of extraction (sec. 3.1.2.2.1; sec. 3.1.2.2.3) produced similar 
phytochemical profiles, the absence of phenolic compounds from the commercial 
tincture extract (sec. 3.1.2.2.4) could be attributed to storage conditions, sample 
preparation, harvesting or drying as discussed previously (sec. 2.1.5; 2.3.1 ). 
Table 4.7. Results of HPLC-DAD analysis of Arctium lappa showing the 
flavonoid/phenolic acid profiles of the commercial tincture extract and crude plant 
extract used in the testing of antioxidant activity. 
Compounds detected at 254nm and 335nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(65/25% EtOH) 
CRUDE PLANT EXTRACT 
(80% EtOH) 
Retention time 
(Minutes) 
No flavonoids or phenolic acid 
compounds could be detected in 
this sample. 
3.28 Caffeic acid derivative 
4.17 Caffeic acid derivative 
4.70 Chloro enic acid 
7.10 Caffeic acid derivative 
10.45 Caffeic acid derivative 
11.70 Caffeic acid derivative 
12.27 Caffeic acid derivative 
12.48 Caffeic acid derivative 
12.80 Caffeic acid derivative 
13.32 Caffeic acid derivative 
13.65 Caffeic acid derivative 
13.92 Caffeic acid derivative 
14.23 Caffeic acid derivative 
14.52 Caffeic acid derivative 
14.63 Caffeic acid derivative 
15.02 Caffeic acid derivative 
15.38 Caffeic acid derivative 
17.63 Flavanone 
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Table 4.8. Results of HPLC-DAD analysis of Arctium lappa showing the 
flavonoid/phenolic acid profiles of the commercial tincture extract and extract 
prepared as tincture 
Compounds detected at 254nm and 335nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(65/25% EtOH) 
EXTRACT PREPARED AS 
TINCTURE (65/25% EtOH) 
Retention time 
(Minutes) 
No flavonoids or phenolic acid 
compounds could be detected in 
. this sample 
4.61 Chlorogenic acid 
6.91 Caffeic acid derivative 
10.11 Caffeic acid derivative 
11.0 Caffeic acid derivative 
11.2 Caffeic acid derivative 
11.8 Caffeic acid derivative 
12.0 Caffeic acid derivative 
12.2 Caffeic acid derivative 
12.4 Caffeic acid derivative 
12.6 Caffeic acid derivative 
13.1 Caffeic acid derivative 
13.4 Caffeic acid derivative 
13.7 Caffeic acid derivative 
14.0 Caffeic acid derivative 
14.4 Caffeic acid derivative 
14.8 Caffeic acid derivative 
16.7 Caffeic acid derivative 
17.5 Flavanone 
4.1.2.4 Calendula officinalis (Marigold) 
4.1.2.4.1 Thin layer Chromatography 
TLC analysis of the crude plant extract (sec. 3.1.2.2.1) carried out using the reference 
compounds rutin and chlorogenic acid gave some of the Rf values consistent with the 
literature (Wagner, 1984, p. 176). The chromatogram showed strong orange and yellow- 
green fluorescent zones between Rf 0.2 and Rf 0.4. Rutin at Rf 0.3 as identified by the 
reference sample was an orange zone which lay between two yellow-green fluorescent 
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zones identified as narcissin (isorhamnetin 3-0-rutinoside) above rutin and 
isorhamnetin rutinorhamnoside below it (Wagner, 1984, p. 176). 
4.1.2.4.2 High Performance Liquid Chromatography 
HPLC was carried out on three different extracts of Calendula officinalis (secs. 
3.1.2.2.1; 3.1.2.2.3; 3.1.2.2.4). The phenolic compounds identified in these extracts are 
listed in Tables 4.9 and 4.10. All the extracts contained a number of flavonols, some of 
which were identified as quercetin and isorhamnetin as reported in the literature (Bilia 
et al, 2001; Barnes et al, 2002, p. 103). Flavonol compounds were generally identified 
by their characteristic UV spectra. Specific flavonols like quercetin were identified by 
comparing their IR values and UV spectra with the corresponding authentic samples, 
combined with advice from experienced staff at Jodrell laboratory, Kew. 
Hydroxycinnamic acids in all three extracts, i. e. caffeic acid derivatives, chlorogenic 
acid and p-coumaric acid were identified by comparing the UV spectra of the peaks 
with pure samples. 
Chromatograms for the crude plant extract and extract prepared as tincture were broadly 
similar and comparable to those available in the literature (Pietta et al, 1992; Bilia et al, 
2001). Although a number of flavonols were identified in the commercial tincture 
extract [Fig. 4.10], this chromatogram was significantly different. Not only were more 
flavonol compounds recovered from the crude plant extract [Fig. 4.9] but two clearly- 
defined peaks at tR 14.78 min and tR 15.50 min in the crude plant extract, identified as 
isorhamnetin glycosides, were missing from the commercial tincture extract. Since 
flavonoid compounds are mainly water soluble (Harborne, 1984, p. 55) the use of 90% 
aqueous ethanol for the initial extraction process of the commercial tincture [Table 3.2] 
may have contributed to a reduced efficiency of extraction. 
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Table 4.9. Results of HPLC-DAD analysis of Calendula officinalis showing the 
flavonoid/phenolic acid profiles of the commercial tincture extract and crude plant 
extract used in the testing of antioxidant activity. 
Compounds detected at 254 nm and 335 nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(90/45% EtOH) 
CRUDE PLANT EXTRACT 
(80% EtOH) 
Retention time 
(Minutes) 
4.73 Chloro enic acid 
Caffeic acid derivative 6.73 
Caffeic acid derivative 7.21 
10.83 Flavonol (quercetin glycoside)* 
11.35 Flavonol (quercetin glycoside)* 
11.70 Flavonol (quercetin glycoside)* 
Flavonol (quercetin glycoside) 12.26 Flavonol (quercetin glycoside)* 
Flavonol (quercetin glycoside) 12.4 
Flavonol (quercetin glycoside) 12.71 Flavonol (quercetin glycoside)* 
12.98 Flavonol (quercetin glycoside)* 
13.25 Flavonol (quercetin glycoside)* 
Flavonol (quercetin glycoside) 13.4 
13.50 Flavonol (ac lated * 
13.70 Caffeic acid derivative 
13.81 Flavonol glycoside 
Flavonol glycoside 14.5 
14.78 Flavonol (isorhamnetin 
glycoside)* 
15.40 Flavonol (isorhamnetin 
glycoside)* 
Flavonol glycoside 15.6 
Flavonol glycoside 16.1 
Flavonol glycoside 16.8 
Flavonol a1 cone 18.6 
18.8 p-coumaric acid derivative 
-coumaric acid derivative 19.0 
Quercetin a1 cone 19.4 Quercetin a1 cone* 
19.6 Flavonol a1 cone 
*Compounds identified by their retention times and on-line UV spectra in collaboration 
with staff at the Jodrell laboratory, Kew (Grayer, 2004). 
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Table 4.10. Results of HPLC-DAD analysis of Calendula offtcinalis showing the 
flavonoid/phenolic acid profiles of the commercial tincture extract and extract 
prepared as tincture. 
Compounds detected at 254 nm and 335 nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(90/45% EtOH) 
EXTRACT PREPARED AS 
TINCTURE (90/45% EtOH) 
Retention time 
(Minutes 
4.3 Caffeic acid derivative 
4.6 Caffeic acid derivative 
(probably chloro epic acid) 
Caffeic acid derivative 6.73 
Caffeic acid derivative 7.21 
10.7 Flavonol (uercetin glycoside) 
11.10 Flavonol (quercetin glycoside) 
11.75 Flavonol (quercetin glycoside) 
Flavonol (uercetin glycoside) 12.26 Flavonol (quercetin glycoside) 
Flavonol (quercetin glycoside) 12.4 Flavonol (quercetin glycoside) 
12.6 Flavonol uercetin glycoside) 
Flavonol (quercetin glycoside) 12.71 
13.2 Flavonol (quercetin glycoside) 
Flavonol (quercetin glycoside) 13.4 
13.7 Caffeic acid derivative 
13.8 Flavonol glycoside 
Flavonol glycoside 14.5 
14.6 Caffeic acid derivative 
15.3 Flavonol glycoside 
Flavonol glycoside 15.6 
Flavonol glycoside 16.1 
Flavonol glycoside 16.8 
17.6 Flavonol a1 cone 
p-coumaric acid derivative 19.0 
Quercetin a1 cone 19.6 
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4.1.2.5 Apium jiraveolens (celery seed) 
4.1.2.5.1 Thin Laver Chromatop-ranh 
Standard methods given for TLC analysis of Apium graveolens provide only a 
fingerprint chromatogram for authentication of the plant material (British Herbal 
Pharmacopoeia, 1996, p. 56; Bisset, 2001, p. 82). TLC analysis of the crude plant extract 
(sec., 3.1.2.2.1) using the method outlined in section 3.1.3.1. showed major bands 
relative to rutin (Rf 0.31) that matched the literature values as follows, a pale orange 
band (1.7) and strong wide orange band (1.05) indicative of Apii fructus (British Herbal 
Pharmacopoeia, 1996, p. 56). 
4.1.2.5.2 High Performance Liquid Chromatography 
HPLC analysis carried out on three different extracts of Apium graveolens (secs. 
3.1.2.2.1; 3.1.2.2.3; 3.1.2.2.4) confirmed the presence of flavones and phenolic acids 
reported in the literature (Bradley, 1992, p. 56). These compounds are listed in Tables 
4.11 and 4.12. Luteolin glycosides, luteolin aglycone and a flavone aglycone 
recognised as either chrysoerial or diosmentin were identified by their tR values and UV 
spectra combined with advice from staff at Jodrell laboratory, Kew (Grayer, 2004). 
Hydroxycinnamic acids, i. e. caffeic acid derivatives p-coumaric acid and ferulic acid 
were identified by comparing the UV spectra of the peaks with authentic standards. The 
phenylpropene compound apiole (tR 20.8 min), a component of the essential oil that 
particularly occurs in the fruits of the apiaceae (Harborne, 1989, p. 52), was tentatively 
identified in the crude plant extract and in the extract prepared as tincture (Grayer, 
2004). 
Chromatograms for all three extracts showed a broadly similar pattern in relation to the 
aforementioned compounds. Three clearly defined peaks at IR 16.0 min - 16.9 min 
(detected at 254 nm) that could not be identified, were also observed on the 
chromatogram of the commercial tincture extract. 
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Table 4.11. Results of HPLC-DAD analysis of Apium graveolens showing the 
flavonoid/phenolic acid profiles of the commercial tincture extract and crude plant 
extract used in the testing of antioxidant activity. 
Compounds detected at 254nm and 335nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(90/60% EtOH) 
CRUDE PLANT EXTRACT 
(80% EtOH) 
Retention time 
(Minutes) 
-coumaric acid derivative 7.7 -coumaric acid derivative 
10.0 p-coumaric acid derivative 
p-coumaric acid derivative 10.8 
Flavone (luteolin glycoside) 12.0 Flavone (luteolin glycoside)* 
Flavone (luteolin glycoside) 12.4 Flavone (luteolin glycoside) * 
Flavone (luteolin glycoside) 12.6 
13.0 Flavone (luteolin glycoside) * 
13.3 Flavone (luteolin glycoside) * 
Flavone (luteolin glycoside) 13.9 Flavone (luteolin glycoside) * 
Flavone (luteolin glycoside) 14.3 Flavone (luteolin glycoside) * 
15.5 Flavone (luteolin glycoside) * 
17.1 Caffeic acid derivative 
Luteolin a1 cone 17.4 Luteolin a1 cone* 
17.8 Caffeic acid derivative 
18.8 -coumaric acid derivative 
Flavone (possibly the same as 
the crude plant extract) 
19.0 Chrysoeriol (luteolin 3'methyl 
ether or diosmetin ( luteolin 4' 
methyl ether) 
Caffeic acid derivative 20.0 
20.8 Apiole* 
24.4 Caffeic acid derivative 
*Compounds identified by their retention times and on-line UV spectra combined with 
advice from staff at Jodrell laboratory, Kew (Grayer, 2004). 
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Table 4.12. Results of HPLC-DAD analysis of Apium graveolens showing the 
flavonoid/phenolic acid profiles of the commercial tincture extract and extract 
prepared as tincture 
Compounds detected at 254nm and 335nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(90/60% EtOH) 
EXTRACT PREPARED AS 
TINCTURE (90/45% EtOH) 
Retention time 
(Minutes) 
7.3 p-coumaric acid derivative 
-coumaric acid derivative 7.7 
9.7 p-coumaric acid derivative 
10.0 p-coumaric acid derivative 
p-coumaric acid derivative 10.8 
11.8 Ferulic acid 
Flavone (luteolin glycoside) 12.0 
12.2 Flavone (luteolin glycoside) 
Flavone (luteolin glycoside) 12.4 
Flavone (luteolin glycoside) 12.6 
12.8 Flavone (luteolin glycoside) 
Flavone (luteolin glycoside) 13.9 Flavone (luteolin glycoside) 
Flavone (luteolin glycoside) 14.3 Flavone (luteolin glycoside) 
15.4 Flavone (luteolin glycoside) 
17.0 Caffeic acid derivative 
Luteolin a1 cone 17.4 Luteolin a1 cone 
17.6 Caffeic acid derivative 
18.8 Flavone (possibly the same as 
the crude plant extract) 
Flavone (possibly the same as 
the crude plant extract) 
19.0 
19.9 p-coumaric acid derivative 
Caffeic acid derivative 20.0 
20.6 Apiole 
24.4 Caffeic acid derivative 
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4.1.2.6 Salix alba (White willow) 
4.1.2.6.1 Thin Layer Chromatography: Thin Layer Chromatography for 
the identification of salicylic acid derivatives in Willow bark 
TLC analysis of the crude plant extract produced a chromatogram consisting of two 
distinct zones of red. Red zones observed between Rf 0.4 - Rf 0.6 were identified by the 
literature as the phenol glycosides that are characteristic of Salix spp. (Wagner 1984, 
p. 282). Salicin is documented as the main compound. The red zones observed above Rf 
0.6 (Rf 0.6- Rf 0.8) are reported to be due to catechin, p-coumaric acid, saligenin and 
salicylic acid (yellow-brown) (Wagner, 1984, p. 282). It was not possible to detect any 
colours other than deep red. No reference compounds were used. 
Since the numerous phenolic compounds contained in Willow bark may be hydrolysed 
to salicin, alkaline hydrolysis was carried out further to identify the presence of salicylic 
acids in the raw plant material [Table 3.1 ]. TLC after alkaline hydrolysis showed only a 
single band of red at Rf 0.45 in accordance with the literature (Upton, 1999c, p. 8). 
Salicin is reported to have an Rf value of 0.44 (Upton, 1999c, p. 8) and it would seem 
reasonable to suppose that this compound was salicin. 
4.1.2.6.2 High Performance Liquid Chromatography (HPLC) 
HPLC analysis carried out on three different extracts of Salix alba (secs. 3.1.2.2.1; 
3.1.2.2.3; 3.1.2.2.4) confirmed the presence of flavonoids, namely flavanones and 
phenolic acids, p-coumaric and caffeic acid derivatives as reported in the literature 
(Bisset 2001, p. 438; Upton, 1999c, p. 7). These compounds are listed in Tables 4.13 and 
4.14. Flavanones in all three extracts were generally identified by their characteristic 
UV spectra. Without authentic samples however, this information was insufficient for 
individual compound analysis. Hydroxycinnamic acids, i. e. p-coumaric acid and caffeic 
acid derivatives, were identified by comparing the UV spectra of the peaks with 
authentic standards. A flavonol glycoside OR 14.5 min) and flavonol aglycone OR 17.55 
min) were identified by their general UV spectra in the crude plant extract only. 
Chromatograms for the crude plant extract and extract prepared as tincture were broadly 
similar [Tables 4.13/14]. Variations in the type and amount of compounds recovered 
from each extract may be attributable to the different methods and solvent ratios used in 
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the initial extraction process e. g. absence of flavonol compounds from both the tincture 
extracts. Although the commercial tincture extract contained similar compounds to the 
other two extracts [Tables 4.13/14], fewer compounds were detected and the 
chromatographic profile was notably different. These differences could be explained by 
insufficient sample preparation, i. e. prior to extraction, the bark should ideally be 
pulverized or shredded to increase the surface area exposed to the solvent; poor 
harvesting of raw material or inherent differences in the original source species (sec. 
2.3.7). 
Table 4.13. Results of HPLC-DAD analysis of Salix alba showing the 
flavonoid/phenolic acid profiles of the commercial tincture extract and crude plant 
extract used in the testing of antioxidant activity. 
Compounds detected at 254nm and 335nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(50/25% EtOH) 
CRUDE PLANT EXTRACT 
(80% EtOH) 
Retention time 
(Minutes) 
6.06 Flavanone 
6.4 Flavanone 
10.2 Flavanone 
10.6 Flavanone 
Flavanone 10.9 Flavanone 
11.2 Flavanone 
12.2 Caffeic acid derivative 
14.17 Flavanone 
Flavanone 14.22 
14.5 Flavonol glycoside 
15.0 -coumaric acid derivative 
15.3 -coumaric acid derivative 
Flavanone 15.44 Flavanone 
15.6 Caffeic acid derivative 
16.4 p-coumaric acid derivative 
p-cournaric acid derivative 16.53 
Caffeic acid derivative 16.95 
p-coumaric acid derivative 19.13 
17.55 Flavonol a1 cone 
21.70 Caffeic acid derivative 
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Table 4.14. Results of HPLC-DAD analysis of Salix alba showing the 
flavonoid/phenolic acid profiles of the commercial tincture extract and extract 
prepared as tincture. 
Compounds detected at 254nm and 335nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(50/25% EtOH) 
EXTRACT PREPARED AS 
TINCTURE (50/25% EtOH) 
Retention time 
Minutes 
6.06 Flavanone 
6.9 Caffeic acid derivative 
9.97 Flavanone 
10.4 Flavanone 
10.6 Flavanone 
Flavanone 10.9 Flavanone 
11.2 Flavanone 
12.1 Caffeic acid derivative 
13.1 Flavanone 
13.6 Flavanone 
13.9 Flavanone 
Flavanone 14.22 
14.8 Caffeic acid derivative 
15.2 Flavanone 
Flavanone 15.44 
16.3 -coumaric acid derivative 
16.5 Flavanone 
p-cournaric acid derivative 16.53 
16.8 Flavanone 
Caffeic acid derivative 16.95 
17.5 Flavanone 
18.9 p-cournaric acid derivative 
-coumaric acid derivative 19.13 
4.1.2.6.3 Detection of plant proanthocyanidins 
Anthocyanidins (anthocyanin aglycones) are formed in acid hydrolysed plant tissue 
from colourless polymeric tannins and proanthocyanidins (Pigman et al, 1953; 
Harborne, 1984, p. 88). Three extracts of Salix spp. (secs. 3.1.2.2.1; 3.1.2.2.3; 3.1.2.2.4) 
were analysed by acid hydrolysis for the presence of proanthocyanidins. Results are 
listed in Table 4.15. All three samples developed different shades of magenta identified 
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by colour as cyanidin (Walker, 1975, p. 54; Harborne, 1984, P. 64) confirming the 
presence of proanthocyanidins as reported in the literature (Kolodziej, 1990; Upton, 
1999c, p. 7). HPLC-DAD analysis of the three extracts detected cyanidin in only the 
crude plant extract that had turned a dark, dense magenta. UV-Vis spectra were 
recorded and visually scanned in the range 210-600 nm and chromatograms viewed at 
280nm, and 535nm. Although all the samples developed a red colour, the depth of 
colour varied and the levels of cyanidin appeared to have been too low in both the 
commercial tincture extract and the extract prepared as tincture to register on the 
chromatogram. This may be attributable to the following factors. 
Since the same plant material was used for both the crude plant extract (sec. 3.1.2.2.1) 
and extract as tincture (sec. 3.1.2.2.3), the preparation of the extracts by two different 
methods may have contributed to the apparently different levels of anthocyanin 
aglycones formed by acid hydrolysis in the two extracts. 
Due to the unstable nature of the acid hydrolysed anthocyanin aglycones, the colour of 
the samples awaiting analysis may have faded slightly indicating changes to the 
structure of the anthocyanin that may have affected the resultant chromatograms 
(Harborne, 1984, p. 63). The colour and stability of an anthocyanin in solution is highly 
dependent on the pH. They are most stable and most highly coloured at low pH values 
and gradually lose colour as the pH is increased. Exposure to light results in loss of 
colour (Walker, 1975, p. 51; Goiffon et al, 1991). 
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Table 4.15. Results of acid hydrolysis to detect the presence of proanthocyanidins 
in Salix alba bark, Crataegus laevigata berries and Crataegus laevigata leaves and 
flowers expressed as the production of anthocyanidins. 
HPLC-DAD Compounds detected at 280 nm and 535 nm. 
Plant/type of Colour Colour of Visible Anthocyanidin 
extract of extract after colour identified by 
extract acid analysis HPLC-DAD 
hydrolysis analysis 
Salix albs (bark) 
Crude plant extract brown Very dense Cyanidin Cyanidin 
(80% EtOH) dark (magenta) 
red 
Commercial tincture Pale Magenta red Cyanidin None detected 
extract (liquid extract) amber (traces) 
(50/25% EtOH) brown 
Plant material (bark) Pale Magenta red Cyanidin None detected 
extracted as tincture amber (traces) 
(50/25% EtOH) brown 
Crataegus laevigata 
(berries) 
Crude plant extract Pale Pinky red Cyanidin None detected 
(80% EtOH) yellow traces 
Commercial tincture Amber Pale pink Cyanidin None detected 
extract (liquid extract) (traces) 
(45/25% EtOH) 
Plant material Pale Pinky red Cyanidin None detected 
(berries) extracted as yellow (traces) 
tincture (45/25% 
EtOH 
Crataegus laevigata 
(leaves and flowers) 
Crude plant extract Pale Deep scarlet Pelargonidin Anthocyanidin 
(80% EtOH) yellow red aglycone 
(unidentified) 
Commercial tincture Orange Pinkish Pelargonidin None detected 
extract (liquid extract) (traces) 
(45/25% EtOH) 
Plant material (leaves Pale Weak red Pelargonidin None detected 
and flowers) extracted yellow (traces) 
as tincture (45/25% 
EtOH) 
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4.1.2.7 Crataej us laevijiata (Hawthorn berries 
4.1.2.7.1 Thin Laver Chromatography 
TLC analysis of the crude plant extract (sec., 3.1.2.2.1) carried out using the 
recommended reference compounds vitexin, hyperoside, rutin, caffeic acid and 
chlorogenic acid produced an unresolved chromatogram that gave some of the Rf values 
consistent with those reported in the literature (Wagner, 1984, p. 178; Upton, 1999a, 
p. 10-12). Three weak bands were observed for the extract. Two pale blue bands were 
identified as caffeic acid (Rf 0.9) and chlorogenic acid (Rf 0.45) and a pale yellow band 
at Rf 0.55 corresponded to hyperoside. 
4.1.2.7.2 Hiah Performance Liquid Chromatograph 
HPLC analysis was carried out on three extracts of Crataegi fructus (secs. 3.1.2.2.1; 
3.1.2.2.3; 3.1.2.2.4). The flavonoids/phenolic acids identified in these extracts are listed 
in Tables 4.16 and 4.17. HPLC analysis of the crude plant extract confirmed the 
presence of flavonoids and hydroxycinnamic acids reported in the literature (Djumlija, 
1994). Hydroxycinnamic acids, i. e. caffeic acid derivatives, chlorogenic acid and p- 
coumaric acid, were identified by comparing the UV spectra of the peaks with authentic 
standards. Crataegi fructus is documented to have a low flavonoid content (Wagner, 
1984, p. 178). However several compounds generally identified as flavonols and 
flavones were identified by their characteristic UV spectra [Table 4.16]. Some of these 
compounds were further identified as a quercetin glycoside OR 12.79 min) and quercetin 
aglycone OR 16.74 min) by comparing their IR values and UV spectra with the 
corresponding authentic standards, combined with advice from experienced staff at 
Jodrell laboratory, Kew (Grayer, 2004). Both the commercial tincture extract and 
extract prepared as tincture contained several hydroxycinnamic acids as outlined above 
for the crude plant extract [Table 4.17]. Only one flavonol compound was identified in 
both tincture extracts corresponding with the quercetin glycoside OR 12.79 min) in the 
crude plant extract. No flavones were identified in the tincture extracts. 
Chromatograms of the crude plant extract and extract prepared as tincture were broadly 
similar with a higher proportion of hydroxycinnamic acids identified in the tincture 
extract and more flavonoids in the crude plant extract [Tables 4.16/17]. Since both 
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extracts originate from the same source material, these differences could be attributed to 
the different methods and solvent ratios used for the initial extraction of the plant 
material. The chromatographic profile of the commercial tincture extract in comparison 
to the previous two extracts was notably dissimilar, especially in relation to the extract 
prepared as tincture. In addition to differences in extraction method, the source material 
for the commercial tincture extract may have originated from another species of 
Crataegus. The composition of the flavonoids present in the berries has been reported 
to differ with each species (Upton, 1999a, p. 10). 
Table 4.16. Results of HPLC - DAD analysis of Crataegi fructus showing the 
flavononid/ phenolic acid profiles of the commercial tincture extract and crude 
plant extract used in the testing of antioxidant activity. 
Compounds detected at 254nm and 335nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(45/25% EtOH) 
CRUDE PLANT EXTRACT 
(80% EtOH) 
Retention 
time 
Minutes 
4.82 Caffeic acid derivative (probably 
chloro enic acid) 
4.87 Caffeic acid derivative 
Caffeic acid derivative 6.61 
Caffeic acid derivative 7.05 
9.22 p-coumaric acid derivative 
p-coumaric acid derivative 10.78 
Flavonol (quercetin glycoside) 12.79 Flavonol (quercetin glycoside) 
14.56 Flavonol glycoside 
15.31 Flavone 
15.92 Flavone 
16.74 Flavonol (uercetin a1 cone 
Caffeic acid derivative 16.85 
p- coumaric acid derivative 19.03 
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Table 4.17. Results of HPLC - DAD analysis of Crataegi fructus showing the 
flavononid/ phenolic acid profiles of the commercial tincture extract and extract 
prepared as tincture. 
Compounds detected at 254nm and 335nm. 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(45/25% EtOH) 
EXTRACT PREPARED AS 
TINCTURE (45/25% EtOH) 
Retention 
time 
(Minutes) 
4.63 Caffeic acid derivative (probably 
chloro enic acid) 
Caffeic acid derivative 6.61 
6.9 Caffeic acid derivative 
Caffeic acid derivative 7.05 
p-coumaric acid derivative 10.78 
12.0 Caffeic acid derivative 
12.2 Caffeic acid derivative 
Flavonol (quercetin glycoside) 12.79 Flavonol (quercetin glycoside) 
14.8 Caffeic acid derivative 
Caffeic acid derivative 16.85 
p-coumaric acid derivative 19.03 
4.1.2.7.3 Detection of plant proanthocyanidins 
Three extracts of Crataegi fructus (secs. 3.1.2.2.1; 3.1.2.2.3; 3.1.2.2.4) were analysed 
for the presence of anthocyanidins following acid hydrolysis. Results are given in Table 
4.15. All three samples developed different depths of a weak pinky red identified by 
colour as cyanidin, confirming the presence of proanthocyanins reported in the literature 
(Bahorun et al, 1994; Upton, 1999a, p. 9). However no anthocyanin aglycones could be 
identified by HPLC-DAD analysis in any of the three extracts. UV-Vis spectra were 
recorded and visually scanned in the range 210-600nm and chromatograms viewed at 
280nm and 535nm. Since the colour developed in all three extracts was weak, the 
levels of cyanidin aglycones formed by acid hydrolysis appear to have been too low to 
register as a peak on the chromatograms. Solutions of anthocyanins are unstable and 
may fade prior to analysis - (sec., 4.1.2.6.3). 
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4 . 
1.2.7.4 Quantification of procyanidin content in Crataegus laevigata 
berries 
Since oligomeric proanthocyanidins are documented as one of the major constituents of 
Crataegi fructus, a spectrometric assay to quantify as a percentage the concentration of 
these compounds in the raw plant material [Table 3.1 ] was carried out using the method 
outlined in section 3.1.5.2.1. The presence of cyanidin chloride expressed as an 
absorbance reading at 545 nm was used as the basis of the calculation (Upton, 1999a, 
p. 11). 
Formula as outlined in section 3.5.2.1.1: - Ax 500/ 75 xm 
0.118x500/75x2.5 = 0.31% 
Total procyanidin concentration calculated as percentage cyanidin chloride in a 2.5g 
sample of dried Crataegus laevigata berries = 0.31% The procyanidin content of 
Crataegus spp. are mainly unknown, however the procyanidin concentration in the 
fruits is dependent on the degree of maturity of the fruits, the concentration being 
highest in immature fruits (Svedstromet et al, 2002). 
4.1.2.8 Cratae2us laeviQata (Hawthorn leaves and flowers 
4.1.2.8.1 Thin Laver Chromatoaraohv 
TLC of the crude plant extract (sec., 3.1.2.2.1) was carried out according to the method 
outlined in section 3.1.3.1 using the reference compounds rutin, hyperoside and vitexin. 
The chromatogram showed three distinct bands, each corresponding to the appropriate 
reference compound that gave Rf values consistent with the literature (Upton, 1999b, 
p. 12-13): - a weak orange band at Rf 0.35 in the region of rutin, a strong orange band 
corresponding with hyperoside at Rf 0.52 and yellowish green band of vitexin at Rr 0.65. 
Rutin at Rf 0.35 is reported to co-elute with vitexin-2"-O-rhamnoside (Wagner, 1984, 
p. 178; Upton, 1999b, p. 12-13). 
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4.1.2.8.2 High Performance Liquid Chromatography 
HPLC analysis carried out on three different extracts of Crataegus spp. leaves and 
flowers (secs. 3.1.2.2.1; 3.1.2.2.3; 3.1.2.2.4) confirmed the presence of some flavonoids 
as reported in the literature (Upton, 1999b, p. 10-11). Flavones and flavonols are the 
main flavonoids of Crataegus spp. leaves and flowers. Identified compounds are listed 
in Tables 4.18 and 4.19. Flavone compounds vitexin (apigenin 8-C glucoside) and 
apigenin C-glycoside were identified in all three extracts by their tR values and UV on- 
line spectra combined with advice from experienced staff at Jodrell laboratory, Kew 
(Greyer, 2004). Flavonol compounds present included kaempferol and quercetin, also 
identified as above. Quercetin glycosides were present in all three extracts. Kaempferol 
glycosides (tR 13.39 min) could be identified only in the crude plant extract and the 
extract prepared as tincture and a quercetin aglycone OR 16.76 min) solely in the crude 
plant extract [Tables 4.18/19]. Hydroxycinnamic acids, caffeic acid derivatives, 
chlorogenic acid and p-coumaric acid were identified by comparing the UV spectra of 
the peaks with authentic samples of these compounds. 
The chromatographic results, particularly for the crude plant extract and the extract 
prepared as tincture, were broadly similar. It is possible however that the difference in 
alcohol content of the two different injected samples, i. e. 80% EtOH (crude plant 
extract) and 25% EtOH (tincture extracts), has caused a slight shift in retention times as 
observed for the same compound of vitexin which registered at tR 11.59 for the crude 
plant extract and tR 11.4 for the extract prepared as tincture. The chromatographic 
differences observed for the commercial tincture may be related to the source material 
which, like the berries, may have originated from another species of Crataegus. Such is 
the variation in flavonoids present in the leaves and flowers of the Crataegus spp. that 
the compounds can often be used to separate the different species (Bisset, 2001, p. 162). 
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Table 4.18. Results of HPLC-DAD analysis of Crataegus spp. leaves and flowers 
showing the flavonoid/phenolic acid profiles of the commercial tincture extract and 
crude plant extract used in the testing of antioxidant activity. 
Compounds detected at 254nm and 335nm 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(45/25% EtOH) 
CRUDE PLANT EXTRACT 
(80% EtOH) 
Retention Time 
(Minutes) 
3.27 Caffeic acid derivative 
Caffeic acid derivative 3.36 
3.89 Caffeic acid derivative 
4.16 Caffeic acid derivative 
Caffeic acid derivative 
(probably chloro enic acid) 
4.69 Caffeic acid derivative 
(probably chloro enic acid)* 
Caffeic acid derivative 6.61 
Caffeic acid derivative 7.09 
7.39 p-cournaric acid derivative 
p-cournaric acid derivative 9.91 
10.22 Flavone 
10.52 Flavone 
p-coumaric acid derivative 10.86 
Flavone (vitexin - apigenin 8- 
C- lucoside 
11.59 Flavone (vitexin - apigenin 8- 
C- lucoside * 
12.12 Caffeic acid derivative 
Flavone 12.63 
12.81 Flavonol (quercetin 
glycoside)* 
Flavonol (quercetin glycoside) 12.83 
13.39 Flavonol (kaempferol 
glycoside)* 
Flavone (apigenin C- 
1 coside) 
14.74 Flavone (apigenin C- 
glycoside)* 
15.71 p-coumaric acid derivative 
16.76 Flavonol (quercetin 
a1 cone * 
Caffeic acid derivative 16.88 
p-coumaric acid derivative 19.04 
*Compounds identified by their retention times and on-line UV spectra combined with 
advice from staff at Jodrell laboratory, Kew (Grayer, 2004). 
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Table 4.19. Results of HPLC-DAD analysis of Crataegus spp. leaves and flowers 
showing the flavonoid/phenolic acid profiles of the commercial tincture extract and 
extract prepared as tincture 
Compounds detected at 254nm and 335nm 
COMMERCIAL TINCTURE 
EXTRACT (Liquid extract) 
(45/25% EtOH) 
EXTRACT PREPARED AS 
TINCTURE (45/25% EtOH) 
Retention Time 
(Minutes) 
Caffeic acid derivative 3.36 
4.6 Caffeic acid derivative 
Caffeic acid derivative 
(probably chloro epic acid) 
4.69 
Caffeic acid derivative 6.61 
7.1 p-coumaric acid derivative 
Caffeic acid derivative 7.09 
p-coumaric acid derivative 9.91 
10.0 Flavone 
10.3 Flavone 
p-coumaric acid derivative 10.86 
11.4 Flavone (vitexin - apigenin 8- 
C- lucoside 
Flavone (vitexin - apigenin 8- 
C-glucoside) 
11.59 
11.9 Caffeic acid derivative 
12.3 Flavone 
Flavone 12.63 
12.81 Flavonol (quercetin glycoside) 
Flavonol (quercetin glycoside) 12.83 
13.3 Flavonol (kaempferol 
glycoside) 
14.6 Flavone (apigenin C- 
1 coside 
Flavone (apigenin C- 
glycoside) 
14.74 
16.7 Caffeic acid derivative 
Caffeic acid derivative 16.88 
p-coumaric acid derivative 19.04 
21.5 -coumaric acid derivative 
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4.1.2.8.3 Quantification of flavonoid concentration in Crataegus laevigata 
leaves and flowers 
Crataegus leaves and flowers contain a wide array of flavonoids that are considered to 
contribute strongly to its pharmacological activity (Upton, 1999b, p. 10). Since the 
concentration of these compounds varies according to species, time of harvesting and 
different plant parts, a spectrophotometric assay to determine the flavonoid content of 
the raw plant material (Table 3.1. ) was carried out using the method outlined in section 
3.1.5.2.2. Percentage calculation of total flavonoids present is based on the 
concentration of hyperoside expressed as an absorbance reading at 410 nm. 
Formula as outlined in section 3.1.5.5.2: - Ax D/ Mx 405 
0.163 x 500/ 0.400 x 405 = 0.5% 
The total flavonoid concentration calculated as hyperoside in a 0.400g sample of dried 
Crataegus laevigata leaves and flowers was therefore calculated as 0.5% and this is 
consistent with levels reported in the literature (Upton, 1999b, p. 10). 
4.1.2.8.4 Detection of plant proanthocyanidins 
Three samples of Crataegus spp. (secs. 3.1.2.2.1; 3.1.2.2.3; 3.1.2.2.4) were analysed for 
the presence of anthocyanidins following acid hydrolysis. Results are listed in Table 
4.15. All three samples developed different depths of scarlet confirming the presence of 
proanthocyanidins as reported in the literature (Upton, 1999b, p. 11). HPLC- DAD 
analysis of the three extracts showed the presence of an anthocyanin aglycone in the 
crude plant extract only that did not give a spectrum typical of cyanidin (Jodrell 
laboratory, 2004). UV-Vis spectra were recorded and visually scanned in the range 
210nm - 600nm and chromatograms viewed at 280nm and 535nm. The resultant 
chromatograms were poor due to the levels of anthocyanin aglycone seemingly being 
too low to produce a spectrum from which a positive identification could be made. 
Tentative identification by colour indicated that the compound may be the orange red 
anthocyanin aglycone pelargonidin (Walker, 1975, p. 54; Harborne, 1984, p. 64). 
Although all the samples developed a red colour, the depth of colour varied and the 
levels of anthocyanin aglycones appeared to have been too low in the two tincture 
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extracts to register on the chromatogram. The same reasons as outlined in sec. 4.1.2.6.3 
may apply. 
4.1.3 Discussion 
The reported findings of the qualitative analysis of all the crude plant extracts confirmed 
the presence of phenolic compounds, including flavonoids and phenolic acids, identified 
by the UV spectra from High Performance Liquid Chromatography and the use of 
authentic samples utilizing Thin Layer Chromatography. Since a crude plant extract is 
not the form in which herbs are generally administered as medicine, a set of commercial 
tinctures in the form of liquid extracts was also evaluated by HPLC for their flavonoid 
content in order to compare the antioxidant activity of the two types of extract, with the 
purpose of investigating whether they exhibit similar levels of antioxidant activity. Due 
to the different extraction procedure and varying strengths of alcohol and water being 
used for the production of the commercial tinctures, replica tincture extractions were 
carried out using the same source material as used for the crude plant extract, to ensure 
a more objective comparison of the two different types of extract (i. e. crude plant 
extract and tincture extract) and to establish if the method of tincture extraction 
produced similar constituent profiles when using different source material. 
In general, more flavonoid compounds and hydroxycinnamic acids were extracted by 
using 80% ethanol than by other ethanol concentrations. Freshly prepared tincture 
extracts were found to contain more compounds than commercially produced extracts 
that had been stored for some time and flavonol aglycones could only be identified in 
extractions made with either 80% or 90% ethanol. Although a colour change after acid 
hydrolysis indicated the presence of proanthocyanidins in all the extracts of Sal ix alba 
and Crataegus lavigata (leaves, flowers and berries), the only anthocyanidin that could 
be identified by HPLC was cyanidin in the crude plant extract of Salix alba. Since 
detectable levels of proanthocyanidins are generally reported for both Salix alba and 
Crataegus lavigata (leaves, flowers and berries) (Kolodziej, 1990; Bahorun et al, 1994), 
the unstable nature of the acid hydrolysed anthocyanidins or method of extraction, 
particularly tincture extraction, may have been responsible for the lack of results from 
HPLC analysis (Walker, 1975, p. 54; Goiffon et al, 1991). According to Harborne 
(1984, p. 87) extraction of the full range of proanthocyanidins can rarely be achieved 
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and analysis of anthocyanidin solutions is dependent on the structural type of the 
original proanthocyanidins. 
Flavonoid profiles and the hydroxycinnamic acid content of crude plant extracts were 
found to be generally dissimilar to those of commercially prepared tinctures, except for 
those prepared from Apium graveolens and Crataegus spp. leaves and flowers,. The 
fresh tincture extracts produced from the same plant material as the crude plant extract 
also, in most cases, produced HPLC chromatograms that were different to their 
commercial tincture counterparts, but broadly similar to the crude plant extracts, with 
the exception of Crataegus spp. fruit and Silybum marianum. The differences observed 
between all three types of extract appeared to be controlled by two factors, firstly, use of 
different source material and secondly, the strength of alcohol and water used for the 
extraction process. As outlined in the results, qualitative analysis of the content of both 
the commercial and replica tincture extracts 25% v/v Silybum marianum showed 
negligible amounts of flavanolignans present in each of these extracts compared to the 
80% ethanol crude plant extract. These findings would appear to support results 
reported by Bilia et al, (2001) whose HPLC analysis of a 40% v/v Silybum marianum 
tincture showed a low flavanolignan content (88.6mg/100ml tincture measured as 
silymarin), compared with a 60% v/v tincture with a content which was much higher 
(178mg/100ml tincture). This illustrates the crucial effect that the solvent ratio can have 
on the final extract. Variations relating to extracts produced from raw material obtained 
from different sources could be associated with factors such as geography, climate and 
harvesting procedures as outlined in 2.1.5. This does not explain however the absence 
of any phenolic compounds, namely caffeic acid derivatives from both Arctium lappa 
(Burdock) and Taraxacum officinale (Dandelion) commercial tincture extracts. Phenolic 
acids such as these are heat-sensitive and susceptible to oxidation under certain pH 
conditions (Batovska et al, 2005). Plant phenols are also very prone to enzyme 
oxidation and due to the action of enzymes like glycosidases, esterases, or oxidases 
present in all plants, phenolic material may be lost or degraded in the production or 
storage of liquid herbal products (Stefan and Chantal, 2005). If plant material is to be 
dried before extraction, this should be carried out as quickly as possible after collection, 
without using high temperatures, to avoid the occurrence of chemical changes 
(Harborne, 1984, p. 4). Due to the complexity of a plant extract, the evaluation of the 
chemical stability of a finished product during the storage period is very challenging 
and current information which is mainly focused on the stability of an isolated 
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compound and its decomposition products does not always accurately reflect the 
chemical stability of the compound in an extract (Stefan and Chantal, 2005). Tinctures 
are traditionally stored at normal room temperature in brown glass to minimise 
degradation by sunlight. Storage of the crude plant extracts at -18°C may have 
contributed to their continuing efficacy. Since HPLC analysis of the `extracts prepared 
as tinctures' of Arctium lappa and Taraxacum officinale was carried out on freshly 
prepared samples and both showed the presence of a range of caffeic acid derivatives, 
manufacturing procedures other than the method of extraction would seem to be 
implicated. Failure to follow harvesting guidelines as outlined in sections 2.3.1 and 
2.3.3 may result in an inferior product. Insufficient sample preparation may affect the 
efficacy of the extraction process. While some plant material can be efficiently 
extracted without extensive preparation, others, like roots, will require some pre- 
treatment for efficient extraction to occur. Plant material such as this should ideally be 
pulverized or shredded to increase the surface area exposed to the solvent. Chen et al, 
(2004) investigating the influence of different treatments, i. e. methods of preparation on 
the free radical scavenging activity of Burdock root, found that the phenolic 
components, caffeic acid and chlorogenic acid, exist mainly in the skin of the root and 
that peeling the root and discarding the skin greatly decreased the concentration of these 
components and subsequent free radical scavenging activity. 
Caffeic acid derivatives detected by HPLC in the `extract prepared as tincture' of 
Arctium lappa using 65% ethanol, although registering at slightly different retention 
times, were equal in number to these compounds detected in the crude plant extract. 
By comparison, using 45% ethanol, fewer caffeic acid derivatives were detected in the 
`extract prepared as tincture' of Taraxacum officinale than the crude plant extract. This 
emphasizes yet again the importance of the solvent ratio. It is still not clear, however, 
what impact the effect of the different extracts, i. e. those extracted using different 
alcohol and water mixtures, would have on the efficacy of the extracts in vivo, which 
would require testing for bioequivalence in a suitable pharmacological model. 
Although various pharmacopoeias like the European Pharmacopoeia (1997) contain 
general monographs about tinctures, in which their modes of preparation and the 
amounts of the herbal drug in the tinctures are specified, the individual herbal 
monographs do not specify the amount of alcohol required to facilitate extraction of the 
phytocomplex. This results in commercially manufactured tinctures that contain 
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different amounts of alcohol and varying phytochemical profiles. Since the 
commercial tinctures evaluated are representative of those widely used by Herbalists in 
the U. K. (Table 3.1) they were tested with the crude plant extracts for their antioxidant 
propensity. 
Analysis of the authentic sample of silymarin by Gas Chromatography did not register 
any of the flavonoid compounds that constitute the silymarin complex, thereby 
confirming the need to derivatise these compounds when using Gas Chromatography 
for flavonoid analysis (Markham and Bloor, 1998, p. 30). It is quite possible however 
that the large molecular weight of these compounds will mean that derivatisation will 
fail to make the compounds sufficiently mobile. The compounds identified by Gas 
Chromatography were generally similar in both types of extract. A number of 
compounds like fatty acids, furan compounds, monocarboxylic acids and simple 
phenols were common to most of the tested extracts, but no flavonoid compounds were 
detected. For this reason only a representative set of results namely Silybum marianum 
were reported. Notably, recent studies suggest that in addition to the polyphenols, 
other compounds like fatty acids (e. g. palmitic acid) and some volatile heterocyclic 
furan compounds that have exhibited antioxidant activity in vitro may contribute to the 
antioxidant activity of some plants (Fuster, 2000; Zhang, 2003). This supports the view 
of some authors that the activity of certain plant extracts is not only due to the 
compounds established as being active but also to the contribution from a number of 
other components (Gordon and An, 1995; Houghton, 2000). 
Although all the plants analysed were shown to contain a range of polyphenolic 
compounds, each plant had its own unique profile of flavonoid compounds and phenolic 
acids. Taraxacum officinale and Arctium lappa were shown to contain only caffeic acid 
derivatives. Calendula officinalis contained a number of flavonols, Apium graveolens 
flavones and Crataegus laevigata (leaves and flowers) contained a mixture of both, all 
in combination with caffeic acid derivatives. Silybum marianum was the only plant to 
contain the dihydroflavonol silymarin and proanthocyanidins (condensed tannins) were 
only detected in Salix alba and Crataegus laevigata (leaves and flowers/berries). 
Although, in general, flavonoid compounds all possess the same basic properties 
(section 1.2.7.4 ), variations in structure and different combinations of these compounds 
are likely to influence their activity and antioxidant potential, along with the presence of 
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other nonflavonoidic compounds such as volatile oils and other plant metabolites not 
analysed in this study (section 1.2.7.5). 
As already outlined, one of the underlying principles of Western Herbal Medicine is that 
the therapeutic value of a plant rests not only on its pharmacologically active 
compounds, but on the complex mix of many different compounds. Numerous studies 
now show that isolation of the pharmacologically active compounds may produce less 
activity than the whole plant extracts (Cott and Misra, cited in Gilbert and Alves 2003; 
Houghton, 2000). Many of the flavonoid compounds and hydroxycinnamic acids 
identified in the selected plant extracts have been shown to possess antioxidant activity 
largely in in vitro systems and it is postulated that these compounds may also exert 
antioxidant effects in the whole plant extract. Generally it is considered that the activity 
of medicinal plants containing flavonoids depends not on the flavonoid fraction alone, 
but also on other components which may either directly contribute or play an adjuvant 
role in strengthening the potency of the flavonoid compounds (Pietta, 1998). The 
reported results support the use of whole plant extracts in this study. 
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4.2 EVALUATION OF PLANT EXTRACTS AS 
ANTIOXIDANTS 
4.2.1 LIPID PEROXIDE ASSAY 
4.2.1.1 Results of the antioxidant action of the crude plant extracts on 
linoleic acid oxidation 
Results of the antioxidant activity of the crude plant extracts (sec. 3.1.2.2.1) on linoleic 
acid oxidation are shown in Figs. 4.4 - 4.11. Results are expressed as percentage 
inhibition of the experimental control (oxidizing substrate without antioxidant). All the 
crude plant extracts were tested at the following concentrations (expressed as mg/ml): - 
0.001; 0.0025; 0.005; 0.01; 0.05; 0.1; 0.2; 0.5; lmg/ml and 5mg/ml. All eight crude 
plant extracts exhibited antioxidant activity for most of these concentrations. Results 
generally showed that the antioxidant activity of the crude plant extracts increased with 
increasing concentration up to 1 mg/ml but with antioxidant activity remaining fairly 
constant in the range from 0.005mg/ml to 0.1 mg/ml. Experimental results for 
0.0025mg/ml and 0.001 mg/ml were variable. At 0.0025mg/ml and 0.001 mg/ml 
Calendula officinalis exhibited consistent pro-oxidant activity. At 0.001mg/ml pro- 
oxidant activity was also recorded for Taraxacum officinale. At this concentration 
however, results for Apium graveolens, Silybum marianum, and Arctium lappa were 
changeable with both pro-oxidant and antioxidant activity recorded, albeit by a very 
narrow margin. For example, results from four experiments for Silybum marianum 
ranged from pro-oxidant activity (results x 2) to antioxidant activity (15%) and a result 
(0%) where neither antioxidant nor pro-oxidant activity were observed. At 0.001 mg/ml 
the only extracts to exhibit antioxidant activity were those shown by phytochemical 
analysis to contain proanthocyanidins which were Salix alba and Crataegus laevigata 
leaves, flowers and berries. Since antioxidant activity was consistently observed for all 
the extracts tested at concentrations 0.005mg/ml and above, results for 0.001 and 0.0025 
mg/ml suggest that antioxidant activity is dose dependent and that a threshold level 
exists for each extract at which a change in behaviour from antioxidant to pro-oxidant is 
observed. 
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The strongest antioxidant activity was exhibited by Crataegus laevigata leaves and 
flowers [92%, Fig. 4.5] and Arctium lappa root [91%, Fig. 4.10] at a final concentration 
of lmg/ml. Maximum antioxidant activity was also observed at this concentration for 
Crataegus laevigata berry [89%, Fig. 4.9]; Taraxacum officinalis root [87%, Fig. 4.7]; 
Salix alba [87%, Fig. 4.11] and Apium graveolens [80%, Fig 4.4]. A decrease in 
antioxidant activity at 5mg/ml was observed for all the crude plant extracts except 
Silybum marianum [90%, Fig 4.6] and Calendula officinalis [86%, Fig. 4.8] which 
exhibited the highest level of antioxidant activity at this concentration. Seemingly 
anomalous results were observed for Calendula officinalis and Crataegus laevigata 
berry which both exhibited over 70% antioxidant activity at 0.2mg/ml, 1 mg/ml and 
5mg/ml, but showed a significant decrease in activity at 0.5mg/ml [Figs. 4.8 and 4.9]. 
Salix alba also registered a similar pattern, with a decrease in antioxidant activity at 
0.2mg/mi [Fig. 4.11]. 
Silybum marianum was the only extract to show a consistent increase in antioxidant 
activity with increasing concentration [Fig. 4.6]. Since the flavanolignans comprising 
the silymarin complex were identified as the main flavonoids present in our crude plant 
extract (sec., 2.3.6) and it is this isolated complex that has mainly been used in 
biochemical and pharmacological studies (Morazoni and Bombanelli, 1995), the 
authentic silymarin compound was evaluated for the inhibition of linoleic acid 
peroxidation at 0.001mg/ml; 0.5mg/ml and lmg/ml as a comparison with the crude 
plant extract. The commercial silymarin complex was pro-oxidant at 0.001 mg/ml. 
Results achieved for 0.5mg/ml (30%) and 1mg/ml (62%) however, were considerably 
lower than those registered for the crude plant extract at the same concentrations i. e. 
0.5mg/ml (79.5%) and 1 mg/ml (85%), suggesting a possible loss of activity when the 
silymarin complex was used in isolation. 
Propyl gallate and caffeic acid at a concentration of 50µM were used as positive 
controls to provide a frame of reference against which to assess the extracts' antioxidant 
activity. Both compounds at this concentration were approximately equivalent to 
0.01mg/ml of extract. Propyl gallate and caffeic acid both inhibited linoleic acid 
peroxidation by 50% (n = the mean of three experiments) showing that when tested at 
an equivalent concentration, most of the crude plant extracts were at least as effective as 
the two reference compounds used as antioxidants. 
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Figure 4.4. Evaluation of the inhibition of linoleic acid peroxidation by a range of concentrations 
of Apium graveolens (seed) crude plant extract (80%EtOH) in a lipid peroxide assay to measure 
antioxidant activity. Results are given as a percentage of the control (oxidizing substrate without 
antioxidant). Each column shows the mean ± SD of triplicate determinations except 0.001mg/m1 
which represent data from four experiments. Average coefficient of variation for concentrations 
(0.0025-5 mg/ml) = 4% 
* (0.001mg/mi) Experimental results were inconsistent and varied from pro-oxidant activity to 17% 
inhibition. 
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Figure 4.5. Evaluation of the inhibition of linoleic acid peroxidation by a range of concentrations 
of Crataegus laevigata (leaves and flowers) crude plant extract (80% EtOH) in a lipid peroxide 
assay to measure antioxidant activity. Results are given as a percentage of the control (oxidizing 
substrate without antioxidant). Each column shows the mean + SD of triplicate determinations 
except 0.001mg/ml which shows the mean of four experiments. 
Average coefficient of variation for concentrations (0.0025-5 mg/ml) = 2% 
0.001 0.0025 0.005 0.01 0.05 0.1 0.2 0.5 15 
Concentration mg/ml 
0.001 0.0025 0.005 0.01 0.05 0.1 0.2 0.5 15 
Concentration mg/ml 
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Figure 4.6. Evaluation of the inhibition of linoleic acid peroxidation by a range of concentrations 
of Silybum marianum (seed) crude plant extract (80%EtOH) in a lipid peroxide assay to measure 
antioxidant aactivity. Results are given as a percentage of the control (oxidizing substrate without 
antioxidant). Each column shows the mean + SD of triplicate determinations except 0.001mg/ml 
which represents the data from four experiments. Average coefficient of variation for 
concentrations (0.0025-5 mg/ml) = 3% 
* (0.001mg/ml) Experimental results were inconsistent and varied from just pro-oxidant to 15% 
inhibition. 
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Figure 4.7. Evaluation of the inhibition of linoleic acid peroxidation by a range of concentrations 
of Taraxacum officinale (root) crude plant extract (80% EtOH) in a lipid peroxide assay to measure 
antioxidant activity. Results are given as a percentage of the control (oxidizing substrate without 
antioxidant). Each column shows the mean + SD of triplicate determinations except 0.001mg/ml 
which represents the data from four experiments. Average coefficient of variation for 
concentrations (0.0025-5 mg/ml) = 4% 
* (0.001mg/ml) Experimental results were consistently pro-oxidant at this concentration. 
0.001 0.0025 0.005 0.01 0.05 0.1 0.2 0.5 15 
Concentration mg/ml 
0.001 0.0025 0.005 0.01 0.05 0.1 0.2 0.5 15 
Concentration mg/ml 
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Figure 4.8. Evaluation of the inhibition of linoleic acid peroxidation by a range of concentrations 
of Calendula offtcinalis (flower) crude plant extract (80% EtOH) in a lipid peroxide assay to 
measure antioxidant activity. Results are given as a percentage of the control (oxidizing substrate 
without antioxidant). Each column shows the mean + SD of triplicate determinations except 
0.001mg/ml which represents the data from four experiments. Average coefficient of variation for 
concentrations (0.005-5 mg/ml) = 4.5% 
* Experimental results suggested consistent pro-oxidant activity at both 0.001mg/ml and 
0.0025mg/ml. 
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Figure 4.9. Evaluation of the inhibition of linoleic acid peroxidation by a range of concentrations 
of Crataegus laevigata (berry) crude plant extract (80% EtOH) in a lipid peroxide assay to measure 
antioxidant activity. Results are given as a percentage of the control (oxidizing substrate without 
antioxidant). Each column shows the mean ± SD of triplicate determinations except 0.001mg/ml 
which shows the mean of four experiments. Average coefficient of variation for concentrations 
(0.0025-5 mg/ml) = 4% 
0.001 0.0025 0.005 0.01 0.05 0.1 0.2 0.5 15 
0.001 0.0025 0.005 0.01 0.05 0.1 0.2 0.5 15 
Concentration mg/ml 
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Figure 4.10. Evaluation of the inhibition of linoleic acid peroxidation by a range of concentrations 
of Arctium lappa (root) crude plant extract (80% EtOH) in a lipid peroxide assay to measure 
antioxidant activity. Results are given as a percentage of the control (oxidizing substrate without 
antioxidant). Each column shows the mean + SD of triplicate determinations except 0.001mg/ml 
which represents the data from four experiments. Average coefficient of variation for 
concentrations (0.0025-5 mg/ml) = 4% 
* (0.001mg/ml) Experimental results were inconsistent and activity varied from pro-oxidant to 
inhibition (10%). 
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Figure 4.11. Evaluation of the inhibition of linoleic acid peroxidation by a range of concentrations 
of Salix alba (bark) crude plant extract (80% EtOH) in a lipid peroxide assay to measure 
antioxidant activity. Results are given as a percentage of the control (oxidizing substrate without 
antioxidant). Each column shows the mean + SD of triplicate determinations except 0.001mg/ml 
which shows the mean of four experiments. Average coefficient of variation for concentrations 
(0.0025-5 mg/ml) = 4.5% 
0.001 0.0025 0.005 0.01 0.05 0.1 0.2 0.5 
Concentration mg/ml 
0.001 0.0025 0.005 0.01 0.05 0.1 0.2 0.5 15 
Concentration mg/ml 
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4.2.1.2 Results of the antioxidant action of the commercial tincture 
extracts on linoleic acid oxidation 
Commercial tincture extracts (sec. 3.1.2.2.4) were evaluated for inhibition of linoleic 
acid peroxidation at the following concentrations: - 0.1mg/ml; 0.5mg/ml and 1mg/ml. 
Results expressed as a percentage inhibition of the control (oxidizing substrate without 
antioxidant), are shown in Figs. 4.12; 4.13 and 4.14. All the extracts except Calendula 
officinalis and Crataegus laevigata berry [0.5mg/ml, Fig. 4.13], exhibited lower levels 
of antioxidant activity than their crude plant extract counterparts. Within the range of 
the concentrations tested, unlike the crude plant extracts, antioxidant activity was not 
generally observed to increase with higher concentration. Only Silybum marianum, 
Taraxacum officinale, Crataegus laevigata (leaves and flowers) and Arctium lappa 
displayed a consistent increase in antioxidant activity with higher concentration [Figs. 
4.12 - 4.14]. The antioxidant activity of Salix alba and Apium graveolens was almost 
the same for all three concentrations [Figs. 4.12 - 4.14], also, similar results were 
observed for Calendula officinalis at 0.1mg/ml [Fig. 4.12] and 0.5mg/ml [Fig. 4.13] and 
Crataegus laevigata berry at 0.5mg/m [Fig. 4.13] and lmg/ml [Fig. 4.14]. The 
strongest antioxidant activity was exhibited by both Crataegus laevigata leaves and 
flowers (65%) and Taraxacum officinalis (64%) at a final concentration of lmg/ml [Fig. 
4.14]. Maximum antioxidant activity was also observed at this concentration for 
Silybum marianum (61.5%); Arctium lappa (56.5%); Calendula officinalis (53%); 
Crataegus laevigata berry (51%) Apium graveolens 43.5% and Salix alba (33%), [Fig. 
4.14]. 
4.2.1.3 Comparison of the antioxidant activity on linoleic acid oxidation 
of the commercial tincture extracts against the crude plant extracts 
In comparison to the antioxidant activity observed for the crude plant extracts, the 
greatest decrease in antioxidant activity was observed for Salix alba tincture extract 
(final concentration lmg/ml). This exhibited only 33% inhibition, 54% less than the 
87% inhibition recorded for its counterpart crude plant extract, [Fig. 4.14]. Compared 
to the crude plant extracts, a significant reduction in antioxidant activity was also 
observed for the following tincture extracts: - a decrease of 44% and 35% for Arctium 
lappa at concentrations of 0.1 mg/ml [Fig. 4.12] and ling/ml [Fig. 4.14] respectively; 
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40% for Taraxacum officinalis [0.5mg/ml - Fig. 4.13]; 38% for Cralaegus laevigata 
leaves and flowers [0.5mg/ml - Fig. 4.13]; 37.5% for Crataegus laevigata berry 
[lmg/ml - Fig. 4.14]; 30% and 36.5% for Apium graveolens at concentrations of 
0.5mg/ml [Fig. 4.13] and 1 mg/ml [Fig. 4.14] respectively and 31.5% and 34% for 
Silybum marianum at concentrations of 0.1mg/ml [Fig. 4.12] and 0.5mg/ml respectively 
[Fig. 4.13]. Excluding the preceding data, the mean average decrease in antioxidant 
activity of the remaining tincture extracts compared to the crude plant extracts over the 
three concentrations tested was approximately 20%. From this data it is apparent that to 
achieve a pharmacological effect equal to that of the crude plant extract a much higher 
dose of tincture may need to be administered. 
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Figure 4.12 Inhibition of linoleic acid peroxidation by crude plant extracts (80% EtOH) and 
commercial tinctures, final concentration 0.1mg/ml, measured using a lipid peroxide assay. 
Results are given as a percentage of the control (oxidizing substrate without antioxidant). 
Each column shows the mean + SD of triplicate determinations. 
175 
100 
90 
80 ät 
E 70 
S 60 
ö 
r50 40 
30 
20 
10 
0 
acýýJý aJýo 
\ej 
d Goa   ConTnercial Tincture' 
  Crude Plant Extract 
Figure 4.13 Inhibition of linoleic acid peroxidation by crude plant extracts (80% EtOH) and 
commercial tinctures, final concentration 0.5mg/ml, measured using a lipid peroxide assay. Results 
are given as a percentage of the control (oxidizing substrate without antioxidant). 
Each column shows the mean ± SD of triplicate determinations. 
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Figure 4.14 Inhibition of linoleic acid peroxidation by crude plant extracts (80% EtOH) and 
commercial tinctures, final concentration lmg/ml, measured using a lipid peroxide assay. Results 
are given as a percentage of the control (oxidizing substrate without antioxidant). 
Each column shows the mean + SD of triplicate determinations. 
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4.2.2 METAL ANALYSIS BY INDUCTIVELY COUPLED PLASMA 
ANALYSIS (ICP) 
4.2.2.1 Results and discussion of metal analysis on the selected plant 
material 
Based on results obtained during early development of the lipid peroxide assay and 
subsequent experimental results of the crude plant extracts tested in this assay at low 
concentrations, ICP analysis was carried out on a selection of transition metals known to 
be contained in the human body. Results are shown in Figs. 4.15 and 4.16. All the 
selected plant material contained all of the metals analysed except Silybum marianum 
and Crataegus laevigata berry that did not contain chromium. This metal was also 
detected in all the other plant samples, at much lower levels (less than 6µg/g), than all 
the other metals [Fig. 4.15]. Iron, copper and cobalt all previously shown in studies to 
catalyse pro-oxidant reactions (Cao, 1997) were present in all the samples in varying 
amounts [Fig. 4.16]. Magnesium, zinc and selenium, essential co-factors of some 
enzymes with antioxidant function (sections 1.1.3 and 3.2.3) that are known to 
contribute to our endogenous antioxidant defence mechanisms, were also present in all 
the plant samples [Figs. 4.15/4.16]. 
Transition metals are strongly implicated in the generation of free radicals by 
decomposition of hydrogen peroxide or hydroperoxide to give hydroxyl or alkoxyl 
radicals (Sugihara, 1999). The ability of flavonoids to form complexes with metal ions 
causes them to behave either as pro-oxidants or antioxidants depending on the target 
molecules. It has been suggested for example, that the interaction of flavonoids with 
iron facilitates the reduction of ferric ion to ferrous ion and produces a hydroxyl radical 
by Fenton reaction (1.1.2.5). 
The proposed mechanism for pro-oxidant activity in lipid peroxidation is that the 
decrease in redox potential of metal ions through interaction with chelators incurs the 
catalyzing potential of lipid peroxidation (Sugihara, 1999). Sugihara, (1999) observed 
that certain flavones and flavonols changed from antioxidant to pro-oxidant activity 
when iron concentrations increased in linolenic acid loaded hepatocytes. When the 
flavonoid concentration increased however, antioxidant effects at high iron 
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concentrations were maintained suggesting that chelation alters the redox potential of 
the metal complexes, depending on the molar ratio of the flavonoid to metal ion. 
Because the exact composition of the extracts, which not only contains one but a 
multiplicity of compounds, and the profile of metal ion concentrations are unknown, no 
conclusions can be reached in regard to any metal-catalysed pro-oxidant activity 
exhibited in the lipid peroxide assay at low concentrations. Some studies have 
established that certain flavonoids in vitro can exert pro-oxidant or antioxidant effects 
depending on the concentration (Cos, 2000; 2001) and that only trace amounts of 
transition metals are needed to catalyse the Fenton reaction (Halliwell, 1987). A pro- 
oxidant mechanism involving transition metal ions and flavonoids should therefore be 
considered a possibility. An electron paramagnetic resonance (EPR) study of 
flavonoids by Cos (2001), demonstrated that the pro-oxidant activity of quercetin at a 
concentration of 500µM was decreased significantly when rutin was added to the 
quercetin at the same concentration. This illustrates the difficulties in analysis that 
exist in the comparison of studies using single compounds against multi-compound 
crude plant extracts present. 
It is appreciated that there are differences in the extraction regimes used for ICP and the 
remainder of the experimental programme. The difficulties alcoholic extracts presented 
for ICP however made this approach necessary. 
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Figure. 4.15. Results of ICP metal analysis showing the concentration (pg / g) of Mg, Cr, 
Ni and Zn in the selected plant samples measured against lppm metal standards. 
(Differences in scale) 
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Figure 4.16. Results of ICP metal analysis showing the concentration (pg / g) of Fe, Cu, 
Co and Se in the selected plant samples measured against lppm metal standards. 
(Differences in scale) 
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4.2.3 DPPH' SCAVENGING ACTIVITY 
4.2.3.1 Results of the one-electron reducing activity of the crude plant 
extracts on the a, a-diphenyl-ß-picrylhydrazil radical (DPPH) 
Results of the one-electron reducing activity of the crude plant extracts (sec. 3.1.2.2.1) 
on the DPPH radical are shown in Table 4.20. Free radical scavenging activity 
expressed as a percentage of the control shows how much each crude plant extract has 
reduced the absorption of the DPPH radical. 
All the crude plant extracts showed high DPPH radical scavenging action, above 80% at 
the three concentrations tested: - 2.5mg/ml; 1mg/ml and 0.5mg/ml. A high percentage 
decrease of DPPH absorption indicates a high reactivity with DPPH hence greater 
hydrogen atom donating activity, i. e. a higher antioxidant activity. Although all the 
crude plant extracts showed consistently high DPPH radical scavenging action, 
reduction of the DPPH radical was never more than 91%. In search of a reason for this, 
spectrophotometric absorbance curves for 0.1 mM DPPH were plotted showing the 
curve for deep violet unreduced DPPH as used in the assay solution, and DPPH 
completely reduced by excess propyl gallate to the yellow-coloured 
diphenypicrylhydrazine, i. e reduction of the DPPH radical results in decolorization and 
concomitant decrease in optical absorbency (section 2.2.3.1). The results showed that at 
the target wavelength, confirmed as 517nm as indicated in the literature (Blois, 1958), 
the reduction product of DPPH (diphenypicrylhydrazine) had a small residual 
absorbance of around 8% that produced a maximum ceiling of 92% for radical 
scavenging action [Fig. 4.171. At a final concentration of 2.5mg/ml both Arctium lappa 
root and Crataegus laevigata leaves and flowers reached this ceiling. 
Extracts were also tested at a concentration of 25 mg/ml but at this concentration the 
reaction mixture for some plant extracts was too turbid to take meaningful absorbance 
readings. 
All crude plant extracts at the three concentrations tested showed a higher or 
comparable DPPH radical scavenging action to the reference compounds propyl gallate, 
a known antioxidant used for preserving oils and fats, and caffeic acid, a natural 
antioxidant compound found in plants (Table 4.20). Strong antioxidant activity on the 
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DPPH radical by propyl gallate and caffeic acid have been previously demonstrated by 
Yan et al, (1998). 
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Figure 4.17. Spectrophotometric absorbance curves of a 0.1mM ethanolic 
solution of DPPH, unreduced (deep purple) and completely reduced by 
antioxidants to diphenypicrylhydrazine (pale yellow), showing that at a wavelength 
of 517nm, the confirmed absorption maximum (Blois, 1958), the reduction product 
diphenypicrylhydrazine had a residual percentage of approximately 8% that 
produced a ceiling of 92% for DPPH radical scavenging action. 
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Table 4.20 Evaluation of the Free Radical Scavenging Activity (FRSA) of the 
selected crude plant extracts on the 1,1-diphenyl-2-picrylhydrazil free radical 
(DPPH). Reduction of the DPPH radical was measured by reading absorbance at 
517 nm. A high percentage decrease of the DPPH radical indicates high reactivity 
with DPPH. 
Each concentration shows the mean of duplicate determinations. 
Concentration 2.5mg/ml 1mg/ml 0.5 mg/ml 
Arctium lappa (root) 
30 sec 88% 86% 87% 
2 min. 89% 86% 87% 
10 min. 90% 86% 87% 
Crataegus laevigata (berry) 
30 sec 83% 83% 83% 
2 min 86% 85% 84% 
10 min 88% 87% 84% 
Crataegus laevigata (leaves and 
flowers) 
30 sec 79% 85% 82% 
2 min 87% 85% 85% 
10 min 91% 89% 85% 
Taraxacum ojfclnale (root) 
30 sec 86% 86% 85% 
2 min 86% 86% 85% 
10 min 86% 86% 85% 
Salix alba (bark) 
30 sec 81% 85% 86% 
2 min 84% 86% 86% 
10 min 87% 87% 86% 
Apium graveolens (seed) 
30 sec 82% 85% 83% 
2 min 84% 86% 83% 
10 min 85% 87% 83% 
Calendula ofcinalis (flower) 
30 sec 81% 87% 84% 
2 min 82% 87% 86% 
10 min 84% 87% 86% 
Silybum marianum (seed) 
30 sec 69% 73% 78% 
2 min 72% 76% 79% 
10 min 79% 80% 81% 
Propyl gallate 100µM final concentration: - 84% 
Caffeic acid 100µM final concentration: - 86% 
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4.2.3.2 DPPH radical-scavenging activities of crude plant extracts (80% 
EtOH) expressed as an ICso value 
Since the DPPH assay was used as an initial screening process to test the propensity of 
the crude plant extracts to any possible antioxidant activity, it was impossible to predict 
such high results for all the crude plant extracts that gave almost the same results for all 
the concentrations initially tested. The antioxidant activity of each extract was therefore 
expressed in terms of IC50 value (concentration in mg/ml or µM required to inhibit 
DPPH radical formation by 50%) that would facilitate a more accurate comparison of 
antioxidant activity. Results are shown in Table 4.21. The most potent DPPH radical 
scavengers were Salix alba (bark) and Crataegus laevigata (leaves and flowers) which 
showed IC50 values of 0.003mg/ml and 0.006mg/ml. Arctium lappa root also showed 
strong scavenging effects with an IC5o value of 0.017mg/ml. After these plants the order 
of potency was Apium graveolens (seed), Crataegus laevigata (berry) and Silybum 
marianum (seed) with IC50 values of 0.025mg/ml and Taraxacum officinale (root) with 
an IC5o value of 0.054mg/mi. Calendula officinalis (flower), although still an effective 
DPPH scavenger, had the highest IC50 value of 0.102mg/ml. 
4.2.3.3 DPPH radical-scavenging activities of commercial tincture 
extracts expressed as an ICso value 
DPPH scavenging activities of commercial tincture extracts (3.1.2.2.4) are shown in 
Table 4.21. Most of the commercial tincture extracts, except Calendula officinalis 
(flower), in comparison to their crude plant extract counterparts showed reduced DPPH 
radical scavenging activity that resulted in higher IC50 values [Table 4.21; Fig. 4.18]. 
The most potent DPPH radical scavengers were Calendula officinalis (flowers) and 
Salix alba (bark) with ICSO values of 0.005mg/ml and 0.007mg/ml. Crataegus laevigata 
(berry), Crataegus laevigata (leaves and flowers) and Apium graveolens (seed) were 
less potent with IC50 values of 0.025,0.035 and 0.05mg/ml respectively. Thereafter the 
order of potency was Silybum marianum (seed), Taraxacum officinale (root) and 
Arctium lappa (root) with IC50 values of 0.17,0.23 and 0.81mg/ml. To achieve 50% 
inhibition of the DPPH radical, considerably higher concentrations of tincture extract 
than crude plant extract were required for Silybum marianum (seed), Taraxacum 
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officinale (root) and Arctium lappa (root) reflecting the significant differences in 
phytochemical profiles of the two types of extract reported in sections 4.1.2.1.3; 
4.1.2.2.2 and 4.1.2.3.2. 
Table 4.21 DPPH radical scavenging activity of the crude plant extracts and 
commercial tincture extracts expressed as the IC% value (mg/ml) graphically 
determined by linear regression analysis. 
PLANT AND CRUDE PLANT COMMERCIAL 
PART USED EXTRACT (80% EtOH) TINCTURE EXTRACT 
IC5o value (mg/ml) IC50 value (mg/ml) 
Apium graveolens 0.025 0.05 
(seed) 
Taraxacum 0.054 0.23 
officinale (root) 
Arctium lappa 0.017 0.81 
(root) 
Crataegus 0.006 0.035 
laevigata (leaves 
and flowers) 
Crataegus 0.025 0.025 
laevigata (berry) 
Silybum 0.025 0.17 
marianum (seed) 
Salix alba 0.003 0.007 
(bark) 
Calendula 0.102 0.005 
officinalis 
(flower) 
Propyl gallate 0.00032 mg/ml 
Caffeic acid 0.00061 mg/ml 
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Figure 4.18. Comparison of the DPPH radical scavenging activity of the crude 
plant extracts and commercial tincture extracts expressed as the IC50 value 
(mg/ml). 
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4.2.3.4 DPPH radical-scavenging activities of the crude plant extracts and 
commercial tincture extracts expressed as an inhibition factor against the 
reference compound propyl gallate 
Using the IC50 of the crude plant extracts and commercial tincture extracts, an inhibition 
factor for each extract calculated against the reference compound propyl gallate is 
shown in Fig. 4.19. Expression of antioxidant activity as an inhibition factor against a 
known reference compound could represent a simple and consistent means of 
comparing DPPH scavenging activity between any future studies. 
Salix alba (crude plant extract), compared to propyl gallate, had the highest inhibition 
factor at 0.107 (i. e. was approximately nine times less effective than propyl gallate), 
followed by Calendula officinalis (commercial tincture extract) and (: 'ralaegus 
laevigata, leaves and flowers (crude plant extract) with inhibition factors of 0.064 and 
0.053. Salix alba (commercial tincture extract) had an inhibition factor of 0.046. 
Thereafter the order of potency was Arclium lappa (crude plant extract) 0.019; Apium 
graveolens (crude plant extract) 0.013; Crataegus luevigata, berry (crude 
plant/commercial tincture extracts) 0.013 and Silybum marianum (crude plant extract) 
0.013. Commercial tincture extracts of Taraxacum officinale, Arctium lappa , 
Silyhum 
marianum, Apium graveolens and Crataegus laevigata, leaves and flowers plus 
Calendula officinalis and Taraxacum officinale crude plant extracts did not register a 
significant inhibition factor, i. e. inhibition factor was below 0.01, less than 1% of that of 
propyl gallate. 
187 
0.12 
0.10 
eß 
0.08 
CL 
o 0.06 
O 
ca 0.04 LL 
O 
0.02 
O 0.00 
dr_, 
\ej Ile, 17Y 
cý aa ýö 4? 
JF c)f 
Gý`a G, ý  
Crude Rant Extract 
  Commercial Tincture 
Fig. 4.19. DPPH radical-scavenging activities of the crude plant extracts and 
commercial tincture extracts expressed as an inhibition factor against the 
reference compound propyl gallate. Inhibition factor calculated as (IC50 extract 
/IC50 propyl gallate) 
4.2.3.5 Experimental results for evaluating the synergistic, additive or 
antagonistic interaction of the crude plant extracts for antioxidant activity 
in the DPPH assay 
Experimentation with combinations of crude plant extracts indicated that there are no 
synergistic effects to be observed between any of the extracts tested in pairs. In all 
cases the results using this assay, i. e. electron scavenging, were purely additive. Even 
triple combinations showed no inclination to synergy. Furthermore, no mutually 
inhibitory activity was noted. 
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4.2.4 SYNOPSIS OF RESULTS: COMPARISON OF CRUDE 
PLANT EXTRACTS AND COMMERCIAL TINCTURE EXTRACTS 
Table 4.22 shows comparative results of the two assays used in this study to assess the 
antioxidant propensity of the crude plant extracts and commercial tincture extracts plus 
the main flavonoid/ hydroxycinnamic acid compounds identified in these extracts by 
phytochemical analysis (sec. 4.1.2). Although in the lipid peroxide assay results for the 
inhibition of linoleic acid oxidation showed variation according to concentration (sec. 
4.2.1), the highest level of antioxidant activity for both the crude plant extract and 
commercial tincture extract was seen at a concentration of 1 mg/ml. The results for 
1 mg/ml are therefore shown in Table 4.22. 
As outlined in section 4.2.1 (4.2.1.2; 4.2.1.3) and section 4.2.3 (4.2.3.2; 4.2.3.3), the 
antioxidant activity of most of the commercial tincture extracts in comparison to their 
crude plant extract counterparts showed reduced radical scavenging action against both 
the DPPH radical and linoleic acid peroxidation. This reduction of antioxidant activity 
was reflected by a significant difference in phytochemical profiles of the two plant 
extracts particularly Silybum marianum, Taraxacum officinale and Arctium lappa. A 
general reduction in the number of flavonoid/hydroxycinamic compounds identified in 
the commercial tincture extracts, compared to the crude plant extracts also appeared to 
influence the level of radical scavenging activity. For example, the apparently higher 
levels of proanthocyanidins detected in Salix alba crude plant extract compared to the 
commercial tincture extract (Table 4.15) may have contributed to the superior radical 
scavenging activity of this crude plant extract. 
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4.2.5 DISCUSSION 
The antioxidant action of the eight selected plant parts in the form of crude plant and 
tincture extracts were evaluated in vitro. All the extracts exhibited varying levels of 
antioxidant activity on both DPPH radical and linoleic acid peroxidation. These 
plants, selected on the basis of successful treatment outcomes (Bell et al, 1999), were 
postulated to have antioxidant activity. 
The results showed that the method of extraction and composition of the solvent 
mixture influenced the activity of the resulting extracts. The crude plant extracts 
generally exhibited the strongest antioxidant activity, in a dose-dependant manner (Figs. 
4.4-4.11). 
The electron-donating properties of flavonoids and many phenolic acids have been 
repeatedly emphasized as the basis of their antioxidant action (Sugihara et al, 1999; 
Rice-Evans, 2001). The scavenging effects of different amounts of crude plant extracts 
and tincture extracts on the free radical DPPH increased with increasing amounts of 
extract. The activity of the extracts could therefore be attributed to their hydrogen 
donating ability. Dub (1998) states that "antioxidants are believed to intercept the free 
radical chain of oxidation and to donate hydrogen from the phenolic hydroxyl groups, 
thereby forming stable radicals which do not initiate nor propagate further oxidation of 
lipids". As DPPH is known to abstract the labile hydrogen atom of chemical 
compounds (Ratty et at., 1988) the antioxidant that can scavenge the DPPH radical is 
expected to depress lipid peroxidation (Aniya et al, 1999). In this study, DPPH 
scavenging activity was found in all the extracts tested and it was confirmed that these 
extracts would also inhibit lipid peroxidation. Thus, the action of the plant extracts on 
DPPH would suggest that they acted as free radical inhibitors and primary antioxidants, 
which is likely to be the main reason for the inhibition of linoleic acid peroxidation in 
the lipid peroxide assay. 
All the plant extracts examined were able to inhibit linoleic acid peroxidation with some 
relationship between concentration and scavenging ability. Inhibitory effects on lipid 
peroxidation may be considered as the principal effect established for flavonoids (Bors 
et at, 1998, p. 119). The reported antioxidant action of flavonoids on lipid peroxidation 
is based on scavenging the principal propagating intermediates, the peroxyl and alkoxyl 
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radicals, by hydrogen donation, halting the radical chain (Bors et al, 1994). It is 
suggested therefore, that the plant extracts which have been shown to contain a variety 
of flavonoid compounds and polyphenols could be acting as electron donors, reacting 
with free radicals to convert them to less reactive compounds like flavonoid 
aroxylradicals, which would terminate a radical chain reaction (Bors et al, 1994). 
Although the polyphenols and flavonoids may not be the only active compounds, their 
antioxidant properties may, in part, explain the mechanism of antioxidant activity in the 
extracts tested. 
The results for the free radical scavenging activity of the crude plant extracts on the 
DPPH radical at the concentrations initially tested, i. e. 2.5mg/mi, 1mg/ml and 
0.5mg/ml, were comparable with, or higher than, the reference compound propyl gallate 
(Table 4.20). The IC50 value for propyl gallate however, was considerably lower than 
the IC50 values of all the crude plant extracts (Table 4.21). The antioxidant activity of 
the crude plant extracts on linoleic acid peroxidation compared to propyl gallate showed 
that when tested at a similar concentration, generally they were equally effective 
(section 4.2.1.1). The differences in the antioxidant activity of propyl gallate in these 
assays may be explained by the different antioxidant mechanisms being investigated. 
As already outlined above, DPPH scavenging involves only a single hydrogen-donating 
mechanism whereas inhibition of linoleic acid oxidation involves a complex sequence 
of oxidation and reduction processes. Since DPPH is a synthetic radical it is generally 
only used for primary screening to test the propensity of a crude plant extract to 
antioxidant activity. It is however, a simple, rapid screening method sensitive enough to 
detect natural and synthetic antioxidants at low concentrations. 
The antioxidant effect of flavonoids has been reported to be dependent on the structure 
of the flavonoid. Flavonoids are antioxidants by virtue of the number and arrangement 
of their phenolic hydroxyl groups attached to ring structures (Rice-Evans, 2001). Their 
ability to act as antioxidants by donating an electron to an oxidant critically depends on 
the reduction potential of their radicals and their availability at the site of the 
pathological oxidative process (Rice-Evans, 2001). Since each individual extract 
contains a mixture of different polyphenol and flavonoid compounds, it is not possible 
to relate antioxidant activity to a specific compound or structural characteristic. It has 
been observed however, that the three crude plant extracts Salix alba (bark) and 
Crataegus laevigata (leaves and flowers/berries) which were the only plant parts to 
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contain proanthocyanins, still exhibited antioxidant activity in the lipid peroxide assay 
at 0.001 mg/ml, the concentration at which all the other crude plant extracts changed 
from antioxidant to pro-oxidant activity. One possible explanation is that the flavonoid 
aroxyl (semiquinone) radicals formed after initial scavenging of an oxidizing radical 
behave differently depending on the type of flavonoid. All the flavonoid aroxyl 
(semiquinone) radicals decay by second-order kinetics, i. e. bi-molecular 
disproportionation, forming quinones (quinone methides) and the parent hydroxy 
compound (Bors et al, 2001). The quinones and quinone methides of flavonols for 
example, can undergo futile redox recycling with the formation of reactive oxygen 
species making them potentially pro-oxidant, whereas the quinones of proanthocyanins 
preferentially react via phenolic coupling reactions to form dimers and oligmers, each 
retaining its original number of reactive hydroxy groups, thereby enhancing their 
antioxidant capacity (Metodiewa et al., 1999; Bors et al, 2001). Crataegus laevigata 
(leaves and flowers), the only crude plant extract to contain a wide range of flavones, 
flavonols, hydroxycinnamic acids and detectable levels of proanthocyanins (Tables 4.15 
and 4.18), displayed the highest level of antioxidant activity (92%) against linoleic acid 
oxidation. 
Tinctures, widely used as herbal medicines, were evaluated against the crude plant 
extracts to ascertain if they exhibited similar levels of antioxidant activity. HPLC 
analysis generally detected fewer polyphenols and flavonoid compounds in the tincture 
extracts (section 4.1.2), which was reflected in reduced levels of antioxidant activity 
against the crude plant extracts when tested at the same dosage on both the free radical 
DPPH and linoleic acid oxidation. Since tinctures are among the most widely employed 
herbal medicinal products, a review of the extraction method, composition of the 
solvent and resultant levels of the active constituents are urgently required to optimize 
extraction of the active constituents. 
Lipid peroxide assays are often used to establish the antioxidant potential of plant 
extracts and individual compounds. Although it is not possible to elucidate exact 
mechanisms of action, the observed antioxidant activity on lipid peroxidation is the 
result of all oxidation and reduction processes which might occur in vivo (Van Acker et 
al, 1998). Comparison of results between authors is generally difficult, due to 
differences in method and experimental conditions. The results obtained for Arctium 
lappa (root) in the linoleic acid system (90%), is comparable however, with those 
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reported by Duh (1998) using a similar method of analysis. Apart from the direct 
scavenging activity of compounds other factors such as interactions with transition 
metals and uptake into membranes may play an important role in antioxidant activity. 
Previous studies have established that besides antioxidant activity, flavonoids can also 
act as pro-oxidants in vitro depending on conditions that include concentration of the 
antioxidant, the presence of other antioxidants and the presence of transition metals 
(Boik, 2001, p. 189; 255). There are two main mechanisms responsible for the pro- 
oxidant activity of flavonoids (Cos, 2001). The first is their ability to participate in 
reactions catalysed by transition metal ions such as the Fenton reaction, which produces 
the highly reactive hydroxyl radical. The second is their polyphenolic structure which 
makes them susceptible to auto-oxidation reactions, resulting in the production of 
reactive oxygen species (Bors et al, 1998). According to Halliwell and Chirico (1993) 
most biological studies of lipid peroxidation involve transition metal ions, added to, or 
contaminating, the reaction mixtures. As outlined in section 4.2.2.1 the decomposition 
of lipid hydroperoxides by transition metals such as iron and copper to give hydroxyl or 
alkoxyl radicals is also strongly implicated in the generation of free radicals. Lipid 
hydroperoxides are thought to be reductively cleaved by metal ions in a low valence 
state to highly reactive alkoxyl radicals, which then remove hydrogen ions from lipids 
to form new lipid alkyl radicals. For the reduction of the metal ions back from the high 
valence state to low valency, reducing compounds are required and flavonoids may 
have the capacity to reduce metal ions directly through autoxidation (Sugihara et al., 
1999). 
At the lowest concentrations tested, 0.001 mg/ml and 0.0025mg/ml, some of the crude 
plant extracts were observed to change from antioxidant to pro-oxidant activity. ICP 
analysis confirmed the presence in all the selected plant parts of transition metals 
capable of participating in metal catalysed reactions that can accelerate production of 
reactive oxygen species. Although the pro-oxidant activity of antioxidants in vitro is 
well documented, most work has been carried out using individual flavonoid standards 
without considering the presence of other components occurring in natural matrices 
(Boik, 2001, p. 189). No conclusions in regard to mechanisms of pro-oxidant activity in 
the crude plant extracts can be reached therefore, especially since the composition of 
each extract as shown by phytochemical analysis is so different. 
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Caution is needed when extrapolating from the in vitro results to the in vivo situation, 
especially since factors such as the bioavailability of flavonoids is still unclear. 
Furthermore, the antioxidant assays used in this study represent only two antioxidant 
mechanisms and it may be important to investigate how these plant extracts perform in 
other antioxidant systems. It has been shown for example that antioxidants that protect 
lipid peroxidation against free radical damage may actually accelerate damage to other 
molecules such as carbohydrates, under certain conditions (Burits and Bucar, 2000). 
Human-body chemistry is complex and it does not currently appear possible to simulate 
in vitro studies accurately in vivo. Data on biological markers such as blood levels of 
flavonoids and their metabolites are not widely available, thus making it difficult to 
determine the individual or the combined role of the flavonoids and other antioxidants 
(Pietta, 2000). There is however strong evidence that flavonoid-containing foods like 
fruit and vegetables and some medicinal plants have a protective effect against many of 
the degenerative diseases of ageing where lipid peroxidation is strongly implicated in 
the pathogenisis (Pietta, 2000). The results of these assays, which have demonstrated 
antioxidant activity of the eight plant parts traditionally used in the treatment of 
osteoarthritis, indicate that their radical scavenging actions may contribute to their 
therapeutic effects and that their use in this way may be useful and reasonable. 
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4.3 EVALUATION OF PLANT SYNERGY 
4.3.1 Experimental results for evaluating the synergistic, additive or 
antagonistic interactions of pairs of crude plant extracts for antioxidant 
activity in the linoleic acid system 
Combining herbs into a formula is common practice throughout traditional medicine. 
Practitioners generally assume that when several plant extracts are combined, synergy 
ensues and that mixtures of different plant extracts will support and enhance each other. 
The term synergy in this context refers to the enhanced effect of a mixture of two or 
more plant extracts, which is greater than that which would be expected by a 
consideration of the effects of the individual components. Although there appears to be 
some evidence in support of herbal synergy, because it is so difficult to prove, there is a 
scarcity of reports in the scientific literature (Williamson, 2001). 
All of the crude plant extracts (sec. 3.1.2.2.1) assessed for antioxidant activity against 
linoleic acid peroxidation were tested in pairs in this assay, to observe if certain two- 
herb combinations would increase antioxidant activity above the levels already achieved 
for the extracts when assessed singly. 28 pairs of extracts were tested at a final total 
concentration of extract in the mixture of 0.01 mg/ml (i. e. 0.005 mg/ml for each plant 
extract). Since there are few documented studies on plant synergy and results for the 
individual crude plant extracts showed no linear relationship to dose, a preliminary 
study at this concentration was deemed appropriate for the following reasons: - 
1) Results for inhibition of linoleic acid oxidation at 0.01 mg/ml (final 
concentration) and 0.005mg/ml (dose at which each crude plant extract was used 
in the pair) were almost the same [Tables 4.4 - 4.11 ]. 
2) Results for the individual extracts tested at 0.01mg/ml that ranged from 32% to 
51% were at a level that would allow for a reasonable percent increase or 
decrease in antioxidant activity to be observed [Tables 4.4 - 4.11 ]. 
There are a number of methods which have been proposed to demonstrate synergistic 
interactions between agents (Berenbaum, 1989), none of which have successfully 
addressed the comparison of two complex plant extracts each comprising many 
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constituents (Wagner, 2004). This work was therefore carried out as an exploratory 
study, using statistical analysis to explore the possibility that an interaction between two 
extracts may have taken place as a precursor to more exhaustive studies. The 
comparative results for each pair of extracts, showing both their individual and 
combined antioxidant activity against linoleic acid peroxidation, as measured using the 
method given in sections 3.2.2.6.1 are illustrated by box plot graphs Figs. 4.20(a-e). 
4.3.2 Statistical analysis 
The Mann Whitney test, a distribution free nonparametric test suitable for comparing 
the difference between the medians of two independent groups of sampled data, was 
used statistically to analyse the results, i. e. the percent antioxidant activity of each single 
extract compared to the combined antioxidant activity of the pair. Results of the 
statistical analysis (Mann Whitney < 0.1) for each pair of crude plant extracts are shown 
in Table 4.23. The results for most pairs of extracts were not significant, indicating zero 
interaction. Increased activity, i. e. more than expected, indicating synergism, was 
displayed by the combinations Silybum marianum (Milkthistle) and Arctium lappa 
(Burdock) (p = 0.03), Fig. 4.20(e) graph B; Crataegus laevigatafruc. (Hawthorn fruit) 
and Arctium lappa (Burdock) (p = 0.03), Fig. 4.20(e) graph C; Calendula officinalis 
(Marigold) and Arctium lappa (Burdock) (p = 0.07), Fig. 4.20(c) graph B; Salix alba 
(White willow) and Crataegus laevigata fol. (Hawthorn leaves and flowers) (p = 0.08), 
Fig. 4.20(b) graph B; Crataegus laevigata fruc. (Hawthorn berry) and Taraxacum 
ofcinale (Dandelion) (p = 0.1), Fig. 4.20(d) graph C. 
A decrease in activity, i. e. less than expected, indicating antagonism was shown by 
Calendula officinalis (Marigold) and Silybum marianum (Milkthistle) (p = 0.03), Fig. 
4.20(e) graph D; Crataegus laevigata fol. (Hawthorn leaves and flowers) and Silybum 
marianum (Milkthistle) (p = 0.03), Fig. 4.20(b) graph A and Calendula officinalis 
(Marigold) and Taraxacum officinale (Dandelion) (p = 0.1), Fig. 4.20(c) graph A. 
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Figure 4.20(a) Boxplot graphs illustrating the % inhibition of linoleic acid peroxidation by crude plant 
extracts (final concentration 0.01mg/ml) of single herbs versus pairs of herbs. The median is shown by 
a line drawn across the box except where data is skewed and the median is either equal to, or too close 
to the upper/lower quartile to be visible on the graph in which case it is marked by a red dot. A black 
dot denotes the mean. No significant differences were found in any of these results. 
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Figure 4.20(c) Boxplot graphs illustrating the % inhibition of linoleic peroxidation by crude plant 
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4.3.3 Discussion 
The combination of crude plant extracts in pairs resulted in a demonstration of synergy 
against linoleic acid oxidation from five of the pairs and antagonism from three, as 
outlined in section 4.3.2, giving a total of eight interactions, approximately one third of 
the possible 28 two-herb combinations tested. Although in terms of magnitude the 
reactions displayed were fairly minor, it was observed by Berenbaum, (1987) 
in 
antibacterial studies, that minor interactions in vitro may result in significant synergism 
in vivo suggesting that the presence of relatively small degrees of synergy and indeed 
antagonism may well be of clinical significance. 
No obvious trends emerged from the results by which any reasonable conclusions could 
be based. The following observations however may be relevant to further antioxidant 
research. All five two-herb combinations that demonstrated synergy against linoleic 
acid oxidation were combinations of 1) flavonoid-containing plants, i. e. flavonoids as 
shown by phytochemical analysis were the principal constituents, and 2) plants that 
primarily contained polyphenolic acids. Arctium lappa for example, shown by 
phytochemical analysis primarily to contain a range of caffeic acid derivatives was 
synergistic with the plants Silybum marianum, Crataegus lavigata (berry) and 
Calendula officinalis, whose primary constituents were confirmed as flavonoids, i. e. a 
range of flavanolignans; proanthocyanidins, flavonols and flavones and flavonols 
respectively. Significantly, Arctium lappa is a primary constituent of the Essiac formula 
(section 1.1.6.3) the potency of which is based anecdotally on the synergistic interaction 
of its four herbal constituents. There is no data on the possible synergistic effect of 
these individual herbs (Tamayo et al, 2000) however, since Arctium lappa has indicated 
a degree of synergy with three of the herbs tested, it possibly has an affinity for being 
synergistic with other herbs. Calendula officinalis, which showed the greatest 
propensity to pro-oxidant activity at low concentrations against lipid peroxidation (Fig. 
4.8 section 4.2.1.1), was synergistic with Arctium lappa, but inhibitory with Taraxacum 
officinale, which was also shown by phytochemical analysis only to contain a range of 
caffeic acid derivatives. Both these herbs, as well as polyphenols, also contain a range 
of other chemical constituents (sections 2.3.1/2.3.3) not investigated in this study, that 
overall give each plant their own unique phytochemical profile, and may affect their 
interaction with other plant extracts quite differently. 
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Silybum marianum, whose principal constituents are flavanolignans, was synergistic 
with Arctium lappa but antagonistic with Calendula officinalis and Crataegus laevigata 
(leaves and flowers). Both plants were shown to contain a high proportion of 
flavonoids, especially flavonols and flavones. Crataegus laevigata (leaves and flowers) 
however, which also contained proanthocyanin flavonoids, was synergistic with Salix 
alba (bark), which, in addition to its range of salicylic acid derivatives, also contains 
proanthocyanins and some flavanones, perhaps suggesting that the combination of 
certain flavonoid types in some plants may affect their compatibility. Apium graveolens 
(seed), a flavonoid-containing plant consisting mainly of flavones, did not interact with 
any of the other seven plant parts tested. 
Interactions in a combination may vary depending on the concentration and ratios 
between the constituents. Synergy apparent at one concentration may, at another, 
express a zero interactive response (Savelev et al., 2003). To substantiate the results 
already achieved therefore at a final concentration of 0.01 mg/ml, dose related synergy 
should also be tested. Results for the antioxidant activity (expressed as percent 
inhibition of linoleic acid peroxidation) of the individual extracts showed no linear 
relation to dose and several anomalous results were observed. It is possible therefore 
that each pair of extracts may interact differently depending on the concentration. Since 
some of the pairs gave different results for both assays, i. e. the two assays used to test 
the antioxidant potential of our individual crude plant extracts, they cannot be 
extrapolated to other antioxidant systems. Pairs of extracts tested on the basis of IC50 
values in the DPPH assay produced only additive effects, even in those combinations 
that had demonstrated either synergy or antagonism by the more complex process of 
inhibiting linoleic acid peroxidation. Although the concentrations used to test the crude 
plant extracts in both assays were different, this is unlikely to have affected the outcome 
for DPPH scavenging, which is quite simply based on the ability of a mixture to 
scavenge this radical via step-by-step hydrogen donation thus producing a purely 
additive effect. Consequentially, these results suggest that in the lipid peroxide assay, 
mechanisms other than hydrogen donation may be contributing to the antioxidant 
activity of some pairs of extracts. 
Most studies on plant synergy have compared the activity of the natural plant extract 
with the activity of individual components combined in their naturally-occurring ratios 
(Savelev et al., 2003; Wagner and Steinke, 2004). Although several in vivo studies 
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using combinations of herbs have been carried out (Williamson, 2001), there are few in 
vitro studies on the interactivity of natural plant extracts in combination. Since 
statistical analysis is based on probability, more research is required to explore the 
interactions observed in this study. The method of Berenbaum, (1978; 1985) based on 
an assumption of zero activity of agents in a combination is the one most commonly 
used at present. Although this approach facilitates analysis of a combination of agents 
with different types of dose-response relation and permits combinations of any number 
of agents, according to Wagner (2004), this cannot plausibly be applied to herbal extract 
mixtures because all these agents must first be defined and isolated. Savalev et al 
(2003), commenting on methodological issues in relation to their investigations into the 
synergistic and antagonistic interactions of the anticholinesterase terpenoids of Salvia 
lavandulaefolia essential oil, demonstrate how two methods may be used to explore the 
interactions between compounds and how this may give different results when applied 
to the same set of data, so that a mixture may appear zero interactive according to one 
and synergistic to another. Thus, a suitable method for assessing combinations of 
herbal mixtures still appears to be elusive, especially since an inappropriate approach 
could lead to misleading information which could influence future research. 
The scientific evaluation of herbal extracts is still very much in its infancy and there is 
much further knowledge to be gained. Investigations now show that most natural plant 
extracts exert multivalent effects and this multivalence of pharmacological actions can 
generate additive or over-additive potentiated synergistic effects (Wagner, 2004). Since 
this multivalent activity forms the main basis of prescribing in Western Herbal 
Medicine, the polyvalent or additive effects of the multiple active constituents of the 
two-herb combinations that did not show any obvious interaction cannot be 
undervalued. These experiments can only be viewed as a starting point. 
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CHAPTER 5: PRODUCT INVESTIGATION AND 
ANALYSIS 
5.1. Introduction 
In Chapter 4.2 plant extracts were investigated for their in vitro antioxidant activity 
against linoleic acid oxidation. During the course of these investigations some 
anomalous results were observed. Assays using certain batches of linoleic acid were 
found not to form hydroperoxides, indicated by a lack of colour change when the 
incubated substrate was measured by the ferrous thiocyanate method (section 3.2.2.1). 
This prompted further investigation to confirm the correct composition of linoleic acid 
and to show the presence of any contaminants that could retard oxidation. 
Several lines of enquiry were used including the addition of a probable initiator, benzoyl 
peroxide, to the assay substrate to promote the production of hydroperoxides, 
discussions with the suppliers of the product and analysis of the different batches of 
linoleic acid, i. e. `active' and `inactive', by Gas Chromatography, Nuclear Magnetic 
Resonance Spectroscopy (NMR) and Infrared Spectral analysis. 
5.2 Results and Discussion 
5.2.1 Experimentation with benzoyl peroxide 
Linoleic acid oxidation occurs as outlined in section 3.2.1.3 by autoxidation, i. e. 
oxidation by exposure to atmospheric oxygen. An important feature of this reaction is 
that it is autocatalytic. Unlike this method, some of the other assays used to test lipid 
antioxidant activity that use substances such as tissue homogenates, liposomes and 
lipoproteins, add an initiator to the substrate to start lipid peroxidation (Halliwell, 1990). 
Using the previously `inactive' batch of linoleic acid, an initiator benzoyl peroxide 
(Revitt, 2004) was added to the assay substrate (section 3.2.2.6.1) to start lipid 
peroxidation. The use of this initiator failed to start the desired reaction, i. e. the 
formation of hydroperoxides in the assay substrate, measured as previously outlined by 
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the ferrous thiocyanate method (section 3.2.2.1). A slight colour change was detected, 
indicating the presence of a very low level of hydroperoxides. The generation of 
hydroperoxides at this level would have been insufficient to test the ability of an 
antioxidant to inhibit linoleic acid oxidation (see section 3.2.2.6). 
5.2.2 Product Suppliers - investigations and discussions 
The product suppliers, i. e. Sigma-Aldrich and Fisher Chemical Company, after their 
own investigations, confirmed that in regard to the linoleic acid product we were using 
there had been no changes to manufacturing procedures. The starting material, 
Safflower oil, remained the same and no chemical (e. g. preservatives) that could have 
inhibited oxidation of the linoleic acid, i. e. one that acted in the same way as an 
antioxidant, had been added. The linoleic acid was extracted from the base material by 
preparative High Performance Liquid Chromatography (HPLC). The presence of any 
oleic acid should not affect the oxidation potential of the linoleic acid under the selected 
assay conditions. Although the batch numbers were different the product itself, in the 
opinion of both suppliers, should be exactly the same. Linoleic acid subsequently 
supplied by Lancaster Synthetics Ltd., which was the product mainly used in this study 
was consistently reactive. 
5.2.3 Instrumental analysis 
5.2.3.1 Gas Chromatography 
Gas chromatography was carried out on different batches of linoleic acid, i. e. `active' 
and `inactive' both at Middlesex University and at the Jodrell laboratory, Kew. 
Chromatograms of underivatised samples carried out at Middlesex University showed 
that the principal component of all the samples was linoleic acid with minor quantities 
of various low oxidation potential compounds present as identified by the chemical 
database. Gas chromatography carried out by the Jodrell laboratory, Kew on a 
selection of samples underivatised in hexane and by borontrifluoride-methanol 
derivatisation, gave the same results as above. 
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An observation by Kew staff that the two types of sample when mixed with solvent 
appeared to have slightly different shades of colour prompted the hypothesis that the 
difference in activity between the two samples could be related to cis-trans isomerism. 
Naturally occurring linoleic acid consists of an 18-carbon chain and 2 double bonds (C18 
H32 02) and is usually found in a cis configuration, i. e. cis cis. There are however, 4 
isomers possible: - cis cis; cis trans; trans cis and trans trans. According to Sigma- 
Aldrich, the naturally occurring product, although primarily of a cis cis configuration, 
can, by a reversible reaction, go from cis to trans or trans trans (personal 
communication, technical dept. ), and the product they supply may also contain these 
configurations. This is relatively unlikely however in a product manufactured by 
preparative HPLC. A consensus of speculative opinion indicated that the significance of 
isomerism in this instance was that the shape of the molecule could affect oxidation 
(Sigma-Aldrich, technical dept; Jodrell laboratory, Kew, personal communications). A 
cis configuration has a "V" shape and a trans configuration looks more like a straight 
line. The more open and straight the molecule the easier it is to oxidise because the 
double bonds are more physically accessible. To test this hypothesis NMR analysis was 
carried out on the `active' and `inactive' linoleic acid samples at the Jodrell Laboratory, 
Kew. 
5.2.3.2 Nuclear Magnetic Resonance Spectroscopy (NMR) 
The NMR spectra of the two samples were found to be similar, making it difficult to 
identify any structural differences, Figs. 5.1 and 5.2. 
5.2.3.3 Infrared Spectra 
Infrared Spectral analysis, that could identify both the organic and inorganic 
components of our samples, was carried out to detect the possible presence of a 
contaminant that could retard oxidation if present in the assay substrate. The analysis 
was carried out on two samples of linoleic acid, i. e. `active' and `inactive' by Peter 
Whitton at Aston University. Infrared Spectra of the two samples are shown in Figs. 5.3 
and 5.4. Although no obvious difference was observed in the previous analysis, i. e. Gas 
Chromatography and N. M. R., the infrared spectra of the two samples indicated a 
difference between the two samples. A large double peak on the infrared spectrum 
between band 650-700cm 1 in Fig. 5.3 is absent from the infrared spectrum in Fig. 5.4. 
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A review of possible compounds that absorb at a wavelength of 650-700 cm -1 showed 
sulphite as the most likely compound (Weast, 1980, page F-263; Williams & Fleming, 
1989). This corroborates the opinion of the NMR staff at the Jodrell laboratory, Kew 
that an inorganic contaminant like sulphite might be the causative factor. 
The compound interpretation shown with each IR spectrum relates to the best match the 
software found in the database, albeit the algorithm is far from foolproof. In Fig. 5.3, 
the compound suggested by the computer's chemical database i. e. phenylhexanoic acid, 
was rejected because a benzene ring usually appears in infrared spectra between bands 
1500-1600 cm -1 (Williams & Fleming, 1989). ), so clearly does not relate to the peak 
between bands 500 - 750 cm-1. This would also be at variance with the N. M. R. 
spectrum and the retention time and spectra from Gas Chromatography. 
Sulphite is a considerably more powerful reducing agent than linoleic acid and would 
preferentially scavenge any oxidants present, thus inhibiting linoleic acid peroxidation 
via autoxidation (Weast, 1980, page D-146). Since sulphite absorbs at a frequency band 
of 650-700 cm-1, it is the author's contention that in view of the limited evidence 
available, it is possible that the bulk containers in which the linoleic acid is stored by the 
suppliers may have been cleaned with a sulphite solution as an antibacterial precaution. 
This is not uncommon industrial practice. This idea was compounded by the discovery 
that linoleic acid from Lancaster Synthetics Ltd. with the same batch number but 
supplied from different bulk containers, was both effective and ineffective depending on 
which container it was supplied from. 
5.3 Conclusions 
The linoleic acid assay provides a relatively quick and effective method of measuring 
the antioxidant activity of a plant extract. The exposure of the linoleic acid-alcohol- 
water substrate to oxygen during incubation however, is crucial to successful lipid 
peroxidation. Thus, due to the sensitivity of this assay, a contaminant like sulphite, 
even at a very low level that could interfere with this oxidative process will retard 
linoleic acid oxidation with a subsequent lack of measurable peroxides. The next step 
would be to test this hypothesis by carrying out further analysis for the presence of 
sulphite by using ion chromatography or other suitable method. 
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Figure 5.3. Infrared spectrum of an `inactive' batch of linoleic acid that did 
not generate the formation of hydroperoxides in the lipid peroxide assay used 
to test the antioxidant activity of the plant extracts on linoleic acid oxidation. 
The double peak that appears between bands 650-750cm"1 does not appear on 
the infrared spectrum shown in Figure 5.4. 
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Figure 5.4. Infrared spectrum of an `active' batch of linoleic acid that 
successfully generated the formation of hydroperoxides in the lipid peroxide 
assay used to test the antioxidant activity of the plant extracts on linoleic acid 
oxidation. The chemical formula shown relates to the best match the software 
found in the database, i. e. the match index was only 815.32 out of a possible 
1000. At this level compound identification becomes speculative. The double 
peak between bands 650-750cm-' in Figure 5.3 is absent from the above 
infrared spectrum. 
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CHAPTER 6: GENERAL DISCUSSION 
Osteoarthritis is the most common form of joint disease strongly associated with ageing 
(Doherty, 2001). Cartilage degeneration is a hallmark of cartilage-ageing and 
osteoarthritis (Tiku et al, 2000). Degeneration of articular cartilage in osteoarthritis is 
accompanied by chronic pain and significant disability. Reactive oxygen species are 
implicated in both cartilage ageing and the pathogenesis of osteoarthritis (Tiku et al, 
2000). Conclusions from a systematic review (Long et al, 2001) on herbal medicine 
used for the treatment of osteoarthritis and a pilot study (Bell et al, 1999) investigating 
herbal treatment outcomes present promising evidence for the effective use of some 
herbal preparations for the treatment of this condition. Since in vitro evidence linking 
chondrocyte lipid peroxidation to cartilage matrix protein (collagen) oxidation and 
degradation suggests that chain breaking antioxidants have a preventive role (Tiku et al, 
2000), the effectiveness of herbal remedies traditionally used in its treatment may be 
linked to their antioxidant potential. Phytochemical analysis of the crude plant extracts 
of the selected plants all showed the presence of a number of phenolic compounds 
including flavonoids, identified firstly by TLC via comparison with authentic samples 
and then by HPLC. Preliminary results indicate that all the crude plant extracts have 
promising antioxidant activity on both the DPPH radical and linoleic acid oxidation, 
thus making them ideal defence agents against peroxyl radical-mediated pathological 
disorders including osteoarthritis, where lipid peroxidation-linked damage plays a 
causative role (Tiku et al, 2000). 
The everyday practice of herbal medicine, as discussed in Chapter 2, involves a multi- 
faceted approach to treatment by means of a prescription containing herbs which have a 
broad range of appropriate actions. Although the plants selected for this study would be 
included in an herbal prescription for their range of different actions (section 2.2.2), 
their collective antioxidant properties may fulfil one of the main treatment objectives for 
osteoarthritis, the reduction of inflammation. The superoxide radical is overproduced in 
inflammation as a result of the bactericidal action of activated phagocytes (Javanovic et 
al, 1998). Although the healthy cell is generally capable of maintaining the balance of 
production and inactivation of the superoxide radical, when it is overproduced, cell 
damage can occur if the excess radicals are not inactivated. A study by Kucera (1998) 
investigating a link between inflammation and the inadequate breakdown of superoxide 
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revealed a severe defect in superoxide degeneration in the articular exudates of patients 
with active synovitis. One of the working hypotheses in the beneficial effects of herbal 
extracts in inflammation is that the excess superoxide is eliminated by the flavonoids 
(Jovanovic et al, 1998) and the inactivation of the superoxide radical by flavonoids has 
been thoroughly studied (Tsujimotov et al., 1993; Jovanovic et al, 1994). Flavonoids 
reduce the superoxide radical to produce hydrogen peroxide and the flavonoid radical 
(Jocanovic et al, 1994). The mechanism of these reactions appears to be electron 
transfer (Jocanovic et al, 1994) and this was the mechanism of action tested in this study 
by the DPPH assay. Since all the extracts of the selected plants tested were shown 
significantly to reduce the DPPH radical, they may also be effective in the reduction of 
inflammation associated with osteoarthritis, thus supporting their traditional use in the 
treatment of this condition. A number of methods are available for the measurement of 
superoxide radicals (Halliwell, 1990). Having established a possible link between the 
antioxidant and anti-inflammatory activity of the selected plant extracts, it is now 
important to carry out further work to evaluate the influence of these extracts on the 
generation of the superoxide radical in conjunction with their ability to scavenge 
hydrogen peroxide, one of its primary metabolites. 
In spite of the widely acclaimed antioxidant effect of flavonoids, in Western Herbal 
Medicine the therapeutic potential of most flavonoid-containing plants is not attributed 
to the flavonoid fraction alone, but rather to the synergistic interaction of a complex 
mixture of chemically different compounds. As a result, although the crude plant 
extracts tested in this study have shown marked antioxidant activity and given that this 
is not the form in which herbs are generally administered as medicines, the antioxidant 
effects of these extracts were compared with tinctures commonly used by herbalists to 
investigate if they exhibit similar levels of antioxidant activity. The results suggest that 
the crude plant extracts in almost all cases appeared to be more active as antioxidants 
than the tinctures in vitro. Whether this is the case in vivo is a matter of conjecture. In 
recent years there has been intensive discussion regarding the comparability of herbal 
medicine products (Vierling et al, 2003). For the production of equally effective herbal 
medicines, it is recommended that not only the active substance, but also the following 
parameters of the finished product are equivalent: mass of native extract, auxiliary 
substances and administered form and daily dose (Vierling et al. 2003). At least this 
goes some way to producing comparable products, but no specific information appears 
to be available on the optimal alcohol-water mixtures required to facilitate the efficient 
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extraction of the active constituents from the individual medicinal plants (Bilia et al, 
2001). This was clearly reflected in most of the results obtained from the 
phytochemical analysis of the commercial tincture extracts, which generally contained 
fewer detected compounds than their crude plant extract counterparts. Although this 
problem has been recognised, phytochemical research is still in its infancy and there is 
only a small amount of published literature addressing this issue (Bilia et al, 2001; 
Vierling et al, 2003). Although the crude plant extracts generally demonstrated higher 
levels of antioxidant activity than the commercial tinctures at identical doses in vitro, 
pharmacological effects in vivo may, or may not be comparable. A study by Vierling 
(2003), investigating the pharmaceutical and pharmacological equivalence of different 
Hawthorn extracts obtained by the same method but using different solvents, showed 
that the extract with a lower quantity of the active compounds measured had a 
comparatively lower potency but similar efficacy on cardiotonic activity in laboratory 
animals. Because efficacy cannot be scientifically proven by the parameters accepted 
by orthodox medicine, the relationship between efficacy and dosage is difficult to 
evaluate in herbal medicine. Providing herbal medicines are pharmaceutically 
comparable, the question of efficacy may be an issue of clinical observation via 
controlled clinical trials. The results of this study show that the solvent-water mixtures 
used as the extraction solvents affected the resulting spectra of constituents, particularly 
the commercial tincture extracts. There is no statutory method of tincture production in 
the U. K. however, so the results reported cannot be extrapolated to other products or 
manufacturers. As the use of complementary therapies, especially herbal remedies, 
increases in the U. K., there is a need to increase efforts to develop more standardisation 
of methods for the preparation of phytomedicines, particularly tinctures that are 
administered as the ingredients of many liquid formulations. 
In traditional holistic healthcare, the use of herbal formulae has been the practice for 
hundreds of years. For example, in both traditional Chinese and Western herbal 
medicine single herbs are rarely prescribed but combinations are routinely used for the 
treatment of patients. The concept of combining herbs in this way is not only the 
polyvalent action of the multi-constituents but the assumed synergistic interaction of all 
the compounds. Until very recently, outside traditional medicine, the use of single- 
substance therapy was the accepted philosophy of classic medicine. During the last 
decade, this treatment approach has seen a shift of emphasis to the treatment of patients 
with drug combinations that have been shown to be therapeutically synergistic (Wagner, 
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2004), with the result that the concept of synergy, a vital feature of phytotherapy, is 
gradually being more widely accepted. The therapeutic superiority of many plant 
extracts over single isolated constituents is now being recognised along with the 
potency and efficacy of mixtures of herbs (Williamson, 2001; Wagner, 2004). Much of 
our knowledge of plant interactions is still theoretical rather than practical and the 
acceptance of the concept of plant synergy requires scientific evidence. Although the 
limitations of method are appreciated, the results of this study imply synergistic 
interactions may have occurred, both positively and negatively between some pairs of 
crude plant extracts that involved an increase or decrease in antioxidant activity against 
lipid peroxidation, demonstrated in vitro via linoleic acid oxidation. The combination 
of crude plant extracts containing certain flavonoid classes appeared to be less 
compatible than others. It cannot be predicted however, how these combinations would 
interact in mixtures greater than the two extracts tested, especially if the additional 
extracts also contained further types of flavonoid. To explore the interactions already 
demonstrated, the use of dose-response curves now used by many workers in the field 
may be the next appropriate step (Williamson, 2001; Savalev et at, 2003). Since it is 
not possible to translate in vitro observations into the reality of the human situation 
however (Rice-Evans, 2001), the best evidence for synergy is demonstrated by results 
obtained from clinical trials. 
Thus, the proof of efficacy of the selected plants investigated in this study may now 
need to be substantiated by scientific evidence via controlled clinical trials that conform 
to the standards outlined by the House of Lords Select Committee Report on 
Complementary and Alternative Medicine (2000). 
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CONCLUSION 
Knowledge in regard to the aetiology of disease has substantially increased over the last 
50 years, particularly in identifying the role of reactive oxygen species, now thought to 
be critically involved in the causation and the progression of numerous diseases, and the 
role of antioxidants as a defence system against them. Due to a paucity of scientific 
research, Medical Herbalists still, to a large degree, rely on anecdotal evidence in their 
prescribing of plant remedies. Osteoarthritis is a common degenerative disease where 
free radical damage has now been partly implicated. This study chose to establish a link 
between the aetiology of osteoarthritis, and the therapeutic efficacy of a small selection 
of plants traditionally used by herbalists in its treatment. These results show that the 
extracts of all the plants tested contained a selection of phenolic compounds including 
flavonoids known to possess antioxidant activity and also demonstrated their 
antioxidant activity in vitro. Although it is not always feasible to extrapolate in vitro 
results to in vivo, it is possible that these medicinal plants, when administered as 
medicines, may be acting therapeutically as antioxidants by contributing to anti- 
inflammatory activity and by halting the destructive process of lipid peroxidation. 
Since the antioxidant assays used in this study represent only two antioxidant 
mechanisms, it may be important to understand how these plant extracts also perform in 
assays for superoxide scavenging, scavenging of hydrogen peroxide, hydroxyl radical 
scavenging activity and chain reaction termination of lipid peroxidation using another 
method such as the liposome model system. 
Herbal remedies are most commonly administered by herbalists as tinctures. These 
results show that the selected plants tested as crude plant extracts were more effective as 
antioxidants in vitro than the tincture extracts. The method of extraction clearly affected 
the resultant constituent profile of the extract raising concerns not only of potency but 
also of efficacy in terms of the possible levels of dosages required to achieve a 
therapeutic effect. Additionally, in regard to quality, with currently no standardised 
methods of production or accepted measure of quality in place for the manufacture of 
tinctures for use by herbalists in their prescribing, there is no guarantee of either their 
potency or efficacy. There is an urgent need for work to be carried out in regard to the 
optimization of the alcohol ratio and extraction procedure of the herbs formulated as 
tinctures that are popularly used by Herbal Practitioners. Traditional methods of 
preparation should be explored as a possible baseline for production. Higher standards 
219 
of quality control are required which include some phytochemical analysis and 
exploration of the chemical stability of the finished product during storage, to ensure the 
production of an efficacious product. Augmentation of the recently introduced EU 
Directive on Traditional Herbal Medicine Products should improve manufacturing 
quality control generally. The author strongly recommends encouragement of Herbal 
Practitioners to the use of standardised extracts to ensure both consistency of quality 
and dosage and to make treatment outcomes easier to evaluate. 
Our understanding of connections between the antioxidant compounds in herbs, their 
antioxidant capacity and their impact on the body's ability to resist oxidative damage is 
still poorly understood. Although the results of this in vitro study suggest that higher 
doses of the tincture formulations may be required than the crude plant extracts to 
obtain a therapeutic effect, it is not clear if reduced potency will necessarily affect their 
therapeutic efficacy in vivo. Further research is warranted into the efficacy of different 
types of herbal extracts and their pharmacological effects in vivo particularly in regard 
to their bioequivalence. 
Phytochemical analysis showed that the plants in this study have the potential to provide 
humans with a broad range of antioxidant compounds and it is probable that, with such 
a mixture of antioxidants, they will enhance a diverse number of physiological 
activities. Administering the plants as whole plant extracts is likely to be associated with 
the best promotion of health, especially since research suggests that these compounds 
are likely to work synergistically. It is also probable that, due to the complex nature of 
a natural plant extract, some compounds may still be unidentified. Statistical analysis 
of the results of experimental work carried out to compare the antioxidant activity of 
single plant extracts against a combination of two extracts tested together indicated that 
interactions of both a synergistic and antagonistic nature may have occurred. For more 
conclusive results, all the two herb combinations should now be tested at a range of 
concentrations to confirm the initial observations. Interactions between key compounds 
isolated from the pairs of extracts exhibiting synergy or antagonism can then be 
explored. 
Herbalists use combinations of medicinal plant extracts in the belief that synergy 
between the various components of the mixture occurs. Due to the variety of 
phytochemicals in each plant extract however, and the possibility that they may act 
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simultaneously, the interactive effects of these substances would appear to be complex 
and difficult to unravel. Given that the efficacy of some herbal mixtures may in part be 
attributed to synergy, the answer to why or how this occurs is likely to be the subject of 
research and conjecture for some time to come. 
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